Recent Updates


Class Action Reports

OCGN Class Action: Learn About the Ocugen Lawsuit

Levi & Korsinsky, LLP

June 21, 2021

Levi & Korsinsky, LLP announces that an OCGN class action lawsuit has been filed on behalf of investors who purchased Ocugen, Inc. (OCGN) securities between February 2, 2021, and June 10, 2021, For more on the OCGN Lawsuit please contact us today.

 

According to the Ocugen lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) the information submitted to the U.S. Food and Drug Administration (“FDA”) was insufficient to support an Emergency Use Authorization (“EUA”), (ii) Ocugen would not file a EUA with the FDA, (iii) as a result of the foregoing, the Company’s financial statements, as well as Defendants’ statements about Ocugen’s business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE OCGN CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Ocugen you have until August 17, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

RLX Class Action: Learn About the RLX Lawsuit

Levi & Korsinsky, LLP

June 17, 2021

Levi & Korsinsky, LLP announces that an RLX class action lawsuit has been filed on behalf of investors who purchased RLX American Depository Shares pursuant or traceable to the documents issued in connection with RLX’s January 2021 initial public stock offering. For more on the RLX Lawsuit please contact us today.

 

According to the RLX lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: According to the filed complaint: the Company’s then-existing exposure to China’s ongoing campaign to establish a national standard for e-cigarettes, which would bring them into line with ordinary cigarette regulations, and that RLX’s reported financials were not nearly as robust as the offering materials projected, nor were they indicative of future results. As a result, investors purchased RLX shares at artificially inflated prices.

 

TO LEARN MORE ABOUT THE RLX CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in RLX you have until August 9, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

NTNX Class Action: Learn About the Nutanix Lawsuit

Levi & Korsinsky, LLP

June 15, 2021

Levi & Korsinsky, LLP announces that an NTNX class action lawsuit has been filed on behalf of investors who purchased Nutanix, Inc. (NTNX) securities between November 30, 2017, and May 30, 2019. For more on the NTNX Lawsuit please contact us today.

 

This securities fraud class action arises from misrepresentations and omissions made by Defendants during the class period intended to misrepresent and/or conceal from investors Nutanix’s rapidly declining sales pipeline and revenue. Among other things, Defendants: 1) knowingly concealed from investors that Nutanix’s purported strong sales hiring was woefully inadequate because a large portion of the Company’s hiring was to replace sales representatives who were leaving, rather than growing the sales force needed to achieve targeted revenue growth; 2) made the undisclosed decision to keep critical spending for lead generation activities “flat” so that Nutanix could divert those funds to the research and development of its public cloud product; and 3) told investors that Nutanix had “experienced record sales productivity”, despite their knowledge to the contrary.

 

TO LEARN MORE ABOUT THE NTNX CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Nutanix you have until August 10, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

FREQ Class Action: Learn About the Frequency Therapeutics Lawsuit

Levi & Korsinsky, LLP

June 7, 2021

Levi & Korsinsky, LLP announces that a FREQ class action lawsuit has been filed on behalf of investors who purchased Frequency Therapeutics, Inc.  (FREQ) securities between November 16, 2020 – March 22, 2021. For more on the FREQ Lawsuit please contact us today.

 

According to the Frequency Therapeutics lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: According to the filed complaint, during the class period, Frequency Therapeutics, Inc. made materially false and/or misleading statements and/or failed to disclose that: the Company’s Phase 2a trial results failed to live up to the Company’s expectations as the results revealed no discernable difference between FX-322 and the placebo. In spite of the disappointing results, the Company continued to conduct the Phase 2a study while releasing positive statements in earnings calls, press releases, SEC filings, and pharmaceutical presentations about FX-322’s potential. These statements materially misled the market and artificially inflated the value of Frequency’s common stock.

 

TO LEARN MORE ABOUT THE FREQ CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Frequency Therapeutics you have until August 2, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

SPCE Class Action: Learn About the Virgin Galactic Lawsuit

Levi & Korsinsky, LLP

June 2, 2021

Levi & Korsinsky, LLP announces that an SPCE class action lawsuit has been filed on behalf of investors who purchased Virgin Galactic Holdings, Inc. (SPCE) securities between October 26, 2019, and April 30, 2021. For more on the SPCE Lawsuit please contact us today.

 

According to the Virgin Galactic lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) for accounting purposes, Social Capital Hedosophia Holdings Corp.’s (“SCH”) warrants were required to be treated as liabilities rather than equities; (ii) Virgin Galactic had deficient disclosure controls and procedures and internal control over financial reporting; (iii) as a result, the Company improperly accounted for SCH warrants that were outstanding at the time of the business combination; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE SPCE CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Virgin Galactic you have until July 27, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

WPG Class Action: Learn About the Washington Prime Group, Inc. Lawsuit

Levi & Korsinsky, LLP

May 26, 2021

Levi & Korsinsky, LLP announces that a WPG class action lawsuit has been filed on behalf of investors who purchased Washington Prime Group, Inc.  (WPG) securities between November 5, 2020, and March 4, 2021. For more on the WPG Lawsuit please contact us today

 

According to the Washington Prime Group, Inc. lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:  (1) WPG’s financial condition was deteriorating substantially; (2) as a result, there was substantial uncertainty about the Company’s ability to meet its capital structure obligations as they become due; and (3) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE WPG CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Washington Prime Group, Inc. you have until July 23, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

PRVB Class Action: Learn About the Provention Bio Lawsuit

Levi & Korsinsky, LLP

May 25, 2021

Levi & Korsinsky, LLP announces that a PRVB class action lawsuit has been filed on behalf of investors who purchased Provention Bio, Inc. (PRVB) securities between November 2, 2020 – April 8, 2021. For more on the PRVB Lawsuit please contact us today.

 

According to the Provention Bio lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) the teplizumab Biologics License Application (“BLA”) was deficient in its submitted form and would require additional data to secure U.S. Food and Drug Administration approval; (ii) accordingly, the teplizumab BLA lacked the evidentiary support the Company had led investors to believe it possessed; (iii) the Company had thus overstated the teplizumab BLA’s approval prospects and hence the commercialization timeline for teplizumab; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE PRVB CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Provention Bio you have until July 20, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

UI Class Action: Learn About the Ubiquiti Lawsuit

Levi & Korsinsky, LLP

May 24, 2021

Levi & Korsinsky, LLP announces that a UI class action lawsuit has been filed on behalf of investors who purchased Ubiquiti Inc. (UI) securities between January 11, 2021, and March 20, 2021. For more on the UI Lawsuit please contact us today.

 

According to the Ubiquiti lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company had downplayed the data breach in January 2021; (2) attackers had obtained administrative access to Ubiquiti’s servers and obtained access to, among other things, all databases, all user database credentials, and secrets required to forge single sign-on (SSO) cookies; (3) as a result, intruders already had credentials needed to remotely access Ubiquiti’s customers’ systems; and (4) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE UI CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Ubiquiti you have until July 19, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

WISH Class Action: Learn About the Contextlogic Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a WISH class action lawsuit has been filed on behalf of investors who purchased Contextlogic Inc.(WISH) securities between December 16, 2020, and May 12, 2021. For more on the WISH Lawsuit please contact us today.

 

According to the Contextlogic lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: In the registration statement and prospectus used to conduct the initial public offering and throughout the class period, defendants made materially false and misleading statements about the strength of ContextLogic’s business operations and financial prospects by overstating its then-present monthly active users (“MAUs”) and MAU growth trends.

 

TO LEARN MORE ABOUT THE WISH CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Contextlogic you have until July 16, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

ARRY Class Action: Learn About the Array Tech Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that an ARRY class action lawsuit has been filed on behalf of investors who purchased Array Technologies, Inc. (ARRY) securities between October 14, 2020, and May 11, 2021, For more on the ARRY Lawsuit please contact us today.

 

According to the Array Tech lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: Defendants repeatedly and consistently painted a materially misleading picture of the Company’s business and prospects that did not reflect rising steel and freight costs. After the October 2020 initial public offering, the December 2020 offering and the March 2021 offering, and subsequent to the class period, Array disclosed that it was experiencing increases in steel prices and substantial increases in the cost of both ocean and truck freight that in turn were having a material impact on its margins for the foreseeable future. This caused Array to miss profit expectations and withdraw its full-year outlook. As a result of Defendants’ wrongful acts and omissions and the precipitous decline in the market value of the Company’s securities, shareholders have suffered significant losses and damages.

 

TO LEARN MORE ABOUT THE ARRY CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Array Tech you have until July 13, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

DNMR Class Action: Learn About the Danimer Scientific Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a DNMR class action lawsuit has been filed on behalf of investors who purchased Danimer Scientific, Inc. (DNMR) securities between October 5, 2020, and May 4, 2021. For more on the DNMR Lawsuit please contact us today.

 

 

According to the Danimer Scientific lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) Danimer had deficient internal controls; (ii) as a result, the Company had misrepresented, inter alia, its operations’ size and regulatory compliance; (iii) Defendants had overstated Nodax’s biodegradability, particularly in oceans and landfills; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE DNMR CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Danimer Scientific you have until July 13, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

ATER Class Action: Learn About the Aterian Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that an ATER class action lawsuit has been filed on behalf of investors who purchased Aterian, Inc.(ATER) securities between December 1, 2020, and May 3, 2021. For more on the ATER Lawsuit please contact us today.

 

According to the Aterian lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) the Company’s organic growth is plummeting; (ii) the Company’s recent, self-lauded acquisitions were overpayments for flawed assets from questionable sources; (iii) Aterian’s purported artificial intelligence software is a flawed product that lacks customer interest; (iv) Aterian uses rebate programs and paid or artificial reviews to pump up their product offerings; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE ATER CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Aterian you have until July 12, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

PCT Class Action: Learn About the PureCycle Lawsuit

Levi & Korsinsky, LLP

May 17, 2021

Levi & Korsinsky, LLP announces that a PCT class action lawsuit has been filed on behalf of investors who purchased PureCycle Technologies, Inc. (PCT) securities between November 16, 2020, and May 5, 2021. For more on the PCT Lawsuit please contact us today.

 

According to the PureCycle lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) the technology PureCycle licensed from Procter & Gamble is not proven and presents serious issues even at lab scale; (ii) the challenges posed by the availability and competition for the raw materials necessary to commercialize the licensed technology are significant; (iii) PureCycle’s financial projections are baseless; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE PCT CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in PureCycle you have until July 12, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

SKLZ Class Action: Learn About the Skillz Inc Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that an SKLZ class action lawsuit has been filed on behalf of investors who purchased Skillz Inc. f/k/a Flying Eagle Acquisition Corp. (SKLZ) securities between December 16, 2020, and April 19, 2021. For more on the SKLZ Lawsuit please contact us today.

 

According to the Skillz Inc lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose those: Representations relating to certain of Skillz’s business operations, performance metrics and ultimate valuation, including, among others, Skillz’s ability to attract new end-users, future profitability, the shrinking popularity of its hosted games that accounted for 88% of its revenue, and the Company’s valuation. For example, one of the Company’s objectively unrealistic promises included the unsupportable claim that the Company was valued at $3.5 billion, based on revenue projections in excess of $550 million for 2022. However, the Company failed to inform investors that downloads of the games that account for a majority share of its revenue have been declining since at least November 2020. In reality, the Company’s prospects for attaining that revenue scale was far from realistic given its size, market share, reliance on third-party app stores, declining downloads of its most popular games and, critically, the enormous amount of incentive Bonus Payments that Skillz routinely provides to its gamer customers, a fact that investors were misled about. These Bonus Payments are routinely provided to its customers, who are expected to use them for game entry fees, which, in turn, artificially inflates Skillz revenue.

 

TO LEARN MORE ABOUT THE SKLZ CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Skillz Inc you have until July 7, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

CCIV Class Action: Learn About the Churchill Capital Lawsuit

Levi & Korsinsky, LLP

May 10, 2021

Levi & Korsinsky, LLP announces that a CCIV class action lawsuit has been filed on behalf of investors who purchased Churchill Capital Corp IV (CCIV) securities between January 11, 2021, and February 22, 2021. For more on the CCIV Lawsuit please contact us today.

 

According to the Churchill Capital lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Lucid was not prepared to deliver vehicles by spring of 2021; (2) Lucid was projecting production of 557 vehicles in 2021 instead of the 6,000 vehicles touted in the run-up to the merger with Churchill; and (3) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

 

TO LEARN MORE ABOUT THE CCIV CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Churchill Capital you have until June 18, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

CCXI Class Action: Learn About the ChemoCentryx Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a CCXI class action lawsuit has been filed on behalf of investors who purchased ChemoCentryx, Inc. (CCXI) securities between November 26, 2019, and May 3, 2021. For more on the CCXI Lawsuit please contact us today.

 

According to the ChemoCentryx lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the study design of the Phase III ADVOCATE trial presented issues about the interpretability of the trial data to define a clinically meaningful benefit of avacopan and its role in the management of ANCA-associated vasculitis; (2) the data from the Phase III ADVOCATE trial raised serious safety concerns for avacopan; (3) these issues presented a substantial concern regarding the viability of ChemoCentryx’s New Drug Application (“NDA”) for avacopan for the treatment of ANCA-associated vasculitis; and (4) as a result of the foregoing, Defendants’ public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE CCXI CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in ChemoCentryx you have until July 6, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

PTON Class Action: Learn About the Peloton Lawsuit

Levi & Korsinsky, LLP

May 5, 2021

Levi & Korsinsky, LLP announces that a PTON class action lawsuit has been filed on behalf of investors who purchased Peloton Interactive, Inc.  (PTON) securities between September 11, 2020, and April 16, 2021. For more on the PTON Lawsuit please contact us today.

 

According to the Peloton lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) in addition to the tragic death of a child, Peloton’s Tread+ had caused a serious safety threat to children and pets as there were multiple incidents of injury to both; (2) safety was not a priority to Peloton as defendants were aware of serious injuries and death resulting from the Tread+, yet did not recall or suggest a halt of the use of the Tread+; (3) as a result of the safety concerns, the U.S. Consumer Product Safety Commission (“CPSC”) declared that the Tread+ posed a serious risk to public health and safety and urgently recommended that consumers with small children cease using the Tread+; (4) the CPSC also found a safety threat to Tread+ users if they lost their balance; and (5) as a result of the foregoing, defendants’ statements about Peloton’s business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

 

TO LEARN MORE ABOUT THE PTON CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Peloton you have until June 28, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

VRUS Class Action: Learn About the Verus International Lawsuit

Levi & Korsinsky, LLP

April 27, 2021

Levi & Korsinsky, LLP announces that a VRUS class action lawsuit has been filed on behalf of investors who purchased Verus International, Inc. (VRUS) securities between June 17, 2019, and November 8, 2020. For more on the VRUS Lawsuit please contact us today.

 

According to the Verus International lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) Verus lacked the requisite resources, infrastructure and/or expertise to exploit its Big League Foods brand and its MLB license; (ii) the Company issues in production ramp-up were not fully resolved to enable the Company to fulfil customer orders; (iii) as a result, the Company’s prospects and outlook were not as represented; (iv) the Company’s internal controls for financial reporting and accounting were not sufficient with specific respect to stock-based compensation and classification of equity instruments; (v) as a result, the Company’s financial results, outlook and prospects were materially worse than represented; and (vi) as a result of the foregoing, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE VIRUS CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Verus International you have until June 22, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

SOS Class Action: Learn About the SOS Limited Lawsuit

Levi & Korsinsky, LLP

April 23, 2021

Levi & Korsinsky, LLP announces that an SOS class action lawsuit has been filed on behalf of investors who purchased SOS Limited (SOS) securities between July 22, 2020 – February 25, 2021. For more on the SOS Lawsuit please contact us today.

 

According to the SOS Limited lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) SOS had misrepresented the true nature, location, and/or existence of at least one of the principal executive offices listed in its SEC filings; (ii) HY and FXK were either undisclosed related parties and/or entities fabricated by the Company; (iii) the Company had misrepresented the type and/or existence of the mining rigs that it claimed to have purchased; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE SOS CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in SOS Limited you have until June 1, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

RMO Class Action: Learn About the Romeo Power Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that an RMO class action lawsuit has been filed on behalf of investors who purchased Romeo Power, Inc. (RMO) securities between October 5, 2020, and March 30, 2021. For more on the RMO Lawsuit please contact us today.

 

According to the Romeo Power lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) Romeo had only two battery cell suppliers, not four, (ii) the future potential risks that Defendants warned of concerning supply disruption or shortage had already occurred and were already negatively affecting Romeo’s business, operations and business prospects, (iii) Romeo did not have the battery cell inventory to accommodate end-user demand and ramp up production in 2021, (iv) Romeo’s supply constraint was a material hindrance to Romeo’s revenue growth, and (v) Romeo’s supply chain for battery cells was not hedged, but in fact, was totally at risk and beholden to just two battery cell suppliers and the spot market for their 2021 inventory. Given the supply constraint that Romeo was experiencing during the Class Period, Defendants had no reasonable basis to represent that the Company had the ability to meet customer demand and that it would support growth in revenue in 2021.

 

TO LEARN MORE ABOUT THE RMO CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Romeo Power you have until June 15, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

EBS Class Action: Learn About the Emergent Bio Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that an EBS class action lawsuit has been filed on behalf of investors who purchased Emergent Biosolutions Inc. (EBS) securities between July 6, 2020, and March 31, 2021. For more on the EBS Lawsuit please contact us today.

 

According to the Emergent Bio lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) Emergent’s Baltimore plant had a history of manufacturing issues increasing the likelihood for massive contaminations; (ii) these longstanding contamination risks and quality control issues at Emergent’s facility led to a string of FDA citations; (iii) the Company previously had to discard the equivalent of millions of doses of COVID-19 vaccines after workers at the Baltimore plant deviated from manufacturing standards; and (iv) as a result of the foregoing, Defendants’ public statements about Emergent’s ability and capacity to mass manufacture multiple COVID-19 vaccines at its Baltimore manufacturing site were materially false and/or misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE EBS CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Emergent Bio you have until June 18, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

ACAD Class Action: Learn About the Acadia Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that an ACAD class action lawsuit has been filed on behalf of investors who purchased Acadia Pharmaceuticals Inc. (ACAD) securities between June 15, 2020, and April 4, 2021. For more on the ACAD Lawsuit please contact us today.

 

According to the Acadia lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) the materials submitted in support of the pimavanserin sNDA contained statistical and design deficiencies; (ii) accordingly, the pimavanserin sNDA lacked the evidentiary support that the Company had led investors to believe it possessed; (iii) the FDA was unlikely to approve the pimavanserin sNDA in its present form; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE ACAD CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Acadia you have until June 18, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

CS Class Action: Learn About the Credit Suisse Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a CS class action lawsuit has been filed on behalf of investors who purchased Credit Suisse Group AG (CS) securities between October 29, 2020, and March 31, 2021. For more on the CS Lawsuit please contact us today.

 

According to the Credit Suisse lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: Defendants concealed material defects in the Company’s risk policies and procedures and compliance oversight functions and efforts to allow high-risk clients to take on excessive leverage, including Greensill Capital (“Greensill”) and Archegos Capital Management (“Archegos”), exposing the Company to billions of dollars in losses.

 

TO LEARN MORE ABOUT THE CS CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Credit Suisse you have until June 15, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

CAN Class Action: Learn About the Canaan Lawsuit

Levi & Korsinsky, LLP

April 19, 2021

Levi & Korsinsky, LLP announces that a CAN class action lawsuit has been filed on behalf of investors who purchased Canaan Inc.  (CAN) securities between February 10, 2021, and April 9, 2021. For more on the CAN Lawsuit please contact us today.

 

According to the Canaan lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: The complaint alleges that throughout the class period Defendants issued materially false and/or misleading statements and/or failed to disclose that: they concealed that due to ongoing supply chain disruptions and the introduction of the Company’s next-generation A12 series bitcoin mining machines – which had cannibalized sales of the older product offerings – Canaan’s 4Q20 sales had declined more than 93% year-over-year compared to its fourth-quarter fiscal year 2019 (“4Q19”) sales and more than 93% quarter-over-quarter compared to its third-quarter FY20 (“3Q20”) sales.

 

TO LEARN MORE ABOUT THE CAN CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Canaan you have until June 14, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

FGEN Class Action: Learn About the FibroGen Lawsuit

Levi & Korsinsky, LLP

April 14, 2021

Levi & Korsinsky, LLP announces that an FGEN class action lawsuit has been filed on behalf of investors who purchased FibroGen, Inc. (FGEN) securities between November 8, 2019 – April 6, 2021 For more on the FGEN Lawsuit please contact us today.

 

According to the FibroGen lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) the Company’s prior disclosures of U.S. primary cardiovascular safety analyses from the roxadustat Phase 3 program for the treatment of anemia certain safety analyses submitted in connection with CKD included post-hoc changes to the stratification factors; (ii) FibroGen’s analyses with the pre-specified stratification factors result in higher hazard ratios (point estimates of relative risk) and 95% confidence intervals; (iii) based on these analyses the Company could not conclude that roxadustat reduces the risk of (or is superior to) MACE+ in dialysis, and MACE and MACE+ in incident dialysis compared to epoetin-alfa; (iv) as a result, the Company faced significant uncertainty that its NDA for roxadustat as a treatment for anemia of CKD would be approved by the FDA; and (v) as a result of the foregoing, Defendants’ statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE FGEN CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in FibroGen you have until June 11, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

DOX Class Action: Learn About the Amdocs Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a DOX class action lawsuit has been filed on behalf of investors who purchased Amdocs Limited (DOX) securities between December 13, 2016, and March 30, 2021. For more on the DOX Lawsuit please contact us today.

 

According to the Amdocs lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) Amdocs overstated its profits, cash, and liquidity while understating its debt; (ii) Amdocs concealed its large borrowing; (iii) while Amdocs’ reported results showed that it’s North American business was stable, that business was actually deteriorating annually, in part because the Company was losing AT&T as a customer; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE DOX CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Amdocs you have until June 8, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

EBON Class Action: Learn About the Ebang International Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that an EBON class action lawsuit has been filed on behalf of investors who purchased Ebang International Holdings Inc. (EBON) securities between June 26, 2020, and April 5, 2021. For more on the EBON Lawsuit please contact us today.

 

According to the Ebang International lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the proceeds from Ebang’s public offerings had been directed to a low yield, long term bonds to an underwriter and to related parties rather than used to develop the Company’s operations; (2) Ebang’s sales were declining and the Company had inflated reported sales, including through the sale of defective units; (3) Ebang’s attempts to go public in Hong Kong had failed due to allegations of embezzling investor funds and inflated sales figures; (4) Ebang’s purported cryptocurrency exchange was merely the purchase of an out-of-the-box crypto exchange; and (5) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE EBON CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Ebang International you have until June 7, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

DDD Class Action: Learn About the 3d Systems Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a DDD class action lawsuit has been filed on behalf of investors who purchased 3D Systems Corporation (DDD) securities between May 6, 2020, and March 1, 2021. For more on the DDD Lawsuit please contact us today.

 

According to the 3d Systems lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:  (1) 3D Systems lacked proper internal controls over financial reporting; and (2) as a result, 3D Systems’ public statements were materially false and/or misleading at all relevant times.

 

TO LEARN MORE ABOUT THE DDD CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in 3d Systems you have until June 8, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky

Class Action News

Eduard Korsinsky: NY Securities Rulings Don’t Constitute Cyan Backlash

Levi & Korsinsky, LLP

April 9, 2021

Eduard Korsinsky, Managing Partner and Attorney at Levi & Korsinsky, LLP disagrees with premise of a recent Law360 article regarding two recent decisions made by the New York Appellate Division in prospective class actions brought under the federal Securities Act, In the Matter of Sundial Growers Inc. and Lyu v. Ruhnn Holdings Ltd. The decisions suggest that there is a growing backlash against the influx of such suits into state courts following the U.S. Supreme Court’s 2018 decision in Cyan Inc. v. Beaver County Employees Retirement Fund.

Eduard Korsinsky’s Career as a Class Action Attorney

Eduard Korsinsky got his LL.M. Expert of Law(s) Taxation from New York University School of Law in 1997 and his J.D. from Brooklyn Law School in 1995. For over 20 years Mr. Korsinsky has addressed customers in protection cases, subsidiary activities, buyer extortion, and complex business matters. He has accomplished critical recuperations for investors, including a $79 million recuperation for investors of E-Trade Financial Corporation and an installment stepping stool repaying financial backers of Google, Inc. up to $8 billion in misfortunes.

 

He has been named a New York “Super Lawyer” by Thomson Reuters and is perceived as one of the nation’s driving experts in class activity and subordinate issues. Mr. Korsinsky additionally filled in as a proofreader of the American Bar Affiliation’s Securities Litigation Section’s bulletin and is an individual from the American Bar Association’s Derivative Suits Subcommittee.

 

Read more about Eduard Korsinsky and find the full article here


Class Action Reports

GOEV Class Action: Learn About the Canoo Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a GOEV class action lawsuit has been filed on behalf of investors who purchased Canoo Inc. (GOEV) securities between August 18, 2020 and March 29, 2021 For more on the GOEV Lawsuit please contact us today.

 

According to the Canoo lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:  (i) the Company’s engineering services was not a viable business, would not provide meaningful revenue in 2021, and would not reduce operational risk; (ii) the Company would no longer be focused on its subscription-based business model; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE GOEV CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Canoo you have until June 1, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

KDMN Class Action: Learn About the Kadmon Lawsuit

Levi & Korsinsky, LLP

April 7, 2021

Levi & Korsinsky, LLP announces that a KDMN class action lawsuit has been filed on behalf of investors who purchased Kadmon Holdings, Inc. (KDMN) securities between October 1, 2020 – March 10, 2021. For more on the KDMN Lawsuit please contact us today.

 

According to the Kadmon lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) the Belumosudil NDA was incomplete and/or deficient; (ii) the additional new data that the Company submitted in support of the Belumosudil NDA in response to an information request from the FDA materially altered the NDA submission; (iii) accordingly, the initial Belumosudil NDA submission lacked the degree of support that the Company had led investors to believe; (iv) accordingly, the FDA was likely to extend the PDUFA target action date to review the Belumosudil NDA; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE KDMN CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Kadmon you have until June 2, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Eduard Korsinsky New York class action attorney

Class Action News

Eduard Korsinsky: Guide To Monitoring Your Securities Portfolio In 2021

Levi & Korsinsky, LLP

Eduard Korsinsky, Managing Partner and Attorney at Levi & Korsinsky, LLP states that institutional investors play a vital role in monitoring, researching and recovering securities portfolios that result from corporate mismanagement or fraud.  He further suggests that adopting best practices in carrying out their fiduciary responsibilities is the equivalent to earning compound interest.

 

Best practices can include retention of non- exclusive outside firms to monitor investment portfolios, maintaining independent decision-making, and leveraging technology.

Who is Eduard Korsinsky?

As a class action attorney, Eduard Korsinsky, has addressed customers in protection cases, subsidiary activities, shopper misrepresentation and complex business matters. Mr. Korsinsky has been recognized as a New York “Super Lawyer”  and is perceived as one of the nation’s driving professionals in class and subsidiary issues.

 

Ed Korsinsky is a quintessential expert, who assumes his liability to his customers very genuinely. Ed is an astounding tactician who is constantly resolved to viably and productively win decisions for his customers.

 

Learn more about Eduard Korsinsky and read the full article here


Class Action Reports

KRMD Class Action: Learn About the Repro Med Systems Lawsuit

Levi & Korsinsky, LLP

March 31, 2021

Levi & Korsinsky, LLP announces that a KRMD class action lawsuit has been filed on behalf of investors who purchased Repro Med Systems, Inc. (KRMD) securities between August 4, 2020 and January 25, 2021 For more on the KRMD Lawsuit please contact us today.

 

According to the Repro Med Systems lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) starting in January 2020, KORU ramped up the use of allowances, including growth rebates, to retain key customers and to incentivize growth; (2) as the rebates accrued, the Company’s net sales were reasonably likely to decline; and (3) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE KRMD CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Repro Med Systems, you have until May 25, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

ROOT Class Action: Learn About the Root Lawsuit

Levi & Korsinsky, LLP

March 25, 2021

Levi & Korsinsky, LLP announces that a ROOT class action lawsuit has been filed on behalf of investors who purchased Root, Inc (ROOT) securities between October 28, 2020 and March 8, 2021. For more on the ROOT Lawsuit please contact us today.

 

According to the Root lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) Root would foreseeably fail to generate positive cash flow for at least several years following the IPO; (ii) accordingly, the Company would foreseeably require significant cash infusions to meet its cash flow needs; (iii) notwithstanding the Defendants’ touting of Root’s purportedly unique, data-driven advantages, several of the Company’s established industry peers in fact possessed significant competitive advantages over Root with respect to, inter alia, telematics data and data engagement; and (iv) as a result, the Offering Documents and Defendants’ public statements throughout the Class Period were materially false and/or misleading and failed to state information required to be stated therein.

 

TO LEARN MORE ABOUT THE ROOT CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Root you have until May 18, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

VRM Class Action: Learn About the Vroom Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a VRM class action lawsuit has been filed on behalf of investors who purchased Vroom, Inc.  (VRM) securities between November 11, 2020 and March 3, 2021. For more on the VRM Lawsuit please contact us today.

 

According to the Vroom lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Vroom had not demonstrated that it was able to control and scale growth in respect to its salesforce to meet the demand for its products; (2) as a result, the Company was forced to discount aged inventory to move through its retail channels or liquidated in its wholesale channels; (3) as a result, the eCommerce gross profit per unit was reasonably likely to decline; and (4) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE VRM CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Vroom you have until May 21, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

NEPT Class Action: Learn About the Neptune Wellness Lawsuit

Levi & Korsinsky, LLP

March 23, 2021

Levi & Korsinsky, LLP announces that a NEPT class action lawsuit has been filed on behalf of investors who purchased Neptune Wellness Solutions Inc. (NEPT) securities between July 24, 2019 and February 16, 2021. For more on the NEPT Lawsuit please contact us today.

 

According to the Neptune Wellness lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) the cost of Neptune’s integration of the assets and operations acquired in the SugarLeaf Acquisition would be larger than the Company had acknowledged, placing significant strain on the Company’s capital reserves; (ii) accordingly, it was reasonably foreseeable that the company would need to conduct additional stock offerings to raise more capital; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE NEPT CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Neptune Wellness you have until May 17, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

RIDE Class Action: Learn About the Lordstown Motors” Lawsuit

Levi & Korsinsky, LLP

March 19, 2021

Levi & Korsinsky, LLP announces that a RIDE class action lawsuit has been filed on behalf of investors who purchased Lordstown Motors Corp (RIDE) securities between August 3, 2020 and March 17, 2021. For more on the RIDE Lawsuit please contact us today.

 

According to the Lordstown Motors” lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) the Company’s purported pre-orders were non-binding; (ii) many of the would-be customers who made these purported pre-orders lacked the means to make such purchases and/or would not have credible demand for Lordstown’s Endurance; (iii) Lordstown is not and has not been “on track” to commence production of the Endurance in September 2021; (iv) the first test run of the Endurance led to the vehicle bursting into flames within 10 minutes; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE RIDE CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Lordstown Motors you have until May 17, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

CYDY Class Action: Learn About the CytoDyn Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a CYDY class action lawsuit has been filed on behalf of investors who purchased CytoDyn Inc.(CYDY) securities between March 27, 2020 and March 9, 2021. For more on the CYDY Lawsuit please contact us today.

 

According to the CytoDyn lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: The complaint alleges that throughout the class period Defendants issued materially false and/or misleading statements and/or failed to disclose that: CytoDyn securities were actively traded over the counter (OTC) in the United States. While the exact number of Class members is unknown to Plaintiff at this time and can be ascertained only through appropriate discovery, Plaintiff believes that there are hundreds or thousands of members in the proposed Class. Record owners and other members of the Class may be identified from records maintained by CytoDyn or its transfer agent and/or OTC Markets and may be notified of the pendency of this action by mail, using the form of notice similar to that customarily used in securities class actions.

 

TO LEARN MORE ABOUT THE CYDY CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in CytoDyn you have until May 17, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

BLU Class Action: Learn About the BELLUS Health Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a BLU class action lawsuit has been filed on behalf of investors who purchased BELLUS Health Inc.  (BLU) securities between September 5, 2019 and July 5, 2020. For more on the BLU Lawsuit please contact us today.

 

According to the BELLUS Health lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: The complaint alleges that throughout the class period Defendants issued materially false and/or misleading statements and/or failed to disclose that: while BLU-5937’s “high selectivity” contributed to the drug causing little to no taste alteration in chronic cough patients, that high selectivity also contributed to the drug potentially being less efficacious and thus likely not be able to meet the primary endpoint of the Company’s Phase 2 trial.

 

TO LEARN MORE ABOUT THE BLU CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in BELLUS Health you have until May 17, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

VLDR Class Action: Learn About the Velodyne Lidar Lawsuit

Levi & Korsinsky, LLP

March 10, 2021

Levi & Korsinsky, LLP announces that a VLDR class action lawsuit has been filed on behalf of investors who purchased Velodyne Lidar, Inc.  (VLDR) securities between November 9, 2020 and February 19, 2021. For more on the VLDR Lawsuit please contact us today.

 

According to the Velodyne Lidar lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) certain of Velodyne’s directors had failed to operate with respect, honesty, integrity, and candor in their dealings with the Company’s officers and directors; (2) the Company was investigating the foregoing matters; and (3) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE VLDR CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Velodyne Lidar you have until May 3, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

PLUG Class Action: Learn About the Plug Power Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a PLUG class action lawsuit has been filed on behalf of investors who purchased Plug Power Inc. (PLUG) securities between November 9, 2020 and March 1, 2021. For more on the PLUG Lawsuit please contact us today.

 

According to the Plug Power lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company would be unable to timely file its 2020 annual report due to delays related to the review of the classification of certain costs and the recoverability of the right to use assets with certain leases; (2) the Company was reasonably likely to report material weaknesses in its internal control over financial reporting; and (3) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE PLUG CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Plug Power you have until May 7, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

XL Class Action: Learn About the Xl Fleet Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that an XL class action lawsuit has been filed on behalf of investors who purchased Fleet Corp. (XL) securities between October 2, 2020 and March 2, 2021. For more on the XL Lawsuit please contact us today.

 

According to the Xl Fleet lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) XL Fleet’s salespeople were pressured to inflate their sales pipelines to boost the Company’s reported sales and backlog; (2) at least 18 of the 33 customers that XL featured were inactive and had not placed an order since 2019; (3) XL’s technology had been materially overstated and offered only 5% to 10% of fleet savings; (4) XL lacks the supply chain and engineers to roll out new products on the announced timelines; and (5) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE XL CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Xl Fleet you have until May 7, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

LDOS Class Action: Learn About the Leidos Holdings Lawsuit

Levi & Korsinsky, LLP

March 8, 2021

Levi & Korsinsky, LLP announces that an LDOS class action lawsuit has been filed on behalf of investors who purchased Leidos Holdings, Inc. (LDOS) securities between May 4, 2020 and February 23, 2021. For more on the LDOS Lawsuit please contact us today.

 

According to the Leidos Holdings lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the purported benefits of the Company’s acquisition of L3Harris’ Security Detection & Automation businesses were significantly overstated; (2) Leidos’ products suffered from numerous product defects, including faulty explosive detection systems at airports, ports, and borders; (3) as a result of the foregoing, the Company’s financial results were significantly overstated; and (4) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE LDOS CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Leidos Holdings you have until May 3, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

OTRK Class Action: Learn About the Ontrak’s Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a OTRK class action lawsuit has been filed on behalf of investors who purchased Ontrak, Inc. (OTRK) securities between November 5, 2020 – February 26, 2021. For more on the OTRK Lawsuit please contact us today.

 

According to Ontrak’s lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Ontrak’s largest customer evaluated the Company on a provisional basis, valuing Ontrak’s performance based on achieving the lowest cost per medical visit rather than clinical outcomes or medical cost savings; (2) as a result, Ontrak’s largest customer did not find the Company’s program to be effective and was reasonably likely to terminate its contract with Ontrak; (3) because this customer accounted for a significant portion of the Company’s revenue, the loss of the customer would have an outsized impact on Ontrak’s financial results; and (4) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE OTRK CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Ontrak’s you have until May 3, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

ATNX Class Action: Learn About the Athenex Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a ATNX class action lawsuit has been filed on behalf of investors who purchased Athenex, Inc. (ATNX) securities between August 7, 2019 and February 26, 2021. For more on the ATNX Lawsuit please contact us today.

 

According to the Athenex lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:(i) the data included in the Oral Paclitaxel plus Encequidar NDA presented a safety risk to patients in terms of an increase in neutropenia-related sequalae; (ii) the uncertainty over the results of the primary endpoint of objective response rate (ORR) at week 19 conducted by BICR; (iii) the BICR reconciliation and re-read process may have introduced unmeasured bias and influence on the BICR; (iv) that the Company’s Phase 3 study that was used to file the NDA was inadequate and not well-conducted in a patient population with metastatic breast cancer representative of the U.S. population, such that the FDA would recommend a new such clinical trial; (v) as a result, it was foreseeable that the FDA would not approve the Company’s NDA in its current form; and (vi) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE ATNX CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Athenex you have until May 3, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

MPLN Class Action: Learn About the MultiPlan Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a MPLN class action lawsuit has been filed on behalf of investors who purchased Multiplan Corporation F/K/A Churchill Capital Corp. Iii (MPLN) securities between July 12, 2020 – November 10, 2020. For more on the MPLN Lawsuit please contact us today.

 

According to the MultiPlan lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (a) MultiPlan was losing tens of millions of dollars in sales and revenues to Naviguard, a competitor created by one of MultiPlan’s largest customers, UnitedHealthcare, which threatened up to 35% of the Company’s sales and 80% of its levered cash flows by 2022; (b) sales and revenue declines in the quarters leading up to the Merger were not due to “idiosyncratic” customer behaviors as represented, but rather due to a fundamental deterioration in demand for MultiPlan’s services and increased competition, as payors developed competing services and sought alternatives to eliminating excessive healthcare costs; (c) MultiPlan was facing significant pricing pressures for its services and had been forced to materially reduce its take rate in the lead up to the Merger by insurers, who had expressed dissatisfaction with the price and quality of MultiPlan’s services and balanced billing practices, causing the Company’s to cut its take rate by up to half in some cases; (d) as a result of (a)-(c) above, MultiPlan was set to continue to suffer from revenues and earnings declines, increased competition and deteriorating pricing dynamics following the Merger; (e) as a result of (a)-(d) above, MultiPlan was forced to seek continued revenue growth and to improve its competitive positioning through pricey acquisitions, including through the purchase of HST for $140 million at a premium price from a former MultiPlan executive only one month after the Merger; and (f) as a result of (a)-(e) above, Churchill III investors had grossly overpaid for the acquisition of MultiPlan in the Merger, and MultiPlan’s business was worth far less than represented to investors.

 

TO LEARN MORE ABOUT THE MPLN CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in MultiPlan you have until April 26, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

REGI Class Action: Learn About the Renewable Energy Lawsuit

Levi & Korsinsky, LLP

March 4, 2021

Levi & Korsinsky, LLP announces that a REGI class action lawsuit has been filed on behalf of investors who purchased Renewable Energy Group, Inc.  (REGI) securities between May 3, 2018 and February 25, 2021. For more on the REGI Lawsuit please contact us today.

 

According to the Renewable Energy lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) due to failures in the diesel additive system, petroleum diesel was not periodically added to certain loads by the Company and was instead added by the Company’s customers; (2) as a result, Renewable Energy was not the proper claimant for certain BTC payments on biodiesel it sold between January 1, 2017 and September 30, 2020; (3) as a result, Renewable Energy’s revenue and net income were overstated for certain periods; (4) there was a material weakness in the Company’s internal control over financial reporting related to the purchase and use of the petroleum diesel gallons when blending with biodiesel; and (5) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE REGI CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Renewable Energy you have until May 3, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

UAVS Class Action: Learn About the AgEagle Lawsuit

Levi & Korsinsky, LLP

March 2, 2021

Levi & Korsinsky, LLP announces that a UAVS class action lawsuit has been filed on behalf of investors who purchased AgEagle Aerial Systems, Inc.  (UAVS) securities between September 3, 2019 and February 18, 2021. For more on the UAVS Lawsuit please contact us today.

 

According to the AgEagle lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) AgEagle did not have a partnership with Amazon and in fact never had any relationship with Amazon; (2) rather than correct the public’s understanding about a partnership with Amazon, Defendants were actively contributing to the rumour that AgEagle had a partnership with Amazon; and (3) as a result, Defendants’ statements about AgEagle’s business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

 

TO LEARN MORE ABOUT THE UAVS CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in AgEagle you have until April 27, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

IQDNX Class Action: Learn About the Infinity Q’s Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a IQDNX class action lawsuit has been filed on behalf of investors who purchased Infinity Q Diversified Alpha Fund Institutional Class (IQDNX) securities between December 21, 2018 – February 22, 2021. For more on the IQDNX Lawsuit please contact us today.

 

According to the Infinity Q’s lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Infinity Q’s Chief Investment Officer made adjustments to certain parameters within the third-party pricing model that affected the valuation of the swaps held by the Fund; (2) consequently, Infinity Q would not be able to calculate NAV correctly; (3) as a result, the previously reported NAVs were unreliable; (4) because of the foregoing, the Fund would halt redemptions and liquidate its assets; and (5) as a result, the Prospectuses were materially false and/or misleading and failed to state information required to be stated therein.

 

TO LEARN MORE ABOUT THE IQDNX CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Infinity Q’s you have until April 27, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

HSACW Class Action: Learn About the Immunovant Lawsuit

Levi & Korsinsky, LLP

February 26, 2021

Levi & Korsinsky, LLP announces that a HSACW class action lawsuit has been filed on behalf of investors who purchased Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation (HSACW) securities between October 2, 2019 and February 1, 2021. For more on the HSACW Lawsuit please contact us today.

 

According to the Immunovant lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) HSAC had performed inadequate due diligence into Legacy Immunovant prior to the Merger, and/or ignored or failed to disclose safety issues associated with IMVT-1401; (ii) IMVT-1401 was less safe than the Company had led investors to believe, particularly with respect to treating TED and WAIHA; (iii) the foregoing foreseeably diminished IMVT-1401’s prospects for regulatory approval, commercial viability, and profitability; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE HSACW CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Immunovant you have until April 20, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

EBIX Class Action: Learn About the Ebix Lawsuit

Levi & Korsinsky, LLP

February 25, 2021

Levi & Korsinsky, LLP announces that a EBIX class action lawsuit has been filed on behalf of investors who purchased Ebix, Inc. (EBIX) securities between November 9, 2020 and February 19, 2021. For more on the EBIX Lawsuit please contact us today.

 

According to the Ebix lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) that there was insufficient audit evidence to determine the business purpose of certain significant unusual transactions in Ebix’s gift card business in India during the fourth quarter of 2020; (2) that there was a material weakness in Company’s internal controls over the gift or prepaid revenue transaction cycle; and (3) that the Company’s independent auditor was reasonably likely to resign over disagreements with Ebix regarding $30 million that had been transferred into a commingled trust account of Ebix’s outside legal counsel; and (4) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE EBIX CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Ebix you have until April 23, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

APA Class Action: Learn About the Apache Corp Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that an APA class action lawsuit has been filed on behalf of investors who purchased Apache Corporation (APA) securities between September 7, 2016 and March 13, 2020. For more on the APA Lawsuit please contact us today.

 

According to the Apache Corp lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:  (i) Apache intentionally used unrealistic assumptions regarding the amount and composition of available oil and gas in Alpine High; (ii) Apache did not have the proper infrastructure in place to safely and/or economically drill and/or transport those resources even if they existed in the amounts purported; (iii) these misleading statements and omissions artificially inflated the value of the Company’s operations in the Permian Basin; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE APA CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Apache Corp you have until April 26, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

FUBO Class Action: Learn About the fuboTV Lawsuit

Levi & Korsinsky, LLP

February 19, 2021

Levi & Korsinsky, LLP announces that a FUBO class action lawsuit has been filed on behalf of investors who purchased fuboTV Inc. (FUBO) securities between March 23, 2020 and January 4, 2021. For more on the FUBO Lawsuit please contact us today.

 

According to the fuboTV lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:  (ii) Fubo offering of products was subject to undisclosed cost escalations; (iii) Fubo could not successfully compete and perform as sportsbook operator and could not capitalize on its only sports wagering opportunity; (iv) Fubo’s data and inventory were not differentiated to allow Fubo to achieve long-term advertising growth goals and forecasts; (v) Fubo’s valuation was overstated in light of its total revenue and subscription levels; (vi) the acquisition of Balto Sport did not provide the stated synergies, internal expertise, and did not expand the Company’s addressable market into online sports wagering; and as a result, Defendants’ public statements were materially false and/or misleading at all relevant times.

 

TO LEARN MORE ABOUT THE FUBO CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in fuboTV you have until April 19, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

EH Class Action: Learn About the Ehang Holdings Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a EH class action lawsuit has been filed on behalf of investors who purchased Ehang Holdings Limited (EH) securities between December 12, 2019 and February 16, 2021. For more on the EH Lawsuit please contact us today.

 

According to the Ehang Holdings lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) the Company’s purported regulatory approvals in Europe and North American for its EH216 were for use as a drone, and not for carrying passengers; (ii) its relationship with its purported primary customer is a sham; (iii) EHang has only collected on a fraction of its reported sales since its ADS began trading on NASDAQ in December 2019; (iv) the Company’s manufacturing facilities were practically empty and lacked evidence of advanced manufacturing equipment or employees; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE EH CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Ehang Holdings you have until April 19, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

BLUE Class Action: Learn About the bluebird Lawsuit

Levi & Korsinsky, LLP

February 17, 2021

Levi & Korsinsky, LLP announces that a BLUE class action lawsuit has been filed on behalf of investors who purchased bluebird bio, Inc. (BLUE) securities between May 11, 2020 and November 4, 2020 For more on the BLUE Lawsuit please contact us today.

 

According to the bluebird lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) data supporting bluebird’s BLA submission for LentiGlobin for SCD was insufficient to demonstrate drug product comparability; (ii) Defendants downplayed the foreseeable impact of disruptions related to the COVID-19 pandemic on the Company’s BLA submission schedule for LentiGlobin for SCD, particularly with respect to manufacturing; (iii) as a result of all the foregoing, it was foreseeable that the Company would not submit the BLA for LentiGlobin for SCD in the second half of 2021; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE BLUE CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in bluebird you have until April 13, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

CLOV Class Action: Learn About the Clover Lawsuit

Levi & Korsinsky, LLP

February 9, 2021

Levi & Korsinsky, LLP announces that a CLOV class action lawsuit has been filed on behalf of investors who purchased Clover Health Investments, Corp. (CLOV) securities between October 6, 2020 and February 3, 2021 For more on the CLOV Lawsuit please contact us today.

 

According to the Clover lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) Clover was the recipient of a Civil Investigative Demand from the DOJ; (ii) much of Clover’s sales are driven by a major related party deal that Clover not only failed to disclose but took active steps to conceal; (iii) Clover’s subsidiary Seek Insurance failed to disclose its relationship with Clover and misled consumers as to its purported independence; (iv) Clover’s software was in fact rudimentary; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE CLOV CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Clover you have until April 6, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

IRTC Class Action: Learn About the iRhythm Lawsuit

Levi & Korsinsky, LLP

February 5, 2021

Levi & Korsinsky, LLP announces that an IRTC class action lawsuit has been filed on behalf of investors who purchased iRhythm Technologies, Inc. (IRTC) securities between August 4, 2020 – January 28, 2021. For more on the IRTC Lawsuit please contact us today.

 

According to the iRhythm lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) iRhythm’s business would suffer as a result of the CMS’ rulemaking; (2) reimbursement rates would in fact plummet; (3) a lack of national pricing in the CMS rule and fee schedule would cause uncertainty and weakness in the Company’s business; and (4) as a result of the foregoing, Defendants’ public statements were materially false and misleading at all relevant times

 

TO LEARN MORE ABOUT THE IRTC CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in iRhythm you have until April 2, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

AZN Class Action: Learn About the AstraZeneca Lawsuit

Levi & Korsinsky, LLP

February 2, 2021

Levi & Korsinsky, LLP announces that an AZN class action lawsuit has been filed on behalf of investors who purchased AstraZeneca Plc (AZN) securities between May 21, 2020 and November 20, 2020. For more on the AZN Lawsuit please contact us today.

 

According to the Astrazeneca  lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (a) initial clinical trials for the Company’s COVID-19 vaccine, AZD1222, had suffered from a critical manufacturing error, resulting in a substantial number of trial participants receiving half the designed dosage; (b) clinical trials for AZD1222 consisted of a patchwork of disparate patient subgroups, each with subtly different treatments, undermining the validity and import of the conclusions that could be drawn from the clinical data across these disparate patient populations; (c) certain clinical trial participants for AZD1222 had not received a second dose at the designated time points, but rather received the second dose up to several weeks after the dose had been scheduled to be delivered according to the original trial design; (d) AstraZeneca had failed to include a substantial number of patients over 55 years of age in its clinical trials for AZD1222, despite this patient population being particularly vulnerable to the effects of COVID-19 and thus a high priority target market for the drug; (e) AstraZeneca’s clinical trials for AZD1222 had been hamstrung by widespread flaws in design, errors in execution, and a failure to properly coordinate and communicate with regulatory authorities and the general public; (f) as a result of (a)-(e) above, the clinical trials for AZD1222 had not been conducted in accordance with industry best practices and acceptable standards and the data and conclusions that could be derived from the clinical trials was of limited utility; and (g) as a result of (a)-(f) above, AZD1222 was unlikely to be approved for commercial use in the United States in the short term, one of the largest potential markets for the drug.

 

TO LEARN MORE ABOUT THE AZN CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Astrazeneca you have until March 29, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

CLSK Class Action: Learn About the Cleanspark Lawsuit

Levi & Korsinsky, LLP

January 26, 2021

Levi & Korsinsky, LLP announces that a CLSK class action lawsuit has been filed on behalf of investors who purchased Cleanspark, Inc. (CLSK) securities between December 31, 2020 and January 14, 2021 For more on the CLSK Lawsuit please contact us today.

 

According to the Cleanspark lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) that the Company had overstated its customer and contract figures; (2) that several of the Company’s recent acquisitions involved undisclosed related party transactions; and (3) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE CLSK CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Cleanspark you have until March 22, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

BTBT Class Action: Learn About the Bit Digital Lawsuit

Levi & Korsinsky, LLP

January 25, 2021

Levi & Korsinsky, LLP announces that a BTBT class action lawsuit has been filed on behalf of investors who purchased Bit Digital, Inc. (BTBT) securities between December 21, 2020 and January 8, 2021. For more on the BTBT Lawsuit please contact us today.

 

According to the Bit Digital lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) that Bit Digital overstated the extent of its a bitcoin mining operation; and (2) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE BTBT CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Bit Digital you have until March 22, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

JFU Class Action: Learn About the 9F Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a JFU  class action lawsuit has been filed on behalf of investors who purchased 9F Inc. (JFU) securities between August 14, 2019 and September 29, 2020. For more on the JFU Lawsuit please contact us today.

 

According to the 9F lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the purported value and benefits of the Company’s financial institution partners and its tri-party cooperation business model did not in fact exist and/or were materially overstated, given that 9F and Property and Casualty Company Limited (“PICC”) had been engaged in an ongoing contractual dispute regarding payment of service fees under their cooperation agreement; (2) the collectability of service fees owed to 9F by PICC under the cooperation agreement was in doubt and at serious risk of non-payment; (3) there was a significant risk that PICC would no longer provide credit insurance and guarantee protection to investors and institutional funding partners; (4) as a result of the foregoing, the Company’s platform, business model, reputation and financial results had been materially impaired; and (5) as a result, Defendants’ statements about the Company’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

 

TO LEARN MORE ABOUT THE JFU CLASS ACTION LAWSUIT, CLICK HERE 

 

If you suffered a loss in 9F you have until March 22, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

PEN Class Action: Learn About the Penumbra Lawsuit

Levi & Korsinsky, LLP

January 20, 2021

Levi & Korsinsky, LLP announces that a PEN class action lawsuit has been filed on behalf of investors who purchased Penumbra, Inc. (PEN) securities between August 3, 2020 and December 15, 2020. For more on the PEN Lawsuit please contact us today.

 

According to the Penumbra lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:  (1) that the Jet 7 Xtra Flex had known design defects that made it unsafe for its normal use; (2) that Penumbra did not adequately address the risk of the Jet 7 Xtra Flex causing serious injury and deaths, which had in fact already occurred; (3) that the Jet 7 Xtra Flex was likely to be recalled due to its safety issues; and (4) as a result, Penumbra’s public statements as set forth above were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE PEN CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Penumbra you have until March 16, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

DECN Class Action: Learn About the Decision Diagnostics Lawsuit 

Levi & Korsinsky, LLP

January 19, 2021

Levi & Korsinsky, LLP announces that a DECN class action lawsuit has been filed on behalf of investors who purchased Decision Diagnostics Corp. (DECN) securities between March 3, 2020 and December 17, 2020. For more on the DECN Lawsuit please contact us today.  

 

According to the Decision Diagnostics lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) Decision Diagnostics had not developed any viable COVID-19 test, much less a test that could detect COVID-19 in less than one minute; (ii) the Company could not meet the FDA’s EUA testing requirements for its purported COVID-19 test; (iii) accordingly, Defendants had misrepresented the timeline within which it could realistically bring its COVID-19 test to market; (iv) all the foregoing subjected Defendants to an increased risk of regulatory oversight and enforcement; and (v) as a result, Defendants’ public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE DECN CLASS ACTION LAWSUIT, CLICK HERE 

 

If you suffered a loss in Decision Diagnostics you have until March 16, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. 

 

CONTACT: 

Levi & Korsinsky, LLP 

Joseph E. Levi, Esq. 

55 Broadway, 10th Floor 

New York, NY 10006 

jlevi@levikorsinsky.com 

Tel: (212) 363-7500 

Fax: (212) 363-7171 

www.zlk.com 

 


Class Action Reports

Splunk Inc. Class Action Lawsuit

Levi & Korsinsky, LLP

January 15, 2021

Levi & Korsinsky, LLP announces that a SPLK class action lawsuit has been commenced on behalf of investors who purchased Splunk Inc. (SPLK) securities between October 21, 2020 and December 2, 2020. For more on the Splunk Class Action please contact us today.

 

According to the Splunk lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Splunk was not closing deals with its largest customers in the third fiscal quarter of 2021; (2) Splunk was not hitting the financial targets it had previously announced; and (3) as a result of the foregoing, Defendants’ public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE SPLK CLASS ACTION, CLICK HERE

 

If you suffered a loss in Splunk you have until February 2, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

K12Inc. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that an LRN class action lawsuit has been commenced on behalf of investors who purchased K12 Inc. (LRN) securities between April 27, 2020 and September 18, 2020. For more on the K12 Class Action please contact us today.

 

According to the K12 lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) K12 lacked the technological capabilities, infrastructures, and expertise to support the increased demand for virtual and blended education necessitated by the global pandemic; (ii) K12 lacked adequate cyberattack protocols and protections to prevent the disabling of its computer system; (iii) K12 was unable to provide the necessary levels of administrative support and training to teachers, students, and parents; and (iv) based on the foregoing, Defendants lacked a reasonable basis for their positive statements about the Company’s business, operations, and prospects and/or lacked a reasonable basis and omitted facts.

 

TO LEARN MORE ABOUT THE LRN CLASS ACTION, CLICK HERE

 

If you suffered a loss in K12 you have until January 19, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Qiwi plc Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a QIWI class action lawsuit has been commenced on behalf of investors who purchased Qiwi plc (QIWI) securities between March 28, 2019 and December 9, 2020. For more on the Qiwi Class Action please contact us today.

 

According to the Qiwi lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:(1) Qiwi’s internal controls related to reporting and record-keeping were ineffective; (2) consequently, the Central Bank of Russia would impose a monetary fine upon the Company and impose restrictions upon the Company’s ability to make payments to foreign merchants and transfer money to pre-paid cards; and (3) as a result, Defendants’ public statements were materially false and/or misleading at all relevant times.

 

TO LEARN MORE ABOUT THE QIWI CLASS ACTION, CLICK HERE

 

If you suffered a loss in QIWI you have until February 9, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Minerva Neurosciences, Inc. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a NERV class action lawsuit has been commenced on behalf of investors who purchased Minerva Neurosciences, Inc. (NERV) securities between May 15, 2017 – November 30, 2020. For more on the Minerva Neurosciences Class Action please contact us today.

 

According to the Minerva Neurosciences lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) the truth about the feedback received from the FDA concerning the “end-of-Phase 2” meeting; (ii) the Phase 2b study did not use the commercial formulation of roluperidone and was conducted solely outside of the United States; (iii) the failure of the Phase 3 study to meet its primary and key secondary endpoints rendered that study incapable of supporting substantial evidence of effectiveness; (iv) the Company’s plan to use the combination of the Phase 2b and Phase 3 studies would be “highly unlikely” to support the submission of an NDA; (v) reliance on these two trials in the submission of an NDA would lead to “substantial review issues” because the trials were inadequate and not well-controlled; and (vi) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE NERV CLASS ACTION, CLICK HERE

 

If you suffered a loss in Minerva Neurosciences you have until February 8, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Triterras, Inc., f/k/a Netfin Acquisition Corp. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a TRIT class action lawsuit has been commenced on behalf of investors who purchased Triterras, Inc., f/k/a Netfin Acquisition Corp. (TRIT) securities between August 20, 2020 and December 16, 2020 For more on the Triterras Class Action please contact us today.

 

According to the Triterras lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the extent to which Company’s revenue growth relied on Triterras’ relationship with Rhodium to refer users to the Kratos platform; (2) that Rhodium faced significant financial liabilities that jeopardized its ability to continue as a going concern; (3) that, as a result, Rhodium was likely to refer fewer users to the Company’s Kratos platform; and (4) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE TRIT CLASS ACTION, CLICK HERE

 

If you suffered a loss in Triterras you have until February 19, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Tricida, Inc. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a TCDA class action lawsuit has been commenced on behalf of investors who purchased Tricida, Inc (TCDA) securities between September 4, 2019 and October 28, 2020. For more on the Tricida Class Action please contact us today.

 

According to the Tricida lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) Tricida’s NDA for veverimer was materially deficient; (ii) accordingly, it was foreseeably likely that the FDA would not accept the NDA for veverimer; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE TCDA CLASS ACTION, CLICK HERE

 

If you suffered a loss in Tricida you have until March 8, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

GoodRx Holdings, Inc. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a GDRX class action lawsuit has been commenced on behalf of investors who purchased GoodRx Holdings (GDRX) securities between September 23, 2020 and November 16, 2020. For more on the GoodRx Class Action please contact us today.

 

According to the GoodRx lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: The complaint alleges that throughout the class period Defendants issued materially false and/or misleading statements and/or failed to disclose that: at the time of the IPO, unbeknownst to investors, Amazon.com, Inc. was developing and would soon introduce its own online and mobile prescription medication ordering and fulfilment service that would directly compete with GoodRx. Defendants timed the IPO so that it was priced before Amazon announced its online pharmaceutical business to facilitate the IPO and create artificial demand for the common shares sold therein, as well to maximize the amount of money the Company and the selling stockholders could raise in the IPO. Given defendants’ knowledge of Amazon’s intention to enter the online pharmaceutical business, and their misleading statements about GoodRx’s competitive position made contemporaneously with that knowledge, defendants’ materially false and/or misleading statements alleged herein were made willfully and caused GoodRx common stock to trade at artificially inflated prices during the Class Period.

 

TO LEARN MORE ABOUT THE GDRX CLASS ACTION, CLICK HERE

 

If you suffered a loss in GoodRx you have until February 16, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Changyou.com Limited Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a CYOU/SOHU class action lawsuit has been commenced on behalf of investors who purchased Changyou.com Limited (CYOU, SOHU) securities between February 14, 2020 and April 23, 2020. For more on the Changyou Class Action please contact us today.

 

According to the Changyou lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: it did not support its disclosed legal conclusions and is at odds with the text of the relevant Cayman Islands statute regarding appraisal rights. Moreover, the Company failed to disclose other rights that may be available to Changyou shareholders under Cayman Islands law, in clear violation of the federal securities laws.

 

TO LEARN MORE ABOUT THE CYOU/SOHU CLASS ACTION, CLICK HERE

 

If you suffered a loss in Changyou you have until  February 8, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

SolarWinds Corporation. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a SWI class action lawsuit has been commenced on behalf of investors who purchased SolarWinds Corporation. (SWI) securities between  March 1, 2020 and December 14, 2020. For more on the SolarWinds Class Action please contact us today.

 

According to the SolarWinds lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) since mid-2020, SolarWinds Orion monitoring products had a vulnerability that allowed hackers to compromise the server upon which the products ran; (2) SolarWinds’ update server had an easily accessible password of ‘solarwinds123′; (3) consequently, SolarWinds’ customers, including, among others, the Federal Government, Microsoft, Cisco, and Nvidia, would be vulnerable to hacks; (4) as a result, the Company would suffer significant reputational harm; and (5) as a result, Defendants’ statements about SolarWinds’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

 

TO LEARN MORE ABOUT THE SWI CLASS ACTION, CLICK HERE

 

If you suffered a loss in SolarWinds you have until March 5, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

CD Projekt S.A. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a OTGLY class action lawsuit has been commenced on behalf of investors who purchased CD Projekt S.A. (OTGLY) securities between January 16, 2020 and December 17, 2020. For more on the CD Projekt Class Action please contact us today.

 

According to the CD Projekt lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Cyberpunk 2077 was virtually unplayable on the current-generation Xbox or Playstation systems due to an enormous number of bugs; (2) as a result, Sony would remove Cyberpunk 2077 from the Playstation Store, and Sony, Microsoft and the Company would be forced to offer full refunds for the game; (3) consequently, the Company would suffer reputational and pecuniary harm; and (4) as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

 

TO LEARN MORE ABOUT THE OTGLY CLASS ACTION, CLICK HERE

 

If you suffered a loss in CD Projekt you have until February 22, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Joyy Inc. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a YY class action lawsuit has been commenced on behalf of investors who purchased Joyy Inc. (YY) securities between April 28, 2016 and November 18, 2020. For more on the Joyy Class Action please contact us today.

 

According to the Joyy lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) JOYY dramatically overstated its revenues from live streaming sources; (2) The majority of users at any given time were bots; (2) the Company utilized these bots to effect a roundtripping scheme that Manufactured the false appearance of revenues; (3) the Company overstated its cash reserves; (4) the Company’s acquisition of Bigo was largely contrived to benefit corporate insiders; and (5) as a result, Defendants’ public statements were materially false and/or misleading at all relevant times.

 

TO LEARN MORE ABOUT THE YY CLASS ACTION, CLICK HERE

 

If you suffered a loss in Joyy you have until January 19, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Quantumscape Corporation. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a QS class action lawsuit has been commenced on behalf of investors who purchased Quantumscape Corporation. (QS) securities between November 27, 2020  and December 31, 2020. For more on the QuantumScape Class Action please contact us today.

 

According to the QuantumScape lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:(1) that the Company’s purported success related to its solid-state battery power, battery life, and energy density were significantly overstated; (2) that the Company is unlikely to be able to scale its technology to the multi-layer cell necessary to power electric vehicles; and (3) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE QS CLASS ACTION, CLICK HERE

 

If you suffered a loss in QuantumScape you have until March 8, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Restaurant Brands International Inc. Class Action Lawsuits

Levi & Korsinsky, LLP

January 14, 2021

Levi & Korsinsky, LLP reminds shareholders that a QSR class action lawsuit has been commenced on behalf of investors who purchased Restaurant Brands International (QSR) securities between April 29, 2019 and October 28, 2019. For more on the Restaurant Brands Class Action please contact us today.

 

According to the Restaurant Brands lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company’s Winning Together Plan was failing to generate substantial, sustainable improvement within the Tim Hortons brand; (2) the Tims Rewards loyalty program was not generating sustainable revenue growth as increased customer traffic was not offsetting promotional discounting; and (3) as a result, Defendants’ statements about the Company’s business, operations, and prospects lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE QSR CLASS ACTION, CLICK HERE

 

If you suffered a loss in Restaurant Brands you have until February 19, 2021  to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

GoodRx Holdings, Inc. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a GDRX class action lawsuit has been commenced on behalf of investors who purchased GoodRx Holdings, Inc. (GDRX) securities between September 23, 2020 and November 16, 2020. For more on the GoodRx Class Action please contact us today.

 

According to the GoodRx lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:  at the time of the IPO, unbeknownst to investors, Amazon.com, Inc. was developing and would soon introduce its own online and mobile prescription medication ordering and fulfilment service that would directly compete with GoodRx. Defendants timed the IPO so that it was priced before Amazon announced its online pharmaceutical business to facilitate the IPO and create artificial demand for the common shares sold therein, as well to maximize the amount of money the Company and the selling stockholders could raise in the IPO. Given defendants’ knowledge of Amazon’s intention to enter the online pharmaceutical business, and their misleading statements about GoodRx’s competitive position made contemporaneously with that knowledge, defendants’ materially false and/or misleading statements alleged herein were made willfully and caused GoodRx common stock to trade at artificially inflated prices during the Class Period.

 

TO LEARN MORE ABOUT THE GDRX CLASS ACTION, CLICK HERE

 

If you suffered a loss in GoodRx you have until February 16, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Northern Dynasty Minerals Ltd. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a NAK class action lawsuit has been commenced on behalf of investors who purchased Northern Dynasty Minerals Ltd. (NAK) securities between December 21, 2017 and November 25, 2020. For more on the Northern Dynasty Class Action please contact us today.

 

According to the Northern Dynasty lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:  (1) the Company’s Pebble Project was contrary to Clean Water Act guidelines and to the public interest; (2) the Company planned that the Pebble Project would be larger in duration and scope than conveyed to the public; (3) as a result, the Company’s permit applications for the Pebble Project would be denied by the U.S. Army Corps of Engineers; and (4) as a result, Defendants’ public statements were materially false and/or misleading at all relevant times.

 

TO LEARN MORE ABOUT THE NAK CLASS ACTION, CLICK HERE

 

If you suffered a loss in Northern Dynasty you have until February 2, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Changyou.com Limited Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a CYOU/SOHU class action lawsuit has been commenced on behalf of investors who purchased Changyou.com Limited (CYOU,SOHU) securities between February 14, 2020 and April 23, 2020. For more on the Changyou Class Action please contact us today.

 

According to the Changyou lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: it did not support its disclosed legal conclusions and is at odds with the text of the relevant Cayman Islands statute regarding appraisal rights. Moreover, the Company failed to disclose other rights that may be available to Changyou shareholders under Cayman Islands law, in clear violation of the federal securities laws.

 

TO LEARN MORE ABOUT THE CYOU/SOHU CLASS ACTION, CLICK HERE

 

If you suffered a loss in Changyou you have until February 8, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Boston Scientific Corporation Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a BSX class action lawsuit has been commenced on behalf of investors who purchased Boston Scientific Corporation (BSX) securities between April 24, 2019 and November 16, 2020. For more on the Boston Scientific Class Action please contact us today.

 

According to the Boston Scientific lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) the LOTUS Edge Aortic Valve System’s product delivery system was dysfunctional and threatened the continued viability of the entire product line; (ii) as a result, the Company had materially overstated the continued commercial viability and profitability of the LOTUS Edge Aortic Valve System; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE BSX CLASS ACTION, CLICK HERE

 

If you suffered a loss in Boston Scientific you have until February 2, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

K12 Inc. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a LRN class action lawsuit has been commenced on behalf of investors who purchased K12 Inc. (LRN) securities between April 27, 2020 and September 18, 2020. For more on the K12 Class Action please contact us today.

 

According to the K12 lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) K12 lacked the technological capabilities, infrastructures, and expertise to support the increased demand for virtual and blended education necessitated by the global pandemic; (ii) K12 lacked adequate cyberattack protocols and protections to prevent the disabling of its computer system; (iii) K12 was unable provide the necessary levels of administrative support and training to teachers, students, and parents; and (iv) based on the foregoing, Defendants lacked a reasonable basis for their positive statements about the Company’s business, operations, and prospects and/or lacked a reasonable basis and omitted facts.

 

TO LEARN MORE ABOUT THE LRN CLASS ACTION, CLICK HERE

 

If you suffered a loss in K12 you have until January 19, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Qiwi plc Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a QIWI class action lawsuit has been commenced on behalf of investors who purchased Qiwi plc (QIWI) securities between March 28, 2019 and December 9, 2020. For more on the Qiwi Class Action please contact us today.

 

According to the Qiwi lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:(1) Qiwi’s internal controls related to reporting and record-keeping were ineffective; (2) consequently, the Central Bank of Russia would impose a monetary fine upon the Company and impose restrictions upon the Company’s ability to make payments to foreign merchants and transfer money to pre-paid cards; and (3) as a result, Defendants’ public statements were materially false and/or misleading at all relevant times.

 

TO LEARN MORE ABOUT THE QIWI CLASS ACTION, CLICK HERE

 

If you suffered a loss in QIWI you have until February 9, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

JOYY Inc. Class Action Lawsuits

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a YY class action lawsuit has been commenced on behalf of investors who purchased Joyy Inc. (YY) securities between April 28, 2016 and November 18, 2020. For more on the Joyy Class Action please contact us today.

 

According to the Joyy lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) JOYY dramatically overstated its revenues from live streaming sources; (2) The majority of users at any given time were bots; (2) the Company utilized these bots to effect a roundtripping scheme that Manufactured the false appearance of revenues; (3) the Company overstated its cash reserves; (4) the Company’s acquisition of Bigo was largely contrived to benefit corporate insiders; and (5) as a result, Defendants’ public statements were materially false and/or Misleading at all relevant times.

 

TO LEARN MORE ABOUT THE YY CLASS ACTION, CLICK HERE

 

If you suffered a loss in Joyy you have until January 19, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Berry Corporation Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a BRY class action lawsuit has been commenced on behalf of investors who purchased Berry Corporation (BRY) securities between July 26, 2018 and November 3, 2020. For more on the Berry Class Action please contact us today.

 

According to the Berry lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:  (i) Berry had materially overstated its operational efficiency and stability; (ii) Berry’s operational inefficiency and instability would foreseeably necessitate operational improvements that would disrupt the Company’s productivity and increase costs; (iii) the foregoing would foreseeably negatively impact the Company’s revenues; and (iv) as a result, the Offering Documents and the Company’s public statements were materially false and/or misleading and failed to state information required to be stated therein.

 

TO LEARN MORE ABOUT THE BRY CLASS ACTION, CLICK HERE

 

If you suffered a loss in Berry you have until January 21, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Minerva Neurosciences Inc. Class Actions Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a NERV class action lawsuit has been commenced on behalf of investors who purchased Minerva Neurosciences Inc. (NERV) securities between May 15, 2017 and November 30, 2020. For more on the Minerva Neurosciences Class Action please contact us today.

 

According to the Minerva Neurosciences lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) the truth about the feedback received from the FDA concerning the “end-of-Phase 2” meeting; (ii) the Phase 2b study did not use the commercial formulation of roluperidone and was conducted solely outside of the United States; (iii) the failure of the Phase 3 study to meet its primary and key secondary endpoints rendered that study incapable of supporting substantial evidence of effectiveness; (iv) the Company’s plan to use the combination of the Phase 2b and Phase 3 studies would be “highly unlikely” to support the submission of an NDA; (v) reliance on these two trials in the submission of an NDA would lead to “substantial review issues” because the trials were inadequate and not well-controlled; and (vi) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE NERV CLASS ACTION, CLICK HERE

 

If you suffered a loss in Minerva Neurosciences you have until February 8, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Splunk Inc. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a SPLK class action lawsuit has been commenced on behalf of investors who purchased Splunk Inc. (SPLK) securities between  October 21, 2020 and December 2, 2020. For more on the Splunk Class Action please contact us today.

 

According to the Splunk lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Splunk was not closing deals with its largest customers in the third fiscal quarter of 2021; (2) Splunk was not hitting the financial targets it had previously announced; and (3) as a result of the foregoing, Defendants’ public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE SPLK CLASS ACTION, CLICK HERE

 

If you suffered a loss in Splunk you have until February 2, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Triterras, Inc., f/k/a Netfin Acquisition Corp. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a TRIT class action lawsuit has been commenced on behalf of investors who purchased Triterras, Inc., f/k/a Netfin Acquisition Corp. (TRIT) securities between August 20, 2020 and December 16, 2020. For more on the Triterras’ Class Action please contact us today.

 

According to the Triterras’ lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the extent to which Company’s revenue growth relied on Triterras’ relationship with Rhodium to refer users to the Kratos platform; (2) that Rhodium faced significant financial liabilities that jeopardized its ability to continue as a going concern; (3) that, as a result, Rhodium was likely to refer fewer users to the Company’s Kratos platform; and (4) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE TRIT CLASS ACTION, CLICK HERE

 

If you suffered a loss in Triterras’ you have until February 19, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

SolarWinds Corporation Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a SWI class action lawsuit has been commenced on behalf of investors who purchased SolarWinds Corporation (SWI) securities between March 1, 2020 and December 14, 2020. For more on the SolarWinds Class Action please contact us today.

 

According to the SolarWinds lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) since mid-2020, SolarWinds Orion monitoring products had a vulnerability that allowed hackers to compromise the server upon which the products ran; (2) SolarWinds’ update server had an easily accessible password of ‘solarwinds123′; (3) consequently, SolarWinds’ customers, including, among others, the Federal Government, Microsoft, Cisco, and Nvidia, would be vulnerable to hacks; (4) as a result, the Company would suffer significant reputational harm; and (5) as a result, Defendants’ statements about SolarWinds’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

 

TO LEARN MORE ABOUT THE SWI CLASS ACTION, CLICK HERE

 

If you suffered a loss in SolarWinds you have until March 5, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Tricida, Inc. Class Actions Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a TCDA class action lawsuit has been commenced on behalf of investors who purchased Tricida, Inc. (TCDA) securities between September 4, 2019 and October 28, 2020. For more on the Tricida Class Action please contact us today.

 

According to the Interface lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) Tricida’s NDA for veverimer was materially deficient; (ii) accordingly, it was foreseeably likely that the FDA would not accept the NDA for veverimer; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE TCDA CLASS ACTION, CLICK HERE

 

If you suffered a loss in Interface you have until March 8, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

QuantumScape Corporation f/k/a Kensington Capital Acquisition Corp. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a QS class action lawsuit has been commenced on behalf of investors who purchased QuantumScape Corporation f/k/a Kensington Capital Acquisition Corp. (QS) securities between December 8, 2020 and December 31, 2020. For more on the QuantumScape Class Action please contact us today.

 

According to the QuantumScape lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:  (1) that the Company’s purported success related to its solid-state battery power, battery life, and energy density were significantly overstated; (2) that the Company is unlikely to be able to scale its technology to the multi-layer cell necessary to power electric vehicles; and (3) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE QS CLASS ACTION, CLICK HERE

 

If you suffered a loss in QuantumScape you have until March 8, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

CD Projekt S.A. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a OTGLY/OTGLF class action lawsuit has been commenced on behalf of investors who purchased CD Projekt S.A. (OTGLY,OTGLF) securities between January 16, 2020 and December 17, 2020. For more on the CD Projekt Class Action please contact us today.

 

According to the CD Projekt lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: Throughout the class period, defendants were materially false and/or misleading because they misrepresented and failed to disclose the following adverse facts pertaining to the Company’s business, operations and prospects, which were known to Defendants or recklessly disregarded by them. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (1) Cyberpunk 2077 was virtually unplayable on the current-generation Xbox or Playstation systems due to an enormous number of bugs; (2) as a result, Sony would remove Cyberpunk 2077 from the Playstation store, and Sony, Microsoft and the Company would be forced to offer full refunds for the game; (3) consequently, the Company would suffer reputational and pecuniary harm; and (4) as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

 

TO LEARN MORE ABOUT THE OTGLY/OTGLF CLASS ACTION, CLICK HERE

 

If you suffered a loss in CD Projekt you have until February 22, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Kandi Technologies Group, Inc. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a KNDI class action lawsuit has been commenced on behalf of investors who purchased Kandi Technologies Group, Inc. (KNDI) securities between March 15, 2019 and November 27, 2020 . For more on the Kandi Class Action please contact us today.

 

According to the Kandi lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:  (i) Kandi artificially inflated its reported revenues through undisclosed related party transactions, or otherwise had relationships with key customers that indicated those customers did not have an arms length relationship with Kandi; (ii) the majority of Kandi’s sales in the past year had been to undisclosed related parties and/or parties with such a close relationship and history with Kandi that it cast doubt on the arms-length nature of their relationship; (iii) all the foregoing, once revealed, was foreseeably likely to cast doubt on the validity of Kandi’s reported revenues and, in turn, have a foreseeable negative impact on the Company’s reputation and valuation; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE KNDI CLASS ACTION, CLICK HERE

 

If you suffered a loss in Kandi you have until February 9, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Pinterest, Inc. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a PINS class action lawsuit has been commenced on behalf of investors who purchased Pinterest, Inc. (PINS) securities between May 16, 2019 and November 1, 2019. For more on the Pinterest Class Action please contact us today.

 

According to the Pinterest lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) the Company’s addressable market in the U.S. was reaching its maximum capacity; (ii) which significantly decelerated Pinterest’s future ability to monetize on U.S. average revenue per user; (iii) Pinterest was at an increased risk of losing advertising revenue; (iv) and as a result, Defendants’ public statements were materially false and misleading at all relevant times or lacked a reasonable basis and omitted material facts.

 

TO LEARN MORE ABOUT THE PINS CLASS ACTION, CLICK HERE

 

If you suffered a loss in Pinterest you have until January 22, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

K12 Inc. Class Action Lawsuit

Levi & Korsinsky, LLP

January 13, 2021

Levi & Korsinsky, LLP reminds shareholders that a LRN class action lawsuit has been commenced on behalf of investors who purchased K12 Inc. (LRN) securities between April 27, 2020 and September 18, 2020. For more on the K12 Class Action please contact us today.

 

According to the K12 lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) K12 lacked the technological capabilities, infrastructures, and expertise to support the increased demand for virtual and blended education necessitated by the global pandemic; (ii) K12 lacked adequate cyberattack protocols and protections to prevent the disabling of its computer system; (iii) K12 was unable provide the necessary levels of administrative support and training to teachers, students, and parents; and (iv) based on the foregoing, Defendants lacked a reasonable basis for their positive statements about the Company’s business, operations, and prospects and/or lacked a reasonable basis and omitted facts.

 

TO LEARN MORE ABOUT THE LRN CLASS ACTION, CLICK HERE

 

If you suffered a loss in K12 you have until January 19, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Boston Scientific Corporation Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a BSX class action lawsuit has been commenced on behalf of investors who purchased Boston Scientific Corporation (BSX) securities between April 24, 2019 and November 16, 2020. For more on the Boston Scientific Class Action please contact us today.

 

According to the Boston Scientific lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) the LOTUS Edge Aortic Valve System’s product delivery system was dysfunctional and threatened the continued viability of the entire product line; (ii) as a result, the Company had materially overstated the continued commercial viability and profitability of the LOTUS Edge Aortic Valve System; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE BSX CLASS ACTION, CLICK HERE

 

If you suffered a loss in Boston Scientific you have until February 2, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

SolarWinds Corporation Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a SWI class action lawsuit has been commenced on behalf of investors who purchased SolarWinds Corporation (SWI) securities between March 1, 2020 and December 14, 2020. For more on the SolarWinds Class Action please contact us today.

 

According to the SolarWinds lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) since mid-2020, SolarWinds Orion monitoring products had a vulnerability that allowed hackers to compromise the server upon which the products ran; (2) SolarWinds’ update server had an easily accessible password of ‘solarwinds123′; (3) consequently, SolarWinds’ customers, including, among others, the Federal Government, Microsoft, Cisco, and Nvidia, would be vulnerable to hacks; (4) as a result, the Company would suffer significant reputational harm; and (5) as a result, Defendants’ statements about SolarWinds’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

 

TO LEARN MORE ABOUT THE SWI CLASS ACTION, CLICK HERE

 

If you suffered a loss in SolarWinds you have until March 5, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Splunk Inc. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a SPLK class action lawsuit has been commenced on behalf of investors who purchased Splunk Inc. (SPLK) securities between  October 21, 2020 and December 2, 2020. For more on the Splunk Class Action please contact us today.

 

According to the Splunk lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Splunk was not closing deals with its largest customers in the third fiscal quarter of 2021; (2) Splunk was not hitting the financial targets it had previously announced; and (3) as a result of the foregoing, Defendants’ public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE SPLK CLASS ACTION, CLICK HERE

 

If you suffered a loss in Splunk you have until February 2, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Berry Corporation Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a BRY class action lawsuit has been commenced on behalf of investors who purchased Berry Corporation (BRY) securities between July 26, 2018 and November 3, 2020. For more on the Berry Class Action please contact us today.

 

According to the Berry lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:  (i) Berry had materially overstated its operational efficiency and stability; (ii) Berry’s operational inefficiency and instability would foreseeably necessitate operational improvements that would disrupt the Company’s productivity and increase costs; (iii) the foregoing would foreseeably negatively impact the Company’s revenues; and (iv) as a result, the Offering Documents and the Company’s public statements were materially false and/or misleading and failed to state information required to be stated therein.

 

TO LEARN MORE ABOUT THE BRY CLASS ACTION, CLICK HERE

 

If you suffered a loss in Berry you have until January 21, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Triterras, Inc., f/k/a Netfin Acquisition Corp. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a TRIT class action lawsuit has been commenced on behalf of investors who purchased Triterras, Inc., f/k/a Netfin Acquisition Corp. (TRIT) securities between August 20, 2020 and December 16, 2020. For more on the Triterras’ Class Action please contact us today.

 

According to the Triterras’ lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the extent to which Company’s revenue growth relied on Triterras’ relationship with Rhodium to refer users to the Kratos platform; (2) that Rhodium faced significant financial liabilities that jeopardized its ability to continue as a going concern; (3) that, as a result, Rhodium was likely to refer fewer users to the Company’s Kratos platform; and (4) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE TRIT CLASS ACTION, CLICK HERE

 

If you suffered a loss in Triterras’ you have until February 19, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Tricida, Inc. Class Actions Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a TCDA class action lawsuit has been commenced on behalf of investors who purchased Tricida, Inc. (TCDA) securities between September 4, 2019 and October 28, 2020. For more on the Tricida Class Action please contact us today.

 

According to the Interface lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) Tricida’s NDA for veverimer was materially deficient; (ii) accordingly, it was foreseeably likely that the FDA would not accept the NDA for veverimer; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE TCDA CLASS ACTION, CLICK HERE

 

If you suffered a loss in Interface you have until March 8, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

CD Projekt S.A. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a OTGLY/OTGLF class action lawsuit has been commenced on behalf of investors who purchased CD Projekt S.A. (OTGLY,OTGLF) securities between January 16, 2020 and December 17, 2020. For more on the CD Projekt Class Action please contact us today.

 

According to the CD Projekt lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: Throughout the class period, defendants were materially false and/or misleading because they misrepresented and failed to disclose the following adverse facts pertaining to the Company’s business, operations and prospects, which were known to Defendants or recklessly disregarded by them. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (1) Cyberpunk 2077 was virtually unplayable on the current-generation Xbox or Playstation systems due to an enormous number of bugs; (2) as a result, Sony would remove Cyberpunk 2077 from the Playstation store, and Sony, Microsoft and the Company would be forced to offer full refunds for the game; (3) consequently, the Company would suffer reputational and pecuniary harm; and (4) as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

 

TO LEARN MORE ABOUT THE OTGLY/OTGLF CLASS ACTION, CLICK HERE

 

If you suffered a loss in CD Projekt you have until February 22, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

GoodRx Holdings, Inc. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a GDRX class action lawsuit has been commenced on behalf of investors who purchased GoodRx Holdings, Inc. (GDRX) securities between September 23, 2020 and November 16, 2020. For more on the GoodRx Class Action please contact us today.

 

According to the GoodRx lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:  at the time of the IPO, unbeknownst to investors, Amazon.com, Inc. was developing and would soon introduce its own online and mobile prescription medication ordering and fulfillment service that would directly compete with GoodRx. Defendants timed the IPO so that it was priced before Amazon announced its online pharmaceutical business to facilitate the IPO and create artificial demand for the common shares sold therein, as well to maximize the amount of money the Company and the selling stockholders could raise in the IPO. Given defendants’ knowledge of Amazon’s intention to enter the online pharmaceutical business, and their misleading statements about GoodRx’s competitive position made contemporaneously with that knowledge, defendants’ materially false and/or misleading statements alleged herein were made willfully and caused GoodRx common stock to trade at artificially inflated prices during the Class Period.

 

TO LEARN MORE ABOUT THE GDRX CLASS ACTION, CLICK HERE

 

If you suffered a loss in GoodRx you have until February 16, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Qiwi plc Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a QIWI class action lawsuit has been commenced on behalf of investors who purchased Qiwi plc (QIWI) securities between March 28, 2019 and December 9, 2020. For more on the Qiwi Class Action please contact us today.

 

According to the Qiwi lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:(1) Qiwi’s internal controls related to reporting and record-keeping were ineffective; (2) consequently, the Central Bank of Russia would impose a monetary fine upon the Company and impose restrictions upon the Company’s ability to make payments to foreign merchants and transfer money to pre-paid cards; and (3) as a result, Defendants’ public statements were materially false and/or misleading at all relevant times.

 

TO LEARN MORE ABOUT THE QIWI CLASS ACTION, CLICK HERE

 

If you suffered a loss in QIWI you have until February 9, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

JOYY Inc. Class Action Lawsuits

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a YY class action lawsuit has been commenced on behalf of investors who purchased Joyy Inc. (YY) securities between April 28, 2016 and November 18, 2020. For more on the Joyy Class Action please contact us today.

 

According to the Joyy lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) JOYY dramatically overstated its revenues from live streaming sources; (2) The majority of users at any given time were bots; (2) the Company utilized these bots to effect a roundtripping scheme that Manufactured the false appearance of revenues; (3) the Company overstated its cash reserves; (4) the Company’s acquisition of Bigo was largely contrived to benefit corporate insiders; and (5) as a result, Defendants’ public statements were materially false and/or Misleading at all relevant times.

 

TO LEARN MORE ABOUT THE YY CLASS ACTION, CLICK HERE

 

If you suffered a loss in Joyy you have until January 19, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Changyou.com Limited Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a CYOU/SOHU class action lawsuit has been commenced on behalf of investors who purchased Changyou.com Limited (CYOU,SOHU) securities between February 14, 2020 and April 23, 2020. For more on the Changyou Class Action please contact us today.

 

According to the Changyou lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: it did not support its disclosed legal conclusions and is at odds with the text of the relevant Cayman Islands statute regarding appraisal rights. Moreover, the Company failed to disclose other rights that may be available to Changyou shareholders under Cayman Islands law, in clear violation of the federal securities laws.

 

TO LEARN MORE ABOUT THE CYOU/SOHU CLASS ACTION, CLICK HERE

 

If you suffered a loss in Changyou you have until February 8, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

QuantumScape Corporation f/k/a Kensington Capital Acquisition Corp. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a QS class action lawsuit has been commenced on behalf of investors who purchased QuantumScape Corporation f/k/a Kensington Capital Acquisition Corp. (QS) securities between December 8, 2020 and December 31, 2020. For more on the QuantumScape Class Action please contact us today.

 

According to the QuantumScape lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:  (1) that the Company’s purported success related to its solid-state battery power, battery life, and energy density were significantly overstated; (2) that the Company is unlikely to be able to scale its technology to the multi-layer cell necessary to power electric vehicles; and (3) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE QS CLASS ACTION, CLICK HERE

 

If you suffered a loss in QuantumScape you have until March 8, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Restaurant Brands International Inc. Class Action Lawsuits

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a QSR class action lawsuit has been commenced on behalf of investors who purchased Restaurant Brands International (QSR) securities between April 29, 2019 and October 28, 2019. For more on the Restaurant Brands Class Action please contact us today.

 

According to the Restaurant Brands lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company’s Winning Together Plan was failing to generate substantial, sustainable improvement within the Tim Hortons brand; (2) the Tims Rewards loyalty program was not generating sustainable revenue growth as increased customer traffic was not offsetting promotional discounting; and (3) as a result, Defendants’ statements about the Company’s business, operations, and prospects lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE QSR CLASS ACTION, CLICK HERE

 

If you suffered a loss in Restaurant Brands you have until February 19, 2021  to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

SolarWinds Corporation Class Action Lawsuit

Levi & Korsinsky, LLP

January 12, 2021

Levi & Korsinsky, LLP reminds shareholders that a SWI class action lawsuit has been commenced on behalf of investors who purchased SolarWinds Corporation (SWI) securities between March 1, 2020 and December 14, 2020. For more on the SolarWinds Class Action please contact us today.

 

According to the SolarWinds lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) since mid-2020, SolarWinds Orion monitoring products had a vulnerability that allowed hackers to compromise the server upon which the products ran; (2) SolarWinds’ update server had an easily accessible password of ‘solarwinds123′; (3) consequently, SolarWinds’ customers, including, among others, the Federal Government, Microsoft, Cisco, and Nvidia, would be vulnerable to hacks; (4) as a result, the Company would suffer significant reputational harm; and (5) as a result, Defendants’ statements about SolarWinds’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

 

TO LEARN MORE ABOUT THE SWI CLASS ACTION, CLICK HERE

 

If you suffered a loss in SolarWinds you have until March 5, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

CD Projekt S.A. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a OTGLY/OTGLF class action lawsuit has been commenced on behalf of investors who purchased CD Projekt S.A. (OTGLY,OTGLF) securities between January 16, 2020 and December 17, 2020. For more on the CD Projekt Class Action please contact us today.

 

According to the CD Projekt lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: Throughout the class period, defendants were materially false and/or misleading because they misrepresented and failed to disclose the following adverse facts pertaining to the Company’s business, operations and prospects, which were known to Defendants or recklessly disregarded by them. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (1) Cyberpunk 2077 was virtually unplayable on the current-generation Xbox or Playstation systems due to an enormous number of bugs; (2) as a result, Sony would remove Cyberpunk 2077 from the Playstation store, and Sony, Microsoft and the Company would be forced to offer full refunds for the game; (3) consequently, the Company would suffer reputational and pecuniary harm; and (4) as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

 

TO LEARN MORE ABOUT THE OTGLY/OTGLF CLASS ACTION, CLICK HERE

 

If you suffered a loss in CD Projekt you have until February 22, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Splunk Inc. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a SPLK class action lawsuit has been commenced on behalf of investors who purchased Splunk Inc. (SPLK) securities between  October 21, 2020 and December 2, 2020. For more on the Splunk Class Action please contact us today.

 

According to the Splunk lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Splunk was not closing deals with its largest customers in the third fiscal quarter of 2021; (2) Splunk was not hitting the financial targets it had previously announced; and (3) as a result of the foregoing, Defendants’ public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE SPLK CLASS ACTION, CLICK HERE

 

If you suffered a loss in Splunk you have until February 2, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Restaurant Brands International Inc. Class Action Lawsuits

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a QSR class action lawsuit has been commenced on behalf of investors who purchased Restaurant Brands International (QSR) securities between April 29, 2019 and October 28, 2019. For more on the Restaurant Brands Class Action please contact us today.

 

According to the Restaurant Brands lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company’s Winning Together Plan was failing to generate substantial, sustainable improvement within the Tim Hortons brand; (2) the Tims Rewards loyalty program was not generating sustainable revenue growth as increased customer traffic was not offsetting promotional discounting; and (3) as a result, Defendants’ statements about the Company’s business, operations, and prospects lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE QSR CLASS ACTION, CLICK HERE

 

If you suffered a loss in Restaurant Brands you have until February 19, 2021  to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Tricida, Inc. Class Actions Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a TCDA class action lawsuit has been commenced on behalf of investors who purchased Tricida, Inc. (TCDA) securities between September 4, 2019 and October 28, 2020. For more on the Tricida Class Action please contact us today.

 

According to the Interface lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) Tricida’s NDA for veverimer was materially deficient; (ii) accordingly, it was foreseeably likely that the FDA would not accept the NDA for veverimer; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE TCDA CLASS ACTION, CLICK HERE

 

If you suffered a loss in Interface you have until March 8, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Alibaba Group Holding Limited Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a BABA class action lawsuit has been commenced on behalf of investors who purchased Alibaba Group Holding Limited (BABA) securities between July 9, 2020  and December 23, 2020. For more on the Alibaba Class Action please contact us today.

 

According to the Alibaba lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Ant Small and Micro Financial Services Group Co., Ltd. (“Ant Group”), a financial technology company in which Alibaba owns a 33% equity interest, did not meet listing qualifications or disclosure requirements for certain material matters; (2) certain impending changes in the Fintech regulatory environment would impact Ant Group’s business; (3) as a result of the foregoing, Ant Group’s initial public offering was reasonably likely to be suspended; and (4) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE BABA CLASS ACTION, CLICK HERE

 

If you suffered a loss in Alibaba you have until January 12, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Biogen Inc. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a BIIB class action lawsuit has been commenced on behalf of investors who purchased Biogen Inc. (BIIB) securities between October 22, 2019 and November 6, 2019. For more on the Biogen Class Action please contact us today.

 

According to the Biogen lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:(1) the larger dataset did not provide necessary data regarding aducanumab’s effectiveness; (2) the EMERGE study did not and would not provide necessary data regarding the effectiveness of aducanumab, Biogen’s investigational human monoclonal antibody studied for the treatment of early Alzheimer’s disease; (3) the PRIME study did not and would not provide necessary data regarding aducanumab’s effectiveness; (4) the data provided by the Company to the U.S. Food and Drug Administration’s Peripheral and Central Nervous System Drugs Advisory Committee did not support finding efficacy of aducanumab; and (5) as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

 

TO LEARN MORE ABOUT THE BIIB CLASS ACTION, CLICK HERE

 

If you suffered a loss in Biogen you have until January 12, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Northern Dynasty Minerals Ltd. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a NAK class action lawsuit has been commenced on behalf of investors who purchased Northern Dynasty Minerals Ltd. (NAK) securities between December 21, 2017 and November 25, 2020. For more on the Northern Dynasty Class Action please contact us today.

 

According to the Northern Dynasty lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:  (1) the Company’s Pebble Project was contrary to Clean Water Act guidelines and to the public interest; (2) the Company planned that the Pebble Project would be larger in duration and scope than conveyed to the public; (3) as a result, the Company’s permit applications for the Pebble Project would be denied by the U.S. Army Corps of Engineers; and (4) as a result, Defendants’ public statements were materially false and/or misleading at all relevant times.

 

TO LEARN MORE ABOUT THE NAK CLASS ACTION, CLICK HERE

 

If you suffered a loss in Northern Dynasty you have until February 2, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Changyou.com Limited Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a CYOU/SOHU class action lawsuit has been commenced on behalf of investors who purchased Changyou.com Limited (CYOU,SOHU) securities between February 14, 2020 and April 23, 2020. For more on the Changyou Class Action please contact us today.

 

According to the Changyou lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: it did not support its disclosed legal conclusions and is at odds with the text of the relevant Cayman Islands statute regarding appraisal rights. Moreover, the Company failed to disclose other rights that may be available to Changyou shareholders under Cayman Islands law, in clear violation of the federal securities laws.

 

TO LEARN MORE ABOUT THE CYOU/SOHU CLASS ACTION, CLICK HERE

 

If you suffered a loss in Changyou you have until February 8, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

QuantumScape Corporation f/k/a Kensington Capital Acquisition Corp. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a QS class action lawsuit has been commenced on behalf of investors who purchased QuantumScape Corporation f/k/a Kensington Capital Acquisition Corp. (QS) securities between December 8, 2020 and December 31, 2020. For more on the QuantumScape Class Action please contact us today.

 

According to the QuantumScape lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:  (1) that the Company’s purported success related to its solid-state battery power, battery life, and energy density were significantly overstated; (2) that the Company is unlikely to be able to scale its technology to the multi-layer cell necessary to power electric vehicles; and (3) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE QS CLASS ACTION, CLICK HERE

 

If you suffered a loss in QuantumScape you have until March 8, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

JOYY Inc. Class Action Lawsuits

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a YY class action lawsuit has been commenced on behalf of investors who purchased Joyy Inc. (YY) securities between April 28, 2016 and November 18, 2020. For more on the Joyy Class Action please contact us today.

 

According to the Joyy lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) JOYY dramatically overstated its revenues from live streaming sources; (2) The majority of users at any given time were bots; (2) the Company utilized these bots to effect a roundtripping scheme that Manufactured the false appearance of revenues; (3) the Company overstated its cash reserves; (4) the Company’s acquisition of Bigo was largely contrived to benefit corporate insiders; and (5) as a result, Defendants’ public statements were materially false and/or Misleading at all relevant times.

 

TO LEARN MORE ABOUT THE YY CLASS ACTION, CLICK HERE

 

If you suffered a loss in Joyy you have until January 19, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Pinterest, Inc. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a PINS class action lawsuit has been commenced on behalf of investors who purchased Pinterest, Inc. (PINS) securities between May 16, 2019 and November 1, 2019. For more on the Pinterest Class Action please contact us today.

 

According to the Pinterest lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) the Company’s addressable market in the U.S. was reaching its maximum capacity; (ii) which significantly decelerated Pinterest’s future ability to monetize on U.S. average revenue per user; (iii) Pinterest was at an increased risk of losing advertising revenue; (iv) and as a result, Defendants’ public statements were materially false and misleading at all relevant times or lacked a reasonable basis and omitted material facts.

 

TO LEARN MORE ABOUT THE PINS CLASS ACTION, CLICK HERE

 

If you suffered a loss in Pinterest you have until January 22, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

K12 Inc. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a LRN class action lawsuit has been commenced on behalf of investors who purchased K12 Inc. (LRN) securities between April 27, 2020 and September 18, 2020. For more on the K12 Class Action please contact us today.

 

According to the K12 lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) K12 lacked the technological capabilities, infrastructures, and expertise to support the increased demand for virtual and blended education necessitated by the global pandemic; (ii) K12 lacked adequate cyberattack protocols and protections to prevent the disabling of its computer system; (iii) K12 was unable provide the necessary levels of administrative support and training to teachers, students, and parents; and (iv) based on the foregoing, Defendants lacked a reasonable basis for their positive statements about the Company’s business, operations, and prospects and/or lacked a reasonable basis and omitted facts.

 

TO LEARN MORE ABOUT THE LRN CLASS ACTION, CLICK HERE

 

If you suffered a loss in K12 you have until January 19, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Minerva Neurosciences Inc. Class Actions Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a NERV class action lawsuit has been commenced on behalf of investors who purchased Minerva Neurosciences Inc. (NERV) securities between May 15, 2017 and November 30, 2020. For more on the Minerva Neurosciences Class Action please contact us today.

 

According to the Minerva Neurosciences lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) the truth about the feedback received from the FDA concerning the “end-of-Phase 2” meeting; (ii) the Phase 2b study did not use the commercial formulation of roluperidone and was conducted solely outside of the United States; (iii) the failure of the Phase 3 study to meet its primary and key secondary endpoints rendered that study incapable of supporting substantial evidence of effectiveness; (iv) the Company’s plan to use the combination of the Phase 2b and Phase 3 studies would be “highly unlikely” to support the submission of an NDA; (v) reliance on these two trials in the submission of an NDA would lead to “substantial review issues” because the trials were inadequate and not well-controlled; and (vi) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE NERV CLASS ACTION, CLICK HERE

 

If you suffered a loss in Minerva Neurosciences you have until February 8, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Kandi Technologies Group, Inc. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a KNDI class action lawsuit has been commenced on behalf of investors who purchased Kandi Technologies Group, Inc. (KNDI) securities between March 15, 2019 and November 27, 2020 . For more on the Kandi Class Action please contact us today.

 

According to the Kandi lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:  (i) Kandi artificially inflated its reported revenues through undisclosed related party transactions, or otherwise had relationships with key customers that indicated those customers did not have an arms length relationship with Kandi; (ii) the majority of Kandi’s sales in the past year had been to undisclosed related parties and/or parties with such a close relationship and history with Kandi that it cast doubt on the arms-length nature of their relationship; (iii) all the foregoing, once revealed, was foreseeably likely to cast doubt on the validity of Kandi’s reported revenues and, in turn, have a foreseeable negative impact on the Company’s reputation and valuation; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE KNDI CLASS ACTION, CLICK HERE

 

If you suffered a loss in Kandi you have until February 9, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

GoodRx Holdings, Inc. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a GDRX class action lawsuit has been commenced on behalf of investors who purchased GoodRx Holdings, Inc. (GDRX) securities between September 23, 2020 and November 16, 2020. For more on the GoodRx Class Action please contact us today.

 

According to the GoodRx lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:  at the time of the IPO, unbeknownst to investors, Amazon.com, Inc. was developing and would soon introduce its own online and mobile prescription medication ordering and fulfillment service that would directly compete with GoodRx. Defendants timed the IPO so that it was priced before Amazon announced its online pharmaceutical business to facilitate the IPO and create artificial demand for the common shares sold therein, as well to maximize the amount of money the Company and the selling stockholders could raise in the IPO. Given defendants’ knowledge of Amazon’s intention to enter the online pharmaceutical business, and their misleading statements about GoodRx’s competitive position made contemporaneously with that knowledge, defendants’ materially false and/or misleading statements alleged herein were made willfully and caused GoodRx common stock to trade at artificially inflated prices during the Class Period.

 

TO LEARN MORE ABOUT THE GDRX CLASS ACTION, CLICK HERE

 

If you suffered a loss in GoodRx you have until February 16, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

SolarWinds Corporation Class Action Lawsuit

Levi & Korsinsky, LLP

January 11, 2021

Levi & Korsinsky, LLP announces that a SWI class action lawsuit has been commenced on behalf of investors who purchased SolarWinds Corporation (SWI) securities between March 1, 2020 and December 14, 2020. For more on the SolarWinds Class Action please contact us today.

 

According to the SolarWinds lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) since mid-2020, SolarWinds Orion monitoring products had a vulnerability that allowed hackers to compromise the server upon which the products ran; (2) SolarWinds’ update server had an easily accessible password of ‘solarwinds123′; (3) consequently, SolarWinds’ customers, including, among others, the Federal Government, Microsoft, Cisco, and Nvidia, would be vulnerable to hacks; (4) as a result, the Company would suffer significant reputational harm; and (5) as a result, Defendants’ statements about SolarWinds’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

 

TO LEARN MORE ABOUT THE SWI CLASS ACTION, CLICK HERE

 

If you suffered a loss in SolarWinds you have until March 5, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Boston Scientific Corporation Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a BSX class action lawsuit has been commenced on behalf of investors who purchased Boston Scientific Corporation (BSX) securities between April 24, 2019 and November 16, 2020. For more on the Boston Scientific Class Action please contact us today.

 

According to the Boston Scientific lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) the LOTUS Edge Aortic Valve System’s product delivery system was dysfunctional and threatened the continued viability of the entire product line; (ii) as a result, the Company had materially overstated the continued commercial viability and profitability of the LOTUS Edge Aortic Valve System; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE BSX CLASS ACTION, CLICK HERE

 

If you suffered a loss in Boston Scientific you have until February 2, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Berry Corporation Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a BRY class action lawsuit has been commenced on behalf of investors who purchased Berry Corporation (BRY) securities between July 26, 2018 and November 3, 2020. For more on the Berry Class Action please contact us today.

 

According to the Berry lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:  (i) Berry had materially overstated its operational efficiency and stability; (ii) Berry’s operational inefficiency and instability would foreseeably necessitate operational improvements that would disrupt the Company’s productivity and increase costs; (iii) the foregoing would foreseeably negatively impact the Company’s revenues; and (iv) as a result, the Offering Documents and the Company’s public statements were materially false and/or misleading and failed to state information required to be stated therein.

 

TO LEARN MORE ABOUT THE BRY CLASS ACTION, CLICK HERE

 

If you suffered a loss in Berry you have until January 21, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Tricida, Inc. Class Actions Lawsuit

Levi & Korsinsky, LLP

January 8, 2021

Levi & Korsinsky, LLP announces that a TCDA class action lawsuit has been commenced on behalf of investors who purchased Tricida, Inc. (TCDA) securities between September 4, 2019 and October 28, 2020. For more on the Tricida Class Action please contact us today.

 

According to the Interface lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) Tricida’s NDA for veverimer was materially deficient; (ii) accordingly, it was foreseeably likely that the FDA would not accept the NDA for veverimer; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE TCDA CLASS ACTION, CLICK HERE

 

If you suffered a loss in Interface you have until March 8, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Interface, Inc. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a TILE class action lawsuit has been commenced on behalf of investors who purchased Interface, Inc. (TILE) securities between March 2, 2018 and September 28, 2020. For more on the Interface Class Action please contact us today.

 

According to the Interface lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) Interface had inadequate disclosure controls and procedures and internal control over financial reporting; (ii) consequently, Interface, inter alia, reported artificially inflated income and earnings per share (“EPS”) in 2015 and 2016; (iii) Interface and certain of its employees were under investigation by the SEC with respect to the foregoing issues since at least as early as November 2017, had impeded the SEC’s investigation, and downplayed the true scope of the Company’s wrongdoing and liability with respect to the SEC investigation; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE TILE CLASS ACTION, CLICK HERE

 

If you suffered a loss in Interface you have until January 11, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Changyou.com Limited Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a CYOU/SOHU class action lawsuit has been commenced on behalf of investors who purchased Changyou.com Limited (CYOU,SOHU) securities between February 14, 2020 and April 23, 2020. For more on the Changyou Class Action please contact us today.

 

According to the Changyou lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: it did not support its disclosed legal conclusions and is at odds with the text of the relevant Cayman Islands statute regarding appraisal rights. Moreover, the Company failed to disclose other rights that may be available to Changyou shareholders under Cayman Islands law, in clear violation of the federal securities laws.

 

TO LEARN MORE ABOUT THE CYOU/SOHU CLASS ACTION, CLICK HERE

 

If you suffered a loss in Changyou you have until February 8, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Splunk Inc. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a SPLK class action lawsuit has been commenced on behalf of investors who purchased Splunk Inc. (SPLK) securities between  October 21, 2020 and December 2, 2020. For more on the Splunk Class Action please contact us today.

 

According to the Splunk lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Splunk was not closing deals with its largest customers in the third fiscal quarter of 2021; (2) Splunk was not hitting the financial targets it had previously announced; and (3) as a result of the foregoing, Defendants’ public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE SPLK CLASS ACTION, CLICK HERE

 

If you suffered a loss in Splunk you have until February 2, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Restaurant Brands International Inc. Class Action Lawsuits

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a QSR class action lawsuit has been commenced on behalf of investors who purchased Restaurant Brands International (QSR) securities between April 29, 2019 and October 28, 2019. For more on the Restaurant Brands Class Action please contact us today.

 

According to the Restaurant Brands lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company’s Winning Together Plan was failing to generate substantial, sustainable improvement within the Tim Hortons brand; (2) the Tims Rewards loyalty program was not generating sustainable revenue growth as increased customer traffic was not offsetting promotional discounting; and (3) as a result, Defendants’ statements about the Company’s business, operations, and prospects lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE QSR CLASS ACTION, CLICK HERE

 

If you suffered a loss in Restaurant Brands you have until February 19, 2021  to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Qiwi plc Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a QIWI class action lawsuit has been commenced on behalf of investors who purchased Qiwi plc (QIWI) securities between March 28, 2019 and December 9, 2020. For more on the Qiwi Class Action please contact us today.

 

According to the Qiwi lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:(1) Qiwi’s internal controls related to reporting and record-keeping were ineffective; (2) consequently, the Central Bank of Russia would impose a monetary fine upon the Company and impose restrictions upon the Company’s ability to make payments to foreign merchants and transfer money to pre-paid cards; and (3) as a result, Defendants’ public statements were materially false and/or misleading at all relevant times.

 

TO LEARN MORE ABOUT THE QIWI CLASS ACTION, CLICK HERE

 

If you suffered a loss in QIWI you have until February 9, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

K12 Inc. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a LRN class action lawsuit has been commenced on behalf of investors who purchased K12 Inc. (LRN) securities between April 27, 2020 and September 18, 2020. For more on the K12 Class Action please contact us today.

 

According to the K12 lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) K12 lacked the technological capabilities, infrastructures, and expertise to support the increased demand for virtual and blended education necessitated by the global pandemic; (ii) K12 lacked adequate cyberattack protocols and protections to prevent the disabling of its computer system; (iii) K12 was unable provide the necessary levels of administrative support and training to teachers, students, and parents; and (iv) based on the foregoing, Defendants lacked a reasonable basis for their positive statements about the Company’s business, operations, and prospects and/or lacked a reasonable basis and omitted facts.

 

TO LEARN MORE ABOUT THE LRN CLASS ACTION, CLICK HERE

 

If you suffered a loss in K12 you have until January 19, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Northern Dynasty Minerals Ltd. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a NAK class action lawsuit has been commenced on behalf of investors who purchased Northern Dynasty Minerals Ltd. (NAK) securities between December 21, 2017 and November 25, 2020. For more on the Northern Dynasty Class Action please contact us today.

 

According to the Northern Dynasty lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:  (1) the Company’s Pebble Project was contrary to Clean Water Act guidelines and to the public interest; (2) the Company planned that the Pebble Project would be larger in duration and scope than conveyed to the public; (3) as a result, the Company’s permit applications for the Pebble Project would be denied by the U.S. Army Corps of Engineers; and (4) as a result, Defendants’ public statements were materially false and/or misleading at all relevant times.

 

TO LEARN MORE ABOUT THE NAK CLASS ACTION, CLICK HERE

 

If you suffered a loss in Northern Dynasty you have until February 2, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Boston Scientific Corporation Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a BSX class action lawsuit has been commenced on behalf of investors who purchased Boston Scientific Corporation (BSX) securities between April 24, 2019 and November 16, 2020. For more on the Boston Scientific Class Action please contact us today.

 

According to the Boston Scientific lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) the LOTUS Edge Aortic Valve System’s product delivery system was dysfunctional and threatened the continued viability of the entire product line; (ii) as a result, the Company had materially overstated the continued commercial viability and profitability of the LOTUS Edge Aortic Valve System; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE BSX CLASS ACTION, CLICK HERE

 

If you suffered a loss in Boston Scientific you have until February 2, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Pinterest, Inc. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a PINS class action lawsuit has been commenced on behalf of investors who purchased Pinterest, Inc. (PINS) securities between May 16, 2019 and November 1, 2019. For more on the Pinterest Class Action please contact us today.

 

According to the Pinterest lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) the Company’s addressable market in the U.S. was reaching its maximum capacity; (ii) which significantly decelerated Pinterest’s future ability to monetize on U.S. average revenue per user; (iii) Pinterest was at an increased risk of losing advertising revenue; (iv) and as a result, Defendants’ public statements were materially false and misleading at all relevant times or lacked a reasonable basis and omitted material facts.

 

TO LEARN MORE ABOUT THE PINS CLASS ACTION, CLICK HERE

 

If you suffered a loss in Pinterest you have until January 22, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

QuantumScape Corporation f/k/a Kensington Capital Acquisition Corp. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a QS class action lawsuit has been commenced on behalf of investors who purchased QuantumScape Corporation f/k/a Kensington Capital Acquisition Corp. (QS) securities between December 8, 2020 and December 31, 2020. For more on the QuantumScape Class Action please contact us today.

 

According to the QuantumScape lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:  (1) that the Company’s purported success related to its solid-state battery power, battery life, and energy density were significantly overstated; (2) that the Company is unlikely to be able to scale its technology to the multi-layer cell necessary to power electric vehicles; and (3) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE QS CLASS ACTION, CLICK HERE

 

If you suffered a loss in QuantumScape you have until March 8, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

SolarWinds Corporation Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a SWI class action lawsuit has been commenced on behalf of investors who purchased SolarWinds Corporation (SWI) securities between March 1, 2020 and December 14, 2020. For more on the SolarWinds Class Action please contact us today.

 

According to the SolarWinds lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) since mid-2020, SolarWinds Orion monitoring products had a vulnerability that allowed hackers to compromise the server upon which the products ran; (2) SolarWinds’ update server had an easily accessible password of ‘solarwinds123′; (3) consequently, SolarWinds’ customers, including, among others, the Federal Government, Microsoft, Cisco, and Nvidia, would be vulnerable to hacks; (4) as a result, the Company would suffer significant reputational harm; and (5) as a result, Defendants’ statements about SolarWinds’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

 

TO LEARN MORE ABOUT THE SWI CLASS ACTION, CLICK HERE

 

If you suffered a loss in SolarWinds you have until March 5, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Kandi Technologies Group, Inc. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a KNDI class action lawsuit has been commenced on behalf of investors who purchased Kandi Technologies Group, Inc. (KNDI) securities between March 15, 2019 and November 27, 2020 . For more on the Kandi Class Action please contact us today.

 

According to the Kandi lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:  (i) Kandi artificially inflated its reported revenues through undisclosed related party transactions, or otherwise had relationships with key customers that indicated those customers did not have an arms length relationship with Kandi; (ii) the majority of Kandi’s sales in the past year had been to undisclosed related parties and/or parties with such a close relationship and history with Kandi that it cast doubt on the arms-length nature of their relationship; (iii) all the foregoing, once revealed, was foreseeably likely to cast doubt on the validity of Kandi’s reported revenues and, in turn, have a foreseeable negative impact on the Company’s reputation and valuation; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE KNDI CLASS ACTION, CLICK HERE

 

If you suffered a loss in Kandi you have until February 9, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Alibaba Group Holding Limited Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a BABA class action lawsuit has been commenced on behalf of investors who purchased Alibaba Group Holding Limited (BABA) securities between July 20, 2020  and November 3, 2020. For more on the Alibaba Class Action please contact us today.

 

According to the Alibaba lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Ant Small and Micro Financial Services Group Co., Ltd. (“Ant Group”), a financial technology company in which Alibaba owns a 33% equity interest, did not meet listing qualifications or disclosure requirements for certain material matters; (2) certain impending changes in the Fintech regulatory environment would impact Ant Group’s business; (3) as a result of the foregoing, Ant Group’s initial public offering was reasonably likely to be suspended; and (4) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE BABA CLASS ACTION, CLICK HERE

 

If you suffered a loss in Alibaba you have until January 12, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Triterras, Inc., f/k/a Netfin Acquisition Corp. Class Action Lawsuit

Levi & Korsinsky, LLP

January 7, 2021

Levi & Korsinsky, LLP reminds shareholders that a TRIT class action lawsuit has been commenced on behalf of investors who purchased Triterras, Inc., f/k/a Netfin Acquisition Corp. (TRIT) securities between August 20, 2020 and December 16, 2020. For more on the Triterras’ Class Action please contact us today.

 

According to the Triterras’ lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the extent to which Company’s revenue growth relied on Triterras’ relationship with Rhodium to refer users to the Kratos platform; (2) that Rhodium faced significant financial liabilities that jeopardized its ability to continue as a going concern; (3) that, as a result, Rhodium was likely to refer fewer users to the Company’s Kratos platform; and (4) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE TRIT CLASS ACTION, CLICK HERE

 

If you suffered a loss in Triterras’ you have until February 19, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Qiwi plc Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a QIWI class action lawsuit has been commenced on behalf of investors who purchased Qiwi plc (QIWI) securities between March 28, 2019 and December 9, 2020. For more on the Qiwi Class Action please contact us today.

 

According to the Qiwi lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:(1) Qiwi’s internal controls related to reporting and record-keeping were ineffective; (2) consequently, the Central Bank of Russia would impose a monetary fine upon the Company and impose restrictions upon the Company’s ability to make payments to foreign merchants and transfer money to pre-paid cards; and (3) as a result, Defendants’ public statements were materially false and/or misleading at all relevant times.

 

TO LEARN MORE ABOUT THE QIWI CLASS ACTION, CLICK HERE

 

If you suffered a loss in QIWI you have until February 9, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Kandi Technologies Group, Inc. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a KNDI class action lawsuit has been commenced on behalf of investors who purchased Kandi Technologies Group, Inc. (KNDI) securities between March 15, 2019 and November 27, 2020 . For more on the Kandi Class Action please contact us today.

 

According to the Kandi lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:  (i) Kandi artificially inflated its reported revenues through undisclosed related party transactions, or otherwise had relationships with key customers that indicated those customers did not have an arms length relationship with Kandi; (ii) the majority of Kandi’s sales in the past year had been to undisclosed related parties and/or parties with such a close relationship and history with Kandi that it cast doubt on the arms-length nature of their relationship; (iii) all the foregoing, once revealed, was foreseeably likely to cast doubt on the validity of Kandi’s reported revenues and, in turn, have a foreseeable negative impact on the Company’s reputation and valuation; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE KNDI CLASS ACTION, CLICK HERE

 

If you suffered a loss in Kandi you have until February 9, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

JOYY Inc. Class Action Lawsuits

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a YY class action lawsuit has been commenced on behalf of investors who purchased Joyy Inc. (YY) securities between April 28, 2016 and November 18, 2020. For more on the Joyy Class Action please contact us today.

 

According to the Joyy lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) JOYY dramatically overstated its revenues from live streaming sources; (2) The majority of users at any given time were bots; (2) the Company utilized these bots to effect a roundtripping scheme that Manufactured the false appearance of revenues; (3) the Company overstated its cash reserves; (4) the Company’s acquisition of Bigo was largely contrived to benefit corporate insiders; and (5) as a result, Defendants’ public statements were materially false and/or Misleading at all relevant times.

 

TO LEARN MORE ABOUT THE YY CLASS ACTION, CLICK HERE

 

If you suffered a loss in Joyy you have until January 19, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

QuantumScape Corporation f/k/a Kensington Capital Acquisition Corp. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a QS class action lawsuit has been commenced on behalf of investors who purchased QuantumScape Corporation f/k/a Kensington Capital Acquisition Corp. (QS) securities between December 8, 2020 and December 31, 2020. For more on the QuantumScape Class Action please contact us today.

 

According to the QuantumScape lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:  (1) that the Company’s purported success related to its solid-state battery power, battery life, and energy density were significantly overstated; (2) that the Company is unlikely to be able to scale its technology to the multi-layer cell necessary to power electric vehicles; and (3) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE QS CLASS ACTION, CLICK HERE

 

If you suffered a loss in QuantumScape you have until March 8, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Changyou.com Limited Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a CYOU/SOHU class action lawsuit has been commenced on behalf of investors who purchased Changyou.com Limited (CYOU,SOHU) securities between February 14, 2020 and April 23, 2020. For more on the Changyou Class Action please contact us today.

 

According to the Changyou lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: it did not support its disclosed legal conclusions and is at odds with the text of the relevant Cayman Islands statute regarding appraisal rights. Moreover, the Company failed to disclose other rights that may be available to Changyou shareholders under Cayman Islands law, in clear violation of the federal securities laws.

 

TO LEARN MORE ABOUT THE CYOU/SOHU CLASS ACTION, CLICK HERE

 

If you suffered a loss in Changyou you have until February 8, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

SolarWinds Corporation Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a SWI class action lawsuit has been commenced on behalf of investors who purchased SolarWinds Corporation (SWI) securities between March 1, 2020 and December 14, 2020. For more on the SolarWinds Class Action please contact us today.

 

According to the SolarWinds lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) since mid-2020, SolarWinds Orion monitoring products had a vulnerability that allowed hackers to compromise the server upon which the products ran; (2) SolarWinds’ update server had an easily accessible password of ‘solarwinds123′; (3) consequently, SolarWinds’ customers, including, among others, the Federal Government, Microsoft, Cisco, and Nvidia, would be vulnerable to hacks; (4) as a result, the Company would suffer significant reputational harm; and (5) as a result, Defendants’ statements about SolarWinds’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

 

TO LEARN MORE ABOUT THE SWI CLASS ACTION, CLICK HERE

 

If you suffered a loss in SolarWinds you have until March 5, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

CD Projekt S.A. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a OTGLY/OTGLF class action lawsuit has been commenced on behalf of investors who purchased CD Projekt S.A. (OTGLY,OTGLF) securities between January 16, 2020 and December 17, 2020. For more on the CD Projekt Class Action please contact us today.

 

According to the CD Projekt lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: Throughout the class period, defendants were materially false and/or misleading because they misrepresented and failed to disclose the following adverse facts pertaining to the Company’s business, operations and prospects, which were known to Defendants or recklessly disregarded by them. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (1) Cyberpunk 2077 was virtually unplayable on the current-generation Xbox or Playstation systems due to an enormous number of bugs; (2) as a result, Sony would remove Cyberpunk 2077 from the Playstation store, and Sony, Microsoft and the Company would be forced to offer full refunds for the game; (3) consequently, the Company would suffer reputational and pecuniary harm; and (4) as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

 

TO LEARN MORE ABOUT THE OTGLY/OTGLF CLASS ACTION, CLICK HERE

 

If you suffered a loss in CD Projekt you have until February 22, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

GoodRx Holdings, Inc. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a GDRX class action lawsuit has been commenced on behalf of investors who purchased GoodRx Holdings, Inc. (GDRX) securities between September 23, 2020 and November 16, 2020. For more on the GoodRx Class Action please contact us today.

 

According to the GoodRx lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:  at the time of the IPO, unbeknownst to investors, Amazon.com, Inc. was developing and would soon introduce its own online and mobile prescription medication ordering and fulfillment service that would directly compete with GoodRx. Defendants timed the IPO so that it was priced before Amazon announced its online pharmaceutical business to facilitate the IPO and create artificial demand for the common shares sold therein, as well to maximize the amount of money the Company and the selling stockholders could raise in the IPO. Given defendants’ knowledge of Amazon’s intention to enter the online pharmaceutical business, and their misleading statements about GoodRx’s competitive position made contemporaneously with that knowledge, defendants’ materially false and/or misleading statements alleged herein were made willfully and caused GoodRx common stock to trade at artificially inflated prices during the Class Period.

 

TO LEARN MORE ABOUT THE GDRX CLASS ACTION, CLICK HERE

 

If you suffered a loss in GoodRx you have until February 16, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Interface, Inc. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a TILE class action lawsuit has been commenced on behalf of investors who purchased Interface, Inc. (TILE) securities between March 2, 2018 and September 28, 2020. For more on the Interface Class Action please contact us today.

 

According to the Interface lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) Interface had inadequate disclosure controls and procedures and internal control over financial reporting; (ii) consequently, Interface, inter alia, reported artificially inflated income and earnings per share (“EPS”) in 2015 and 2016; (iii) Interface and certain of its employees were under investigation by the SEC with respect to the foregoing issues since at least as early as November 2017, had impeded the SEC’s investigation, and downplayed the true scope of the Company’s wrongdoing and liability with respect to the SEC investigation; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE TILE CLASS ACTION, CLICK HERE

 

If you suffered a loss in Interface you have until January 11, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Minerva Neurosciences Inc. Class Actions Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a NERV class action lawsuit has been commenced on behalf of investors who purchased Minerva Neurosciences Inc. (NERV) securities between May 15, 2017 and November 30, 2020. For more on the Minerva Neurosciences Class Action please contact us today.

 

According to the Minerva Neurosciences lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) the truth about the feedback received from the FDA concerning the “end-of-Phase 2” meeting; (ii) the Phase 2b study did not use the commercial formulation of roluperidone and was conducted solely outside of the United States; (iii) the failure of the Phase 3 study to meet its primary and key secondary endpoints rendered that study incapable of supporting substantial evidence of effectiveness; (iv) the Company’s plan to use the combination of the Phase 2b and Phase 3 studies would be “highly unlikely” to support the submission of an NDA; (v) reliance on these two trials in the submission of an NDA would lead to “substantial review issues” because the trials were inadequate and not well-controlled; and (vi) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE NERV CLASS ACTION, CLICK HERE

 

If you suffered a loss in Minerva Neurosciences you have until February 8, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Restaurant Brands International Inc. Class Action Lawsuits

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a QSR class action lawsuit has been commenced on behalf of investors who purchased Restaurant Brands International (QSR) securities between April 29, 2019 and October 28, 2019. For more on the Restaurant Brands Class Action please contact us today.

 

According to the Restaurant Brands lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company’s Winning Together Plan was failing to generate substantial, sustainable improvement within the Tim Hortons brand; (2) the Tims Rewards loyalty program was not generating sustainable revenue growth as increased customer traffic was not offsetting promotional discounting; and (3) as a result, Defendants’ statements about the Company’s business, operations, and prospects lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE QSR CLASS ACTION, CLICK HERE

 

If you suffered a loss in Restaurant Brands you have until February 19, 2021  to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Pinterest, Inc. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a PINS class action lawsuit has been commenced on behalf of investors who purchased Pinterest, Inc. (PINS) securities between May 16, 2019 and November 1, 2019. For more on the Pinterest Class Action please contact us today.

 

According to the Pinterest lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) the Company’s addressable market in the U.S. was reaching its maximum capacity; (ii) which significantly decelerated Pinterest’s future ability to monetize on U.S. average revenue per user; (iii) Pinterest was at an increased risk of losing advertising revenue; (iv) and as a result, Defendants’ public statements were materially false and misleading at all relevant times or lacked a reasonable basis and omitted material facts.

 

TO LEARN MORE ABOUT THE PINS CLASS ACTION, CLICK HERE

 

If you suffered a loss in Pinterest you have until January 22, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Berry Corporation Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a BRY class action lawsuit has been commenced on behalf of investors who purchased Berry Corporation (BRY) securities between July 26, 2018 and November 3, 2020. For more on the Berry Class Action please contact us today.

 

According to the Berry lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:  (i) Berry had materially overstated its operational efficiency and stability; (ii) Berry’s operational inefficiency and instability would foreseeably necessitate operational improvements that would disrupt the Company’s productivity and increase costs; (iii) the foregoing would foreseeably negatively impact the Company’s revenues; and (iv) as a result, the Offering Documents and the Company’s public statements were materially false and/or misleading and failed to state information required to be stated therein.

 

TO LEARN MORE ABOUT THE BRY CLASS ACTION, CLICK HERE

 

If you suffered a loss in Berry you have until January 21, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Boston Scientific Corporation Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a BSX class action lawsuit has been commenced on behalf of investors who purchased Boston Scientific Corporation (BSX) securities between April 24, 2019 and November 16, 2020. For more on the Boston Scientific Class Action please contact us today.

 

According to the Boston Scientific lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) the LOTUS Edge Aortic Valve System’s product delivery system was dysfunctional and threatened the continued viability of the entire product line; (ii) as a result, the Company had materially overstated the continued commercial viability and profitability of the LOTUS Edge Aortic Valve System; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE BSX CLASS ACTION, CLICK HERE

 

If you suffered a loss in Boston Scientific you have until February 2, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Northern Dynasty Minerals Ltd. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a NAK class action lawsuit has been commenced on behalf of investors who purchased Northern Dynasty Minerals Ltd. (NAK) securities between December 21, 2017 and November 25, 2020. For more on the Northern Dynasty Class Action please contact us today.

 

According to the Northern Dynasty lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:  (1) the Company’s Pebble Project was contrary to Clean Water Act guidelines and to the public interest; (2) the Company planned that the Pebble Project would be larger in duration and scope than conveyed to the public; (3) as a result, the Company’s permit applications for the Pebble Project would be denied by the U.S. Army Corps of Engineers; and (4) as a result, Defendants’ public statements were materially false and/or misleading at all relevant times.

 

TO LEARN MORE ABOUT THE NAK CLASS ACTION, CLICK HERE

 

If you suffered a loss in Northern Dynasty you have until February 2, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Splunk Inc. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a SPLK class action lawsuit has been commenced on behalf of investors who purchased Splunk Inc. (SPLK) securities between  October 21, 2020 and December 2, 2020. For more on the Splunk Class Action please contact us today.

 

According to the Splunk lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Splunk was not closing deals with its largest customers in the third fiscal quarter of 2021; (2) Splunk was not hitting the financial targets it had previously announced; and (3) as a result of the foregoing, Defendants’ public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE SPLK CLASS ACTION, CLICK HERE

 

If you suffered a loss in Splunk you have until February 2, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

CD Projekt S.A. Class Action Lawsuit

Levi & Korsinsky, LLP

January 6, 2021

Levi & Korsinsky, LLP reminds shareholders that a OTGLY/OTGLF class action lawsuit has been commenced on behalf of investors who purchased CD Projekt S.A. (OTGLY,OTGLF) securities between January 16, 2020 and December 17, 2020. For more on the CD Projekt Class Action please contact us today.

 

According to the CD Projekt lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: Throughout the class period, defendants were materially false and/or misleading because they misrepresented and failed to disclose the following adverse facts pertaining to the Company’s business, operations and prospects, which were known to Defendants or recklessly disregarded by them. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (1) Cyberpunk 2077 was virtually unplayable on the current-generation Xbox or Playstation systems due to an enormous number of bugs; (2) as a result, Sony would remove Cyberpunk 2077 from the Playstation store, and Sony, Microsoft and the Company would be forced to offer full refunds for the game; (3) consequently, the Company would suffer reputational and pecuniary harm; and (4) as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

 

TO LEARN MORE ABOUT THE OTGLY/OTGLF CLASS ACTION, CLICK HERE

 

If you suffered a loss in CD Projekt you have until February 22, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Biogen Inc. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a BIIB class action lawsuit has been commenced on behalf of investors who purchased Biogen Inc. (BIIB) securities between October 22, 2019 and November 6, 2019. For more on the Biogen Class Action please contact us today.

 

According to the Biogen lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:(1) the larger dataset did not provide necessary data regarding aducanumab’s effectiveness; (2) the EMERGE study did not and would not provide necessary data regarding the effectiveness of aducanumab, Biogen’s investigational human monoclonal antibody studied for the treatment of early Alzheimer’s disease; (3) the PRIME study did not and would not provide necessary data regarding aducanumab’s effectiveness; (4) the data provided by the Company to the U.S. Food and Drug Administration’s Peripheral and Central Nervous System Drugs Advisory Committee did not support finding efficacy of aducanumab; and (5) as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

 

TO LEARN MORE ABOUT THE BIIB CLASS ACTION, CLICK HERE

 

If you suffered a loss in Biogen you have until January 12, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Kandi Technologies Group, Inc. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a KNDI class action lawsuit has been commenced on behalf of investors who purchased Kandi Technologies Group, Inc. (KNDI) securities between March 15, 2019 and November 27, 2020 . For more on the Kandi Class Action please contact us today.

 

According to the Kandi lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:  (i) Kandi artificially inflated its reported revenues through undisclosed related party transactions, or otherwise had relationships with key customers that indicated those customers did not have an arms length relationship with Kandi; (ii) the majority of Kandi’s sales in the past year had been to undisclosed related parties and/or parties with such a close relationship and history with Kandi that it cast doubt on the arms-length nature of their relationship; (iii) all the foregoing, once revealed, was foreseeably likely to cast doubt on the validity of Kandi’s reported revenues and, in turn, have a foreseeable negative impact on the Company’s reputation and valuation; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE KNDI CLASS ACTION, CLICK HERE

 

If you suffered a loss in Kandi you have until February 9, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Changyou.com Limited Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a CYOU/SOHU class action lawsuit has been commenced on behalf of investors who purchased Changyou.com Limited (CYOU,SOHU) securities between February 14, 2020 and April 23, 2020. For more on the Changyou Class Action please contact us today.

 

According to the Changyou lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: it did not support its disclosed legal conclusions and is at odds with the text of the relevant Cayman Islands statute regarding appraisal rights. Moreover, the Company failed to disclose other rights that may be available to Changyou shareholders under Cayman Islands law, in clear violation of the federal securities laws.

 

TO LEARN MORE ABOUT THE CYOU/SOHU CLASS ACTION, CLICK HERE

 

If you suffered a loss in Changyou you have until February 8, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

GoodRx Holdings, Inc. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a GDRX class action lawsuit has been commenced on behalf of investors who purchased GoodRx Holdings, Inc. (GDRX) securities between September 23, 2020 and November 16, 2020. For more on the GoodRx Class Action please contact us today.

 

According to the GoodRx lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:  at the time of the IPO, unbeknownst to investors, Amazon.com, Inc. was developing and would soon introduce its own online and mobile prescription medication ordering and fulfillment service that would directly compete with GoodRx. Defendants timed the IPO so that it was priced before Amazon announced its online pharmaceutical business to facilitate the IPO and create artificial demand for the common shares sold therein, as well to maximize the amount of money the Company and the selling stockholders could raise in the IPO. Given defendants’ knowledge of Amazon’s intention to enter the online pharmaceutical business, and their misleading statements about GoodRx’s competitive position made contemporaneously with that knowledge, defendants’ materially false and/or misleading statements alleged herein were made willfully and caused GoodRx common stock to trade at artificially inflated prices during the Class Period.

 

TO LEARN MORE ABOUT THE GDRX CLASS ACTION, CLICK HERE

 

If you suffered a loss in GoodRx you have until February 16, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Berry Corporation Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a BRY class action lawsuit has been commenced on behalf of investors who purchased Berry Corporation (BRY) securities between July 26, 2018 and November 3, 2020. For more on the Berry Class Action please contact us today.

 

According to the Berry lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:  (i) Berry had materially overstated its operational efficiency and stability; (ii) Berry’s operational inefficiency and instability would foreseeably necessitate operational improvements that would disrupt the Company’s productivity and increase costs; (iii) the foregoing would foreseeably negatively impact the Company’s revenues; and (iv) as a result, the Offering Documents and the Company’s public statements were materially false and/or misleading and failed to state information required to be stated therein.

 

TO LEARN MORE ABOUT THE BRY CLASS ACTION, CLICK HERE

 

If you suffered a loss in Berry you have until January 21, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Alibaba Group Holding Limited Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a BABA class action lawsuit has been commenced on behalf of investors who purchased Alibaba Group Holding Limited (BABA) securities between July 20, 2020  and November 3, 2020. For more on the Alibaba Class Action please contact us today.

 

According to the Alibaba lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Ant Small and Micro Financial Services Group Co., Ltd. (“Ant Group”), a financial technology company in which Alibaba owns a 33% equity interest, did not meet listing qualifications or disclosure requirements for certain material matters; (2) certain impending changes in the Fintech regulatory environment would impact Ant Group’s business; (3) as a result of the foregoing, Ant Group’s initial public offering was reasonably likely to be suspended; and (4) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE BABA CLASS ACTION, CLICK HERE

 

If you suffered a loss in Alibaba you have until January 12, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

JOYY Inc. Class Action Lawsuits

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a YY class action lawsuit has been commenced on behalf of investors who purchased Joyy Inc. (YY) securities between April 28, 2016 and November 18, 2020. For more on the Joyy Class Action please contact us today.

 

According to the Joyy lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) JOYY dramatically overstated its revenues from live streaming sources; (2) The majority of users at any given time were bots; (2) the Company utilized these bots to effect a roundtripping scheme that Manufactured the false appearance of revenues; (3) the Company overstated its cash reserves; (4) the Company’s acquisition of Bigo was largely contrived to benefit corporate insiders; and (5) as a result, Defendants’ public statements were materially false and/or Misleading at all relevant times.

 

TO LEARN MORE ABOUT THE YY CLASS ACTION, CLICK HERE

 

If you suffered a loss in Joyy you have until January 19, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Restaurant Brands International Inc. Class Action Lawsuits

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a QSR class action lawsuit has been commenced on behalf of investors who purchased Restaurant Brands International (QSR) securities between April 29, 2019 and October 28, 2019. For more on the Restaurant Brands Class Action please contact us today.

 

According to the Restaurant Brands lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company’s Winning Together Plan was failing to generate substantial, sustainable improvement within the Tim Hortons brand; (2) the Tims Rewards loyalty program was not generating sustainable revenue growth as increased customer traffic was not offsetting promotional discounting; and (3) as a result, Defendants’ statements about the Company’s business, operations, and prospects lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE QSR CLASS ACTION, CLICK HERE

 

If you suffered a loss in Restaurant Brands you have until February 19, 2021  to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Biogen Inc. Class Action Lawsuit

Levi & Korsinsky, LLP

January 5, 2021

Levi & Korsinsky, LLP announces that a BIIB class action lawsuit has been commenced on behalf of investors who purchased Biogen Inc. (BIIB) securities between October 22, 2019 and November 6, 2019. For more on the Biogen Class Action please contact us today.

 

According to the Biogen lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:(1) the larger dataset did not provide necessary data regarding aducanumab’s effectiveness; (2) the EMERGE study did not and would not provide necessary data regarding the effectiveness of aducanumab, Biogen’s investigational human monoclonal antibody studied for the treatment of early Alzheimer’s disease; (3) the PRIME study did not and would not provide necessary data regarding aducanumab’s effectiveness; (4) the data provided by the Company to the U.S. Food and Drug Administration’s Peripheral and Central Nervous System Drugs Advisory Committee did not support finding efficacy of aducanumab; and (5) as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

 

TO LEARN MORE ABOUT THE BIIB CLASS ACTION, CLICK HERE

 

If you suffered a loss in Biogen you have until January 12, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Interface, Inc. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a TILE class action lawsuit has been commenced on behalf of investors who purchased Interface, Inc. (TILE) securities between March 2, 2018 and September 28, 2020. For more on the Interface Class Action please contact us today.

 

According to the Interface lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) Interface had inadequate disclosure controls and procedures and internal control over financial reporting; (ii) consequently, Interface, inter alia, reported artificially inflated income and earnings per share (“EPS”) in 2015 and 2016; (iii) Interface and certain of its employees were under investigation by the SEC with respect to the foregoing issues since at least as early as November 2017, had impeded the SEC’s investigation, and downplayed the true scope of the Company’s wrongdoing and liability with respect to the SEC investigation; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE TILE CLASS ACTION, CLICK HERE

 

If you suffered a loss in Interface you have until January 11, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Splunk Inc. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a SPLK class action lawsuit has been commenced on behalf of investors who purchased Splunk Inc. (SPLK) securities between  October 21, 2020 and December 2, 2020. For more on the Splunk Class Action please contact us today.

 

According to the Splunk lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Splunk was not closing deals with its largest customers in the third fiscal quarter of 2021; (2) Splunk was not hitting the financial targets it had previously announced; and (3) as a result of the foregoing, Defendants’ public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE SPLK CLASS ACTION, CLICK HERE

 

If you suffered a loss in Splunk you have until February 2, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

JOYY Inc. Class Action Lawsuits

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a YY class action lawsuit has been commenced on behalf of investors who purchased Joyy Inc. (YY) securities between April 28, 2016 and November 18, 2020. For more on the Joyy Class Action please contact us today.

 

According to the Joyy lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) JOYY dramatically overstated its revenues from live streaming sources; (2) The majority of users at any given time were bots; (2) the Company utilized these bots to effect a roundtripping scheme that Manufactured the false appearance of revenues; (3) the Company overstated its cash reserves; (4) the Company’s acquisition of Bigo was largely contrived to benefit corporate insiders; and (5) as a result, Defendants’ public statements were materially false and/or Misleading at all relevant times.

 

TO LEARN MORE ABOUT THE YY CLASS ACTION, CLICK HERE

 

If you suffered a loss in Joyy you have until January 19, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Restaurant Brands International Inc. Class Action Lawsuits

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a QSR class action lawsuit has been commenced on behalf of investors who purchased Restaurant Brands International (QSR) securities between April 29, 2019 and October 28, 2019. For more on the Restaurant Brands Class Action please contact us today.

 

According to the Restaurant Brands lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company’s Winning Together Plan was failing to generate substantial, sustainable improvement within the Tim Hortons brand; (2) the Tims Rewards loyalty program was not generating sustainable revenue growth as increased customer traffic was not offsetting promotional discounting; and (3) as a result, Defendants’ statements about the Company’s business, operations, and prospects lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE QSR CLASS ACTION, CLICK HERE

 

If you suffered a loss in Restaurant Brands you have until February 19, 2021  to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Triterras, Inc., f/k/a Netfin Acquisition Corp. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a TRIT class action lawsuit has been commenced on behalf of investors who purchased Triterras, Inc., f/k/a Netfin Acquisition Corp. (TRIT) securities between August 20, 2020 and December 16, 2020. For more on the Triterras’ Class Action please contact us today.

 

According to the Triterras’ lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the extent to which Company’s revenue growth relied on Triterras’ relationship with Rhodium to refer users to the Kratos platform; (2) that Rhodium faced significant financial liabilities that jeopardized its ability to continue as a going concern; (3) that, as a result, Rhodium was likely to refer fewer users to the Company’s Kratos platform; and (4) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE TRIT CLASS ACTION, CLICK HERE

 

If you suffered a loss in Triterras’ you have until February 19, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

HP Inc. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a HPQ class action lawsuit has been commenced on behalf of investors who purchased HP Inc. (HPQ) securities between November 6, 2015 and June 21, 2016. For more on the HP Class Action please contact us today.

 

According to the HP lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (a) HP’s channel inventory management and sales practices resulted in the sale of supplies to customers that did not need or want the product in order to artificially increase revenues and profits; (b) HP’s channel inventory management and sales practices resulted in the sale of supplies to customers outside of designated regions at unsustainable discounts in order to artificially increase revenues and profits; (c) HP’s channel inventory management and sales practices resulted in the sale of supplies at steep discounts to customers to encourage those customers to sell the supplies further down the supply channel, out of HP’s inventory management metrics; and (d) as a result of (a)-(c) above, defendants’ statements about HP’s business condition and prospects were materially false and misleading when made.

 

TO LEARN MORE ABOUT THE HPQ CLASS ACTION, CLICK HERE

 

If you suffered a loss in HP you have until January 4, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Kandi Technologies Group, Inc. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a KNDI class action lawsuit has been commenced on behalf of investors who purchased Kandi Technologies Group, Inc. (KNDI) securities between March 15, 2019 and November 27, 2020 . For more on the Kandi Class Action please contact us today.

 

According to the Kandi lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:  (i) Kandi artificially inflated its reported revenues through undisclosed related party transactions, or otherwise had relationships with key customers that indicated those customers did not have an arms length relationship with Kandi; (ii) the majority of Kandi’s sales in the past year had been to undisclosed related parties and/or parties with such a close relationship and history with Kandi that it cast doubt on the arms-length nature of their relationship; (iii) all the foregoing, once revealed, was foreseeably likely to cast doubt on the validity of Kandi’s reported revenues and, in turn, have a foreseeable negative impact on the Company’s reputation and valuation; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE KNDI CLASS ACTION, CLICK HERE

 

If you suffered a loss in Kandi you have until February 9, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Northern Dynasty Minerals Ltd. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a NAK class action lawsuit has been commenced on behalf of investors who purchased Northern Dynasty Minerals Ltd. (NAK) securities between December 21, 2017 and November 25, 2020. For more on the Northern Dynasty Class Action please contact us today.

 

According to the Northern Dynasty lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:  (1) the Company’s Pebble Project was contrary to Clean Water Act guidelines and to the public interest; (2) the Company planned that the Pebble Project would be larger in duration and scope than conveyed to the public; (3) as a result, the Company’s permit applications for the Pebble Project would be denied by the U.S. Army Corps of Engineers; and (4) as a result, Defendants’ public statements were materially false and/or misleading at all relevant times.

 

TO LEARN MORE ABOUT THE NAK CLASS ACTION, CLICK HERE

 

If you suffered a loss in Northern Dynasty you have until February 2, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Changyou.com Limited Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a CYOU/SOHU class action lawsuit has been commenced on behalf of investors who purchased Changyou.com Limited (CYOU,SOHU) securities between February 14, 2020 and April 23, 2020. For more on the Changyou Class Action please contact us today.

 

According to the Changyou lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: it did not support its disclosed legal conclusions and is at odds with the text of the relevant Cayman Islands statute regarding appraisal rights. Moreover, the Company failed to disclose other rights that may be available to Changyou shareholders under Cayman Islands law, in clear violation of the federal securities laws.

 

TO LEARN MORE ABOUT THE CYOU/SOHU CLASS ACTION, CLICK HERE

 

If you suffered a loss in Changyou you have until February 8, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

K12 Inc. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a LRN class action lawsuit has been commenced on behalf of investors who purchased K12 Inc. (LRN) securities between April 27, 2020 and September 18, 2020. For more on the K12 Class Action please contact us today.

 

According to the K12 lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) K12 lacked the technological capabilities, infrastructures, and expertise to support the increased demand for virtual and blended education necessitated by the global pandemic; (ii) K12 lacked adequate cyberattack protocols and protections to prevent the disabling of its computer system; (iii) K12 was unable provide the necessary levels of administrative support and training to teachers, students, and parents; and (iv) based on the foregoing, Defendants lacked a reasonable basis for their positive statements about the Company’s business, operations, and prospects and/or lacked a reasonable basis and omitted facts.

 

TO LEARN MORE ABOUT THE LRN CLASS ACTION, CLICK HERE

 

If you suffered a loss in K12 you have until January 19, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Pinterest, Inc. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a PINS class action lawsuit has been commenced on behalf of investors who purchased Pinterest, Inc. (PINS) securities between May 16, 2019 and November 1, 2019. For more on the Pinterest Class Action please contact us today.

 

According to the Pinterest lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) the Company’s addressable market in the U.S. was reaching its maximum capacity; (ii) which significantly decelerated Pinterest’s future ability to monetize on U.S. average revenue per user; (iii) Pinterest was at an increased risk of losing advertising revenue; (iv) and as a result, Defendants’ public statements were materially false and misleading at all relevant times or lacked a reasonable basis and omitted material facts.

 

TO LEARN MORE ABOUT THE PINS CLASS ACTION, CLICK HERE

 

If you suffered a loss in Pinterest you have until January 22, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

CD Projekt S.A. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a OTGLY/OTGLF class action lawsuit has been commenced on behalf of investors who purchased CD Projekt S.A. (OTGLY,OTGLF) securities between January 16, 2020 and December 17, 2020. For more on the CD Projekt Class Action please contact us today.

 

According to the CD Projekt lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: Throughout the class period, defendants were materially false and/or misleading because they misrepresented and failed to disclose the following adverse facts pertaining to the Company’s business, operations and prospects, which were known to Defendants or recklessly disregarded by them. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (1) Cyberpunk 2077 was virtually unplayable on the current-generation Xbox or Playstation systems due to an enormous number of bugs; (2) as a result, Sony would remove Cyberpunk 2077 from the Playstation store, and Sony, Microsoft and the Company would be forced to offer full refunds for the game; (3) consequently, the Company would suffer reputational and pecuniary harm; and (4) as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

 

TO LEARN MORE ABOUT THE OTGLY/OTGLF CLASS ACTION, CLICK HERE

 

If you suffered a loss in CD Projekt you have until February 22, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Qiwi plc Class Action Lawsuit

Levi & Korsinsky, LLP

January 4, 2021

Levi & Korsinsky, LLP reminds shareholders that a QIWI class action lawsuit has been commenced on behalf of investors who purchased Qiwi plc (QIWI) securities between March 28, 2019 and December 9, 2020. For more on the Qiwi Class Action please contact us today.

 

According to the Qiwi lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:(1) Qiwi’s internal controls related to reporting and record-keeping were ineffective; (2) consequently, the Central Bank of Russia would impose a monetary fine upon the Company and impose restrictions upon the Company’s ability to make payments to foreign merchants and transfer money to pre-paid cards; and (3) as a result, Defendants’ public statements were materially false and/or misleading at all relevant times.

 

TO LEARN MORE ABOUT THE QIWI CLASS ACTION, CLICK HERE

 

If you suffered a loss in QIWI you have until February 9, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Minerva Neurosciences Inc. Class Actions Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a NERV class action lawsuit has been commenced on behalf of investors who purchased Minerva Neurosciences Inc. (NERV) securities between May 15, 2017 and November 30, 2020. For more on the Minerva Neurosciences Class Action please contact us today.

 

According to the Minerva Neurosciences lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) the truth about the feedback received from the FDA concerning the “end-of-Phase 2” meeting; (ii) the Phase 2b study did not use the commercial formulation of roluperidone and was conducted solely outside of the United States; (iii) the failure of the Phase 3 study to meet its primary and key secondary endpoints rendered that study incapable of supporting substantial evidence of effectiveness; (iv) the Company’s plan to use the combination of the Phase 2b and Phase 3 studies would be “highly unlikely” to support the submission of an NDA; (v) reliance on these two trials in the submission of an NDA would lead to “substantial review issues” because the trials were inadequate and not well-controlled; and (vi) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE NERV CLASS ACTION, CLICK HERE

 

If you suffered a loss in Minerva Neurosciences you have until February 8, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Alibaba Group Holding Limited Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a BABA class action lawsuit has been commenced on behalf of investors who purchased Alibaba Group Holding Limited (BABA) securities between July 20, 2020  and November 3, 2020. For more on the Alibaba Class Action please contact us today.

 

According to the Alibaba lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Ant Small and Micro Financial Services Group Co., Ltd. (“Ant Group”), a financial technology company in which Alibaba owns a 33% equity interest, did not meet listing qualifications or disclosure requirements for certain material matters; (2) certain impending changes in the Fintech regulatory environment would impact Ant Group’s business; (3) as a result of the foregoing, Ant Group’s initial public offering was reasonably likely to be suspended; and (4) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE BABA CLASS ACTION, CLICK HERE

 

If you suffered a loss in Alibaba you have until January 12, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Intercept Pharmaceuticals, Inc. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that an ICPT class action lawsuit has been commenced on behalf of investors who purchased Intercept Pharmaceuticals, Inc. (ICPT) securities between between September 28, 2019 and October 7, 2020. For more on the Intercept Class Action please contact us today.

 

According to the Intercept lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:  (i) Defendants downplayed the true scope and severity of safety concerns associated with the use of Ocaliva (obeticholic acid (“OCA”)), Intercept’s lead product candidate, in treating primary biliary cholangitis; (ii) the foregoing increased the likelihood of a U.S. Food and Drug Administration (“FDA”) investigation into Ocaliva’s development, thereby jeopardizing Ocaliva’s continued marketability and the sustainability of its sales; (iii) any purported benefits associated with OCA’s efficacy in treating nonalcoholic steatohepatitis (“NASH”) were outweighed by the risks of its use; (iv) as a result, the FDA was unlikely to approve the Company’s New Drug Application for OCA in treating patients with liver fibrosis due to NASH; and (v) as a result of all the foregoing, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE ICPT CLASS ACTION, CLICK HERE

 

If you suffered a loss in Intercept you have until January 4, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Boston Scientific Corporation Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a BSX class action lawsuit has been commenced on behalf of investors who purchased Boston Scientific Corporation (BSX) securities between April 24, 2019 and November 16, 2020. For more on the Boston Scientific Class Action please contact us today.

 

According to the Boston Scientific lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) the LOTUS Edge Aortic Valve System’s product delivery system was dysfunctional and threatened the continued viability of the entire product line; (ii) as a result, the Company had materially overstated the continued commercial viability and profitability of the LOTUS Edge Aortic Valve System; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE BSX CLASS ACTION, CLICK HERE

 

If you suffered a loss in Boston Scientific you have until February 2, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Northern Dynasty Minerals Ltd. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a NAK class action lawsuit has been commenced on behalf of investors who purchased Northern Dynasty Minerals Ltd. (NAK) securities between December 21, 2017 and November 25, 2020. For more on the Northern Dynasty Class Action please contact us today.

 

According to the Northern Dynasty lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:  (1) the Company’s Pebble Project was contrary to Clean Water Act guidelines and to the public interest; (2) the Company planned that the Pebble Project would be larger in duration and scope than conveyed to the public; (3) as a result, the Company’s permit applications for the Pebble Project would be denied by the U.S. Army Corps of Engineers; and (4) as a result, Defendants’ public statements were materially false and/or misleading at all relevant times.

 

TO LEARN MORE ABOUT THE NAK CLASS ACTION, CLICK HERE

 

If you suffered a loss in Northern Dynasty you have until February 2, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Pinterest, Inc. Class Action Lawsuit

Levi & Korsinsky, LLP

December 30, 2020

Levi & Korsinsky, LLP announces that a PINS class action lawsuit has been commenced on behalf of investors who purchased Pinterest, Inc. (PINS) securities between May 16, 2019 and November 1, 2019. For more on the Pinterest Class Action please contact us today.

 

According to the Pinterest lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) the Company’s addressable market in the U.S. was reaching its maximum capacity; (ii) which significantly decelerated Pinterest’s future ability to monetize on U.S. average revenue per user; (iii) Pinterest was at an increased risk of losing advertising revenue; (iv) and as a result, Defendants’ public statements were materially false and misleading at all relevant times or lacked a reasonable basis and omitted material facts.

 

TO LEARN MORE ABOUT THE PINS CLASS ACTION, CLICK HERE

 

If you suffered a loss in Pinterest you have until January 22, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

GoodRx Holdings, Inc. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a GDRX class action lawsuit has been commenced on behalf of investors who purchased GoodRx Holdings, Inc. (GDRX) securities between September 23, 2020 and November 16, 2020. For more on the GoodRx Class Action please contact us today.

 

According to the GoodRx lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:  at the time of the IPO, unbeknownst to investors, Amazon.com, Inc. was developing and would soon introduce its own online and mobile prescription medication ordering and fulfillment service that would directly compete with GoodRx. Defendants timed the IPO so that it was priced before Amazon announced its online pharmaceutical business to facilitate the IPO and create artificial demand for the common shares sold therein, as well to maximize the amount of money the Company and the selling stockholders could raise in the IPO. Given defendants’ knowledge of Amazon’s intention to enter the online pharmaceutical business, and their misleading statements about GoodRx’s competitive position made contemporaneously with that knowledge, defendants’ materially false and/or misleading statements alleged herein were made willfully and caused GoodRx common stock to trade at artificially inflated prices during the Class Period.

 

TO LEARN MORE ABOUT THE GDRX CLASS ACTION, CLICK HERE

 

If you suffered a loss in GoodRx you have until February 16, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Splunk Inc. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a SPLK class action lawsuit has been commenced on behalf of investors who purchased Splunk Inc. (SPLK) securities between  October 21, 2020 and December 2, 2020. For more on the Splunk Class Action please contact us today.

 

According to the Splunk lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Splunk was not closing deals with its largest customers in the third fiscal quarter of 2021; (2) Splunk was not hitting the financial targets it had previously announced; and (3) as a result of the foregoing, Defendants’ public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE SPLK CLASS ACTION, CLICK HERE

 

If you suffered a loss in Splunk you have until February 2, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Berry Corporation Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a BRY class action lawsuit has been commenced on behalf of investors who purchased Berry Corporation (BRY) securities between July 26, 2018 and November 3, 2020. For more on the Berry Class Action please contact us today.

 

According to the Berry lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:  (i) Berry had materially overstated its operational efficiency and stability; (ii) Berry’s operational inefficiency and instability would foreseeably necessitate operational improvements that would disrupt the Company’s productivity and increase costs; (iii) the foregoing would foreseeably negatively impact the Company’s revenues; and (iv) as a result, the Offering Documents and the Company’s public statements were materially false and/or misleading and failed to state information required to be stated therein.

 

TO LEARN MORE ABOUT THE BRY CLASS ACTION, CLICK HERE

 

If you suffered a loss in Berry you have until January 21, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Boston Scientific Corporation Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a BSX class action lawsuit has been commenced on behalf of investors who purchased Boston Scientific Corporation (BSX) securities between April 24, 2019 and November 16, 2020. For more on the Boston Scientific Class Action please contact us today.

 

According to the Boston Scientific lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) the LOTUS Edge Aortic Valve System’s product delivery system was dysfunctional and threatened the continued viability of the entire product line; (ii) as a result, the Company had materially overstated the continued commercial viability and profitability of the LOTUS Edge Aortic Valve System; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE BSX CLASS ACTION, CLICK HERE

 

If you suffered a loss in Boston Scientific you have until February 2, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

HP Inc. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a HPQ class action lawsuit has been commenced on behalf of investors who purchased HP Inc. (HPQ) securities between November 6, 2015 and June 21, 2016. For more on the HP Class Action please contact us today.

 

According to the HP lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (a) HP’s channel inventory management and sales practices resulted in the sale of supplies to customers that did not need or want the product in order to artificially increase revenues and profits; (b) HP’s channel inventory management and sales practices resulted in the sale of supplies to customers outside of designated regions at unsustainable discounts in order to artificially increase revenues and profits; (c) HP’s channel inventory management and sales practices resulted in the sale of supplies at steep discounts to customers to encourage those customers to sell the supplies further down the supply channel, out of HP’s inventory management metrics; and (d) as a result of (a)-(c) above, defendants’ statements about HP’s business condition and prospects were materially false and misleading when made.

 

TO LEARN MORE ABOUT THE HPQ CLASS ACTION, CLICK HERE

 

If you suffered a loss in HP you have until January 4, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Kandi Technologies Group, Inc. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a KNDI class action lawsuit has been commenced on behalf of investors who purchased Kandi Technologies Group, Inc. (KNDI) securities between March 15, 2019 and November 27, 2020 . For more on the Kandi Class Action please contact us today.

 

According to the Kandi lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:  (i) Kandi artificially inflated its reported revenues through undisclosed related party transactions, or otherwise had relationships with key customers that indicated those customers did not have an arms length relationship with Kandi; (ii) the majority of Kandi’s sales in the past year had been to undisclosed related parties and/or parties with such a close relationship and history with Kandi that it cast doubt on the arms-length nature of their relationship; (iii) all the foregoing, once revealed, was foreseeably likely to cast doubt on the validity of Kandi’s reported revenues and, in turn, have a foreseeable negative impact on the Company’s reputation and valuation; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE KNDI CLASS ACTION, CLICK HERE

 

If you suffered a loss in Kandi you have until February 9, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Qiwi plc Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a QIWI class action lawsuit has been commenced on behalf of investors who purchased Qiwi plc (QIWI) securities between March 28, 2019 and December 9, 2020. For more on the Qiwi Class Action please contact us today.

 

According to the Qiwi lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:(1) Qiwi’s internal controls related to reporting and record-keeping were ineffective; (2) consequently, the Central Bank of Russia would impose a monetary fine upon the Company and impose restrictions upon the Company’s ability to make payments to foreign merchants and transfer money to pre-paid cards; and (3) as a result, Defendants’ public statements were materially false and/or misleading at all relevant times.

 

TO LEARN MORE ABOUT THE QIWI CLASS ACTION, CLICK HERE

 

If you suffered a loss in QIWI you have until February 9, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Northern Dynasty Minerals Ltd. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a NAK class action lawsuit has been commenced on behalf of investors who purchased Northern Dynasty Minerals Ltd. (NAK) securities between December 21, 2017 and November 25, 2020. For more on the Northern Dynasty Class Action please contact us today.

 

According to the Northern Dynasty lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:  (1) the Company’s Pebble Project was contrary to Clean Water Act guidelines and to the public interest; (2) the Company planned that the Pebble Project would be larger in duration and scope than conveyed to the public; (3) as a result, the Company’s permit applications for the Pebble Project would be denied by the U.S. Army Corps of Engineers; and (4) as a result, Defendants’ public statements were materially false and/or misleading at all relevant times.

 

TO LEARN MORE ABOUT THE NAK CLASS ACTION, CLICK HERE

 

If you suffered a loss in Northern Dynasty you have until February 2, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Interface, Inc. Class Actions Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a TILE class action lawsuit has been commenced on behalf of investors who purchased Interface, Inc. (TILE) securities between March 2, 2018 and September 28, 2020. For more on the Interface Class Action please contact us today.

 

According to the Interface lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) Interface had inadequate disclosure controls and procedures and internal control over financial reporting; (ii) consequently, Interface, inter alia, reported artificially inflated income and earnings per share (“EPS”) in 2015 and 2016; (iii) Interface and certain of its employees were under investigation by the SEC with respect to the foregoing issues since at least as early as November 2017, had impeded the SEC’s investigation, and downplayed the true scope of the Company’s wrongdoing and liability with respect to the SEC investigation; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE TILE CLASS ACTION, CLICK HERE

 

If you suffered a loss in Interface you have until January 11, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

JOYY Inc. Class Action Lawsuits

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a YY class action lawsuit has been commenced on behalf of investors who purchased Joyy Inc. (YY) securities between April 28, 2016 and November 18, 2020. For more on the Joyy Class Action please contact us today.

 

According to the Joyy lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) JOYY dramatically overstated its revenues from live streaming sources; (2) The majority of users at any given time were bots; (2) the Company utilized these bots to effect a roundtripping scheme that Manufactured the false appearance of revenues; (3) the Company overstated its cash reserves; (4) the Company’s acquisition of Bigo was largely contrived to benefit corporate insiders; and (5) as a result, Defendants’ public statements were materially false and/or Misleading at all relevant times.

 

TO LEARN MORE ABOUT THE YY CLASS ACTION, CLICK HERE

 

If you suffered a loss in Joyy you have until January 19, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Restaurant Brands International Inc. Class Action Lawsuits

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP reminds shareholders that a QSR class action lawsuit has been commenced on behalf of investors who purchased Restaurant Brands International (QSR) securities between April 29, 2019 and October 28, 2019. For more on the Restaurant Brands Class Action please contact us today.

 

According to the Restaurant Brands lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company’s Winning Together Plan was failing to generate substantial, sustainable improvement within the Tim Hortons brand; (2) the Tims Rewards loyalty program was not generating sustainable revenue growth as increased customer traffic was not offsetting promotional discounting; and (3) as a result, Defendants’ statements about the Company’s business, operations, and prospects lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE QSR CLASS ACTION, CLICK HERE

 

If you suffered a loss in Restaurant Brands you have until February 19, 2021  to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Biogen Inc. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a BIIB class action lawsuit has been commenced on behalf of investors who purchased Biogen Inc. (BIIB) securities between October 22, 2019 and November 6, 2019. For more on the Biogen Class Action please contact us today.

 

According to the Biogen lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:(1) the larger dataset did not provide necessary data regarding aducanumab’s effectiveness; (2) the EMERGE study did not and would not provide necessary data regarding the effectiveness of aducanumab, Biogen’s investigational human monoclonal antibody studied for the treatment of early Alzheimer’s disease; (3) the PRIME study did not and would not provide necessary data regarding aducanumab’s effectiveness; (4) the data provided by the Company to the U.S. Food and Drug Administration’s Peripheral and Central Nervous System Drugs Advisory Committee did not support finding efficacy of aducanumab; and (5) as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

 

TO LEARN MORE ABOUT THE BIIB CLASS ACTION, CLICK HERE

 

If you suffered a loss in Biogen you have until January 12, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Changyou.com Limited Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a CYOU/SOHU class action lawsuit has been commenced on behalf of investors who purchased Changyou.com Limited (CYOU,SOHU) securities between February 14, 2020 and April 23, 2020. For more on the Changyou Class Action please contact us today.

 

According to the Changyou lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: it did not support its disclosed legal conclusions and is at odds with the text of the relevant Cayman Islands statute regarding appraisal rights. Moreover, the Company failed to disclose other rights that may be available to Changyou shareholders under Cayman Islands law, in clear violation of the federal securities laws.

 

TO LEARN MORE ABOUT THE CYOU/SOHU CLASS ACTION, CLICK HERE

 

If you suffered a loss in Changyou you have until February 8, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

CD Projekt S.A. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a OTGLY/OTGLF class action lawsuit has been commenced on behalf of investors who purchased CD Projekt S.A. (OTGLY,OTGLF) securities between January 16, 2020 and December 17, 2020. For more on the CD Projekt Class Action please contact us today.

 

According to the CD Projekt lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: Throughout the class period, defendants were materially false and/or misleading because they misrepresented and failed to disclose the following adverse facts pertaining to the Company’s business, operations and prospects, which were known to Defendants or recklessly disregarded by them. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (1) Cyberpunk 2077 was virtually unplayable on the current-generation Xbox or Playstation systems due to an enormous number of bugs; (2) as a result, Sony would remove Cyberpunk 2077 from the Playstation store, and Sony, Microsoft and the Company would be forced to offer full refunds for the game; (3) consequently, the Company would suffer reputational and pecuniary harm; and (4) as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

 

TO LEARN MORE ABOUT THE OTGLY/OTGLF CLASS ACTION, CLICK HERE

 

If you suffered a loss in CD Projekt you have until February 22, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

GoodRx Holdings, Inc Class Action Lawsuit

Levi & Korsinsky, LLP

December 29, 2020

Levi & Korsinsky, LLP announces that a GDRX class action lawsuit has been commenced on behalf of investors who purchased GoodRx Holdings, Inc. (GDRX) securities between September 23, 2020 and November 16, 2020. For more on the GoodRx Class Action please contact us today.

 

According to the GoodRx lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: at the time of the IPO, unbeknownst to investors, Amazon.com, Inc. was developing and would soon introduce its own online and mobile prescription medication ordering and fulfillment service that would directly compete with GoodRx. Defendants timed the IPO so that it was priced before Amazon announced its online pharmaceutical business to facilitate the IPO and create artificial demand for the common shares sold therein, as well to maximize the amount of money the Company and the selling stockholders could raise in the IPO. Given defendants’ knowledge of Amazon’s intention to enter the online pharmaceutical business, and their misleading statements about GoodRx’s competitive position made contemporaneously with that knowledge, defendants’ materially false and/or misleading statements alleged herein were made willfully and caused GoodRx common stock to trade at artificially inflated prices during the Class Period.

 

TO LEARN MORE ABOUT THE GDRX CLASS ACTION, CLICK HERE

 

If you suffered a loss in GoodRx you have until February 16, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Splunk Inc. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a SPLK class action lawsuit has been commenced on behalf of investors who purchased Splunk Inc. (SPLK) securities between October 21, 2020 and December 2, 2020. For more on the Splunk Class Action please contact us today.

 

According to the Splunk lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:  (1) Splunk was not closing deals with its largest customers in the third fiscal quarter of 2021; (2) Splunk was not hitting the financial targets it had previously announced; and (3) as a result of the foregoing, Defendants’ public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE SPLK CLASS ACTION, CLICK HERE

 

If you suffered a loss in Splunk you have until February 2, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Zosano Pharma Corporation Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a ZSAN class action lawsuit has been commenced on behalf of investors who purchased Zosano Pharma Corporation (ZSAN) securities between February 13, 2017 and September 30, 2020. For more on the Zosano Pharma Class Action please contact us today.

 

According to the Zosano Pharma lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company’s clinical results reflected differences in zolmitriptan exposures observed between subjects receiving different lots; (2) pharmocokinetic studies submitted in connection with the Company’s New Drug Application included patients exhibiting unexpected high plasma concentrations of zolmitriptan; (3) as a result of the foregoing differences among patient results, the U.S. Food and Drug Administration was reasonably likely to require further studies to support regulatory approval of the Company’s lead product candidate, Qtrypta; (4) as a result, regulatory approval of Qtrypta was reasonably likely to be delayed; and (5) as a result of the foregoing, Defendants’ public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE ZSAN CLASS ACTION, CLICK HERE

 

If you suffered a loss in Zosano Pharma you have until December 28, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

K12 Inc. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a LRN class action lawsuit has been commenced on behalf of investors who purchased K12 Inc. (LRN) securities between April 27, 2020 and September 18, 2020. For more on the K12 Class Action please contact us today.

 

According to the K12 lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) K12 lacked the technological capabilities, infrastructures, and expertise to support the increased demand for virtual and blended education necessitated by the global pandemic; (ii) K12 lacked adequate cyberattack protocols and protections to prevent the disabling of its computer system; (iii) K12 was unable provide the necessary levels of administrative support and training to teachers, students, and parents; and (iv) based on the foregoing, Defendants lacked a reasonable basis for their positive statements about the Company’s business, operations, and prospects and/or lacked a reasonable basis and omitted facts.

 

TO LEARN MORE ABOUT THE LRN CLASS ACTION, CLICK HERE

 

If you suffered a loss in K12 you have until January 19, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

HP Inc. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a HPQ class action lawsuit has been commenced on behalf of investors who purchased HP Inc. (HPQ) securities between November 6, 2015 and June 21, 2016. For more on the HP Class Action please contact us today.

 

According to the HP lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:(a) HP’s channel inventory management and sales practices resulted in the sale of supplies to customers that did not need or want the product in order to artificially increase revenues and profits; (b) HP’s channel inventory management and sales practices resulted in the sale of supplies to customers outside of designated regions at unsustainable discounts in order to artificially increase revenues and profits; (c) HP’s channel inventory management and sales practices resulted in the sale of supplies at steep discounts to customers to encourage those customers to sell the supplies further down the supply channel, out of HP’s inventory management metrics; and (d) as a result of (a)-(c) above, defendants’ statements about HP’s business condition and prospects were materially false and misleading when made.

 

TO LEARN MORE ABOUT THE HPQ CLASS ACTION, CLICK HERE

 

If you suffered a loss in HP you have until January 4, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Minerva Neurosciences, Inc. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a NERV class action lawsuit has been commenced on behalf of investors who purchased Minerva Neurosciences Inc. (NERV) securities between May 15, 2017 and November 30, 2020. For more on the Minerva Neurosciences Class Action please contact us today.

 

According to the Minerva Neurosciences lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) the truth about the feedback received from the FDA concerning the “end-of-Phase 2” meeting; (ii) the Phase 2b study did not use the commercial formulation of roluperidone and was conducted solely outside of the United States; (iii) the failure of the Phase 3 study to meet its primary and key secondary endpoints rendered that study incapable of supporting substantial evidence of effectiveness; (iv) the Company’s plan to use the combination of the Phase 2b and Phase 3 studies would be “highly unlikely” to support the submission of an NDA; (v) reliance on these two trials in the submission of an NDA would lead to “substantial review issues” because the trials were inadequate and not well-controlled; and (vi) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE NERV CLASS ACTION, CLICK HERE

 

If you suffered a loss in Minerva Neurosciences you have until February 8, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Northern Dynasty Minerals Ltd. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a NAK class action lawsuit has been commenced on behalf of investors who purchased Northern Dynasty Minerals Ltd. (NAK) securities between December 21, 2017 and January 25, 2020. For more on the Northern Dynasty Minerals Class Action please contact us today.

 

According to the Northern Dynasty Minerals lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company’s Pebble Project was contrary to Clean Water Act guidelines and to the public interest; (2) the Company planned that the Pebble Project would be larger in duration and scope than conveyed to the public; (3) as a result, the Company’s permit applications for the Pebble Project would be denied by the U.S. Army Corps of Engineers; and (4) as a result, Defendants’ public statements were materially false and/or misleading at all relevant times.

 

TO LEARN MORE ABOUT THE NAK CLASS ACTION, CLICK HERE

 

If you suffered a loss in Northern Dynasty Minerals Ltd. you have until February 2, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Restaurant Brands International Inc. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a QSR class action lawsuit has been commenced on behalf of investors who purchased Restaurant Brands International Inc. (QSR) securities between April 29, 2019 and October 28, 2019. For more on the Restaurant Brands Class Action please contact us today.

 

According to the Restaurant Brands lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company’s Winning Together Plan was failing to generate substantial, sustainable improvement within the Tim Hortons brand; (2) the Tims Rewards loyalty program was not generating sustainable revenue growth as increased customer traffic was not offsetting promotional discounting; and (3) as a result, Defendants’ statements about the Company’s business, operations, and prospects lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE QSR CLASS ACTION, CLICK HERE

 

If you suffered a loss in Restaurant Brands you have until February 19, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Alibaba Group Holding Limited Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a BABA class action lawsuit has been commenced on behalf of investors who purchased Alibaba Group Holding Limited (BABA) securities between July 20, 2020  and November 3, 2020. For more on the Alibaba Class Action please contact us today.

 

According to the Alibaba lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Ant Small and Micro Financial Services Group Co., Ltd. (“Ant Group”), a financial technology company in which Alibaba owns a 33% equity interest, did not meet listing qualifications or disclosure requirements for certain material matters; (2) certain impending changes in the Fintech regulatory environment would impact Ant Group’s business; (3) as a result of the foregoing, Ant Group’s initial public offering was reasonably likely to be suspended; and (4) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE BABA CLASS ACTION, CLICK HERE

 

If you suffered a loss in Alibaba you have until January 12, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Raytheon Technologies Corporation Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a RTX class action lawsuit has been commenced on behalf of investors who purchased Raytheon Technologies Corporation (RTX) securities between February 10, 2016 and October 27, 2020. For more on the Raytheon Class Action please contact us today.

 

According to the Raytheon lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:(1) Raytheon had inadequate disclosure controls and procedures and inadequate internal control over financial reporting; (2) Raytheon had faulty financial accounting; (3) as a result, Raytheon misreported its costs regarding Raytheon Company’s Missiles & Defense business since 2009; (4) as a result of the foregoing, Raytheon was at risk of increased scrutiny from the government; (5) as a result of the foregoing, Raytheon would face a criminal investigation by the U.S. Department of Justice; and (6) as a result, Defendants’ public statements were materially false and/or misleading at all relevant times.

 

TO LEARN MORE ABOUT THE RTX CLASS ACTION, CLICK HERE

 

If you suffered a loss in Raytheon you have until  December 29, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Interface, Inc. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a TILE class action lawsuit has been commenced on behalf of investors who purchased Interface, Inc. (TILE) securities between March 2, 2018 and September 28, 2020. For more on the Interface Class Action please contact us today.

 

According to the Interface lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) Interface had inadequate disclosure controls and procedures and internal control over financial reporting; (ii) consequently, Interface, inter alia, reported artificially inflated income and earnings per share (“EPS”) in 2015 and 2016; (iii) Interface and certain of its employees were under investigation by the SEC with respect to the foregoing issues since at least as early as November 2017, had impeded the SEC’s investigation, and downplayed the true scope of the Company’s wrongdoing and liability with respect to the SEC investigation; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE TILE CLASS ACTION, CLICK HERE

 

If you suffered a loss in Interface you have until January 11, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Joyy Inc. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a YY class action lawsuit has been commenced on behalf of investors who purchased Joy Inc. (YY) securities between April 28,2016 and November 18,2020. For more on the Joyy Class Action please contact us today.

 

According to the Joyy lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:(1) JOYY dramatically overstated its revenues from live streaming sources; (2) The majority of users at any given time were bots; (2) the Company utilized these bots to effect a roundtripping scheme that Manufactured the false appearance of revenues; (3) the Company overstated its cash reserves; (4) the Company’s acquisition of Bigo was largely contrived to benefit corporate insiders; and (5) as a result, Defendants’ public statements were materially false and/or Misleading at all relevant times.

 

TO LEARN MORE ABOUT THE YY CLASS ACTION, CLICK HERE 

 

If you suffered a loss in Joyy you have until January 19, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Intercept Pharmaceuticals, Inc. Class Action Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that an ICPT class action lawsuit has been commenced on behalf of investors who purchased Intercept (ICPT) securities between between September 28, 2019 and October 7, 2020. For more on the Intercept Class Action please contact us today.

 

According to the Intercept lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:  (i) Defendants downplayed the true scope and severity of safety concerns associated with the use of Ocaliva (obeticholic acid (“OCA”)), Intercept’s lead product candidate, in treating primary biliary cholangitis; (ii) the foregoing increased the likelihood of a U.S. Food and Drug Administration (“FDA”) investigation into Ocaliva’s development, thereby jeopardizing Ocaliva’s continued marketability and the sustainability of its sales; (iii) any purported benefits associated with OCA’s efficacy in treating nonalcoholic steatohepatitis (“NASH”) were outweighed by the risks of its use; (iv) as a result, the FDA was unlikely to approve the Company’s New Drug Application for OCA in treating patients with liver fibrosis due to NASH; and (v) as a result of all the foregoing, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE ICPT CLASS ACTION, CLICK HERE

 

If you suffered a loss in Intercept you have until January 4, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Beyond Meat Class Action Investigation; BYND Lawsuit

Class Action Reports

Levi & Korsinsky Announces Beyond Meat Class Action Investigation; BYND Lawsuit

Levi & Korsinsky, LLP

February 17, 2020

Levi & Korsinsky, LLP announces that a BYND class action lawsuit has been commenced on behalf of investors who purchased Beyond Meat, Inc., (BYND) securities between May 2, 2019 and January 27, 2020. For more on the Beyond Meat Class Action please contact us today.

According to the Beyond Meat lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Beyond Meat’s termination of its supply agreement with Don Lee constituted a breach of that agreement, thus exposing the Company to foreseeable legal liability and reputational harm; (2) Beyond Meat and certain of its employees had doctored and omitted material information from a food safety consultant’s report, which the Company represented as accurate to Don Lee; and (3) as a result, the Company’s public statements were materially false and misleading at all relevant times.

TO LEARN MORE ABOUT THE BYND CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/beyond-meat-inc-loss-form?prid=5448&wire=9

If you suffered a loss in Beyond Meat you have until March 30, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Sasol Class Action Investigation; SSL Lawsuit

Class Action Reports

Levi & Korsinsky Announces Sasol Class Action Investigation; SSL Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a SSL class action lawsuit has been commenced on behalf of investors who purchased Sasol Limited, (SSL) securities between March 10, 2015 and January 13, 2020. For more on the Sasol Class Action please contact us today.

According to the Sasol lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Sasol had conducted insufficient due diligence into, and failed to account for multiple issues with, the Lake Charles Chemicals Project (“LCCP”), as well as the true cost of the project; (2) construction and operation of the LCCP was consequently plagued by control weaknesses, delays, rising costs, and technical issues; (3) these issues were exacerbated by Sasol’s top-level management, who engaged in improper and unethical behavior with respect to financial reporting for the LCCP and the project’s oversight; (4) all the foregoing was reasonably likely to render the LCCP significantly more expensive than disclosed and negatively impact the Company’s financial results; and (5) as a result, the Company’s public statements were materially false and misleading at all relevant times.

TO LEARN MORE ABOUT THE SSL CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/sasol-limited-loss-form?prid=5448&wire=9

If you suffered a loss in Sasol you have until April 6, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Westpac Banking Class Action Investigation; WBK Lawsuit

Class Action Reports

Levi & Korsinsky Announces Westpac Banking Class Action Investigation; WBK Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a WBK class action lawsuit has been commenced on behalf of investors who purchased Westpac Banking Corporation (WBK) securities between November 11, 2015 and November 19, 2019. For more on the Westpac Banking Class Action please contact us today.

According to the Westpac Banking lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) contrary to Australian law, the Company failed to report over 19.5 million international funds transfer instructions to the Australian Transaction Reports and Analysis Centre (“AUSTRAC”); (2) the Company did not appropriately monitor and assess the ongoing money laundering and terrorism financing risks associated with movement of money into and out of Australia; (3) the Westpac did not pass on requisite information about the source of funds to other banks in the transfer chain; (4) despite being aware of the heightened risks, the Company did not carry out appropriate due diligence on transactions in South East Asia and the Philippines that had known financial indicators relating to child exploitation risks; (5) the Company’s Anti-Money Laundering and Counter-Terrorism Financing Policy Program was inadequate to identify, mitigate and manage money laundering and terrorism financing risks; and (6) as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

TO LEARN MORE ABOUT THE WBK CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/westpac-banking-corporation-loss-form?prid=5452&wire=9

If you suffered a loss in Westpac Banking you have until March 30, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Opera Class Action Investigation; OPRA Lawsuit

Class Action Reports

Levi & Korsinsky Announces Opera Class Action Investigation; OPRA Lawsuit

Levi & Korsinsky, LLP

February 10, 2020

Levi & Korsinsky, LLP announces that a OPRA class action lawsuit has been commenced on behalf of investors who purchased Opera Limited, (OPRA) (a) Opera American depositary shares pursuant and/or traceable to the Company’s initial public offering commenced on or about July 27, 2018 and/or (b) Opera securities between July 27, 2018 and January 15, 2020. For more on the Opera Class Action please contact us today.

According to the Opera lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Opera’s sustainable growth and market opportunity for its browser applications was significantly overstated; (2) Defendants’ funded, owned, or otherwise controlled loan services applications and/or businesses relied on predatory lending practices; (3) all the foregoing, once revealed, were reasonably likely to have a material negative impact on Opera’s financial prospects, especially with respect to its lending applications’ continued availability on the Google Play Store; and (4) as a result, the Offering Documents and Defendants’ statements were materially false and/or misleading and failed to state information required to be stated therein.

TO LEARN MORE ABOUT THE OPRA CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/opera-limited-loss-form?wire=9&prid=5367

If you suffered a loss in Opera you have until March 24, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Exelon Corporation Class Action Investigation; EXC Lawsuit

Class Action Reports

Levi & Korsinsky Announces Exelon Corporation Class Action Investigation; EXC Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a EXC class action lawsuit has been commenced on behalf of investors who purchased Exelon Corporation (EXC) securities between February 9, 2019 and November 1, 2019. For more on the Exelon Corporation Class Action please contact us today.

According to the Exelon Corporation lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Exelon and/or its employees were engaged in unlawful lobbying activities; (2) the foregoing increased the risk of a criminal investigation into Exelon; (3) Exelon subsidiary Commonwealth Edison’s revenues were in part the product of unlawful conduct and thus unsustainable; and (4) that, as a result, the Company’s public statements were materially false and misleading at all relevant times.

TO LEARN MORE ABOUT THE EXC CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/exelon-corporation-loss-form?prid=5363&wire=9

If you suffered a loss in Exelon Corporation you have until February 14, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Qudian Class Action Investigation; QD Lawsuit

Class Action Reports

Levi & Korsinsky Announces Qudian Class Action Investigation; QD Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a QD class action lawsuit has been commenced on behalf of investors who purchased Qudian Inc. (QD) securities between December 13, 2018 and January 15, 2020. For more on the Qudian Class Action please contact us today.

According to the Qudian lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) regulatory developments in China threatened to negatively impact Qudian’s fiscal full year 2019 (“FY19”) financial results; (2) Qudian’s business was unprepared to mitigate the risks associated with these regulatory changes; (3) as a result, Qudian’s loan portfolio was plagued by growing delinquency rates; (4) all of the foregoing made Qudian’s repeated assertions concerning its FY19 financial guidance unrealistic; and (5) as a result, the Company’s public statements were materially false and misleading at all relevant times.

TO LEARN MORE ABOUT THE QD CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/qudian-inc-loss-form?prid=5351&wire=9

If you suffered a loss in Qudian you have until March 23, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Geron Corporation Class Action Investigation; GERN Lawsuit

Class Action Reports

Levi & Korsinsky Announces Geron Corporation Class Action Investigation; GERN Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a GERN class action lawsuit has been commenced on behalf of investors who purchased Geron Corporation (GERN) securities between March 19, 2018 and September 26, 2018. For more on the Geron Corporation Class Action please contact us today.

According to the Geron Corporation lawsuit, the filed complaint alleges that defendants misled investors regarding a drug called imetelstat, which was intended to treat certain cancers that occur in bone marrow. Specifically, defendants misled investors about the results of a clinical drug study of imetelstat called IMbark. That study was designed to ascertain whether imetelstat helped patients with a cancer called myelofibrosis.

TO LEARN MORE ABOUT THE GERN CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/geron-corporation-et-al-loss-form?wire=9&prid=5348

If you suffered a loss in Geron Corporation you have until March 23, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Fiat Chrysler Automobiles N.V. Class Action Investigation; FCAU Lawsuit

Class Action Reports

Levi & Korsinsky Announces Fiat Chrysler Automobiles N.V. Class Action Investigation; FCAU Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a FCAU class action lawsuit has been commenced on behalf of investors who purchased Fiat Chrysler Automobiles N.V. (FCAU) securities between February 26, 2016 and November 20, 2019. For more on the Fiat Chrysler Automobiles N.V. Class Action please contact us today.

According to the Fiat Chrysler Automobiles N.V. lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company employed a bribery scheme to obtain favorable terms in its collective bargaining agreement with United Automobile, Aerospace and Agricultural Implement Workers of America; (2) high-ranking Fiat officials were aware of and authorized the scheme; and (3) as a result, Defendants’ statements about Fiat’s business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis at all relevant times.

TO LEARN MORE ABOUT THE FCAU CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/fiat-chrysler-automobiles-n-v-loss-form?wire=9&prid=5348

If you suffered a loss in Fiat Chrysler Automobiles N.V. you have until January 31, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Forescout Technologies Class Action Investigation; FSCT Lawsuit

Class Action Reports

Levi & Korsinsky Announces Forescout Technologies Class Action Investigation; FSCT Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a FSCT class action lawsuit has been commenced on behalf of investors who purchased Forescout Technologies, Inc. (FSCT) securities between February 7, 2019 and October 9, 2019. For more on the Forescout Technologies Class Action please contact us today.

According to the Forescout Technologies lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Forescout was experiencing significant volatility with respect to large deals and issues related to the timing and execution of deals in the Company’s pipeline, especially in Europe, the Middle East, and Africa; (2) the foregoing was reasonably likely to have a material negative impact on the Company’s financial results; and (3) as a result, the Company’s public statements were materially false and misleading at all relevant times.

TO LEARN MORE ABOUT THE FSCT CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/forescout-technologies-inc-loss-form?prid=5342&wire=9

If you suffered a loss in Forescout Technologies you have until March 2, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Merit Medical Systems Class Action Investigation; MMSI Lawsuit

Class Action Reports

Levi & Korsinsky Announces Merit Medical Systems Class Action Investigation; MMSI Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a MMSI class action lawsuit has been commenced on behalf of investors who purchased Merit Medical Systems, Inc. (MMSI) securities between February 26, 2019 and October 30, 2019. For more on the Merit Medical Systems Class Action please contact us today.

According to the Merit Medical Systems lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the integrations of acquired companies Cianna Medical, Inc. and Vascular Insights, LLC, including their products, sales people, and R&D facilities, had caused operational disruptions and reduced sales and were months behind schedule; (2) sales of acquired company products had slowed substantially due to pre-acquisition pipeline fill, in particular for Vascular Insights products which, as late as July 2019, had zero orders during FY19; and (3) in light of the foregoing, the Company’s reported financial guidance for FY19 and FY20 was made without a reasonable basis.

TO LEARN MORE ABOUT THE MMSI CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/merit-medical-systems-inc-loss-form?prid=5342&wire=9

If you suffered a loss in Merit Medical Systems you have until February 3, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Portola Pharmaceuticals Class Action Investigation; PTLA Lawsuit

Class Action Reports

Levi & Korsinsky Announces Portola Pharmaceuticals Class Action Investigation; PTLA Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a PTLA class action lawsuit has been commenced on behalf of investors who purchased Portola Pharmaceuticals, Inc. (PTLA) securities between November 5, 2019 and January 9, 2020. For more on the Portola Pharmaceuticals Class Action please contact us today.

According to the Portola Pharmaceuticals lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Portola’s internal control over financial reporting regarding reserve for product returns was not effective; (2) Portola was shipping longer-dated product with 36-month shelf life; (3) Portola had not established adequate reserve for returns of prior shipments of short-dated product; (4) as a result, Portola was reasonably likely to need to “catch up” on accounting for return reserves; and (5) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

TO LEARN MORE ABOUT THE PTLA CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/portola-pharmaceuticals-inc-loss-form?prid=5375&wire=9

If you suffered a loss in Portola Pharmaceuticals you have until March 16, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Green Dot Class Action Investigation; GDOT Lawsuit

Class Action Reports

Levi & Korsinsky Announces Green Dot Class Action Investigation; GDOT Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a GDOT class action lawsuit has been commenced on behalf of investors who purchased Green Dot Corporation (GDOT) securities between May 9, 2018 and November 7, 2019. For more on the Green Dot Class Action please contact us today.

According to the Green Dot lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Green Dot’s strategy to attract “high-value” long-term customers was at the expense of “one and done” customers; (2) Green Dot’s “one and done” customers represented a significant source of revenues in its legacy segment; (3) consequently, Green Dot’s strategy was self-sabotaging; and (4) as a result of the foregoing, Defendants’ statements about its business and operations were materially false and misleading at all relevant times.

TO LEARN MORE ABOUT THE GDOT CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/green-dot-corporation-loss-form?prid=5375&wire=9

If you suffered a loss in Green Dot you have until February 18, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Baozun Class Action Investigation; BZUN Lawsuit

Class Action Reports

Levi & Korsinsky Announces Baozun Class Action Investigation; BZUN Lawsuit

Levi & Korsinsky, LLP

December 31, 2019

Levi & Korsinsky, LLP announces that a BZUN class action lawsuit has been commenced on behalf of investors who purchased Baozun Inc. (BZUN) securities between March 6, 2019 and November 20, 2019. For more on the Baozun Class Action please contact us today.

According to the Baozun lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Baozun was heavily reliant upon a single brand partner, Huawei, for the exponential service fee growth it had been reporting historically, which was in turn fueling its historical revenue growth; (2) compared to other brands Baozun had as brand partners, the Huawei work had historically included a lot of additional add-on service fees, increasing the revenue reported from Huawei vis-a-via its other brand partners; (3) Huawei, like other large brands, was actively preparing to bring its online merchandising in-house, meaning Baozun knew that it was losing a significant brand partner; and (4) as a result of the foregoing, the Company was not on track to achieve the financial results and performance Defendants claimed the Company was on track to achieve during the class period.

TO LEARN MORE ABOUT THE BZUN CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/baozun-inc-loss-form?wire=9&prid=4837

If you suffered a loss in Baozun you have until February 10, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces X Financial Class Action Investigation; XYF Lawsuit

Class Action Reports

Levi & Korsinsky Announces X Financial Class Action Investigation; XYF Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a XYF class action lawsuit has been commenced on behalf of investors who purchased X Financial, (XYF) pursuant and/or traceable to the Company’s initial public offering in September 19, 2018. For more on the X Financial Class Action please contact us today.

According to the X Financial lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company’s total loan facilitation amount was not growing, but rather was contracting; (2) the number of investors actively using X Financial’s platform was shrinking; (3) demand from small- and medium-sized enterprises for the Company’s preferred loans was plummeting; (4) the Company’s preferred loans had performed so poorly that it had begun drastically scaling back its preferred loans in the first quarter of 2018, several months before the initial public offering (“IPO”), and was in the process of phasing out such loans completely; (5) demand for the Company’s card loans was also plummeting; (6) the revenue and loan facilitation growth provided in the registration statement leading up to the IPO was achieved by relaxed credit and due diligence standards, under which the Company had underwritten tens of millions of dollars’ worth of poor quality loans that suffered from a disproportionately high risk of default as compared to the Company’s earlier loan vintages; (7) the Company was suffering from accelerated delinquency rates from poor quality loans that it had underwritten in the first, second, and third quarters of 2018, which had caused the Company’s delinquency rate to sharply rise; (8) the Company’s product mix had significantly deteriorated; (9) the Company’s net revenue was on track to decline by 22% during the third quarter of 2018; and (10) as a result, the Registration Statement was materially false and/or misleading and failed to state information required to be stated therein.

TO LEARN MORE ABOUT THE XYF CLASS ACTION, VISIThttps://www.zlk.com/pslra-1/x-financial-loss-form?wire=9&prid=4837

If you suffered a loss in X Financial you have until February 7, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Adamas Pharmaceuticals Class Action Investigation; ADMS Lawsuit

Class Action Reports

Levi & Korsinsky Announces Adamas Pharmaceuticals Class Action Investigation; ADMS Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a ADMS class action lawsuit has been commenced on behalf of investors who purchased Adamas Pharmaceuticals, Inc. (ADMS) securities between August 8, 2017 and September 30, 2019. For more on the Adamas Pharmaceuticals Class Action please contact us today.

According to the Adamas Pharmaceuticals lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) health insurers were excluding Adamas’s primary product, GOCOVRI, from their prescription formularies or requiring patients to use “step therapy” – i.e., making patients try immediate-release amantadine prior to covering GOCOVRI; (2) the rapid increase in physicians prescribing GOCOVRI during the Class Period was not due to its efficacy; and (3) as a result of the foregoing, the Company’s financial statements about Adamas’s business, operations, and prospects were materially false and misleading at all relevant times.

TO LEARN MORE ABOUT THE ADMS CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/adamas-pharmaceuticals-inc-loss-form?wire=9&prid=4837

If you suffered a loss in Adamas Pharmaceuticals you have until February 10, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Baxter International Class Action Investigation; BAX Lawsuit

Class Action Reports

Levi & Korsinsky Announces Baxter International Class Action Investigation; BAX Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a BAX class action lawsuit has been commenced on behalf of investors who purchased Baxter International Inc. (BAX) securities between February 21, 2019 and October 23, 2019. For more on the Baxter International Class Action please contact us today.

According to the Baxter International lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) certain intra-Company transactions, undertaken for the purpose of generating foreign exchange gains and losses, used foreign exchange rate conventions that were not in accordance with GAAP and enabled intra-Company transactions to be undertaken after the related exchange rates were already known; (2) the Company lacked effective internal control over financial reporting; (3) as a result, the Company’s financial statements were misstated and would likely require correction or amendment; (4) due to the Company’s internal investigation, Baxter would not be able to file its quarterly report for the period ending September 30, 2019, with the SEC on Form 10-Q in a timely manner; and (5) as a result of the foregoing, Defendants’ statements about the Company’s business and operations lacked a reasonable basis.

TO LEARN MORE ABOUT THE BAX CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/baxter-international-inc-loss-form?prid=4806&wire=9

If you suffered a loss in Baxter International you have until January 24, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Prudential Financial Class Action Investigation; PRU Lawsuit

Class Action Reports

Levi & Korsinsky Announces Prudential Financial Class Action Investigation; PRU Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a PRU class action lawsuit has been commenced on behalf of investors who purchased Prudential Financial, Inc. (PRU) securities between February 15, 2019 and August 2, 2019. For more on the Prudential Financial Class Action please contact us today.

According to the Prudential Financial lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company’s reserve assumptions failed to account for adversely developing mortality experience in the Individual Life business segment; (2) the Company was not over-reserved, but instead, its reported reserves, particularly for the Individual Life business segment, were insufficient to satisfy its future policy benefits liabilities; and (3) the Company had materially understated its liabilities and overstated net income as a result of flawed assumptions in calculating mortality experience.

TO LEARN MORE ABOUT THE PRU CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/prudential-financial-inc-loss-form?prid=4824&wire=9

If you suffered a loss in Prudential Financial you have until January 27, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces HEXO Class Action Investigation; HEXO Lawsuit

Class Action Reports

Levi & Korsinsky Announces HEXO Class Action Investigation; HEXO Lawsuit

Levi & Korsinsky, LLP

December 2, 2019

Levi & Korsinsky, LLP announces that a HEXO class action lawsuit has been commenced on behalf of investors who purchased HEXO Corp. (HEXO) securities between January 25, 2019 and November 15, 2019. For more on the HEXO Class Action please contact us today.

According to the HEXO lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) HEXO’s reported inventory was misstated as the Company was failing to write down or write off obsolete product that no longer had value; (2) HEXO was engaging in channel-stuffing in order to inflate its revenue figures and meet or exceed revenue guidance provided to investors; (3) HEXO was cultivating cannabis at its facility in Niagara, Ontario that was not appropriately licensed by Health Canada; and (4) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

TO LEARN MORE ABOUT THE HEXO CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/hexo-corp-loss-form?wire=9&prid=4629

If you suffered a loss in HEXO you have until January 27, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces The RealReal Class Action Investigation; REAL Lawsuit

Class Action Reports

Levi & Korsinsky Announces The RealReal Class Action Investigation; REAL Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a REAL class action lawsuit has been commenced on behalf of investors who purchased The RealReal, Inc. (REAL) pursuant and/or traceable to the Company’s initial public offering in June 27, 2019. For more on the The RealReal Class Action please contact us today.

According to the The RealReal lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company’s employees received little training on how to spot fake items; (2) the Company’s strict quotas on its employees exacerbated product authentication issues; (3) consequently, the potential for counterfeit or mislabeled items to make it through Company’s authentication process was higher than disclosed; and (4) as a result, Defendants’ statements about the Company’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

TO LEARN MORE ABOUT THE REAL CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/the-realreal-inc-loss-form?wire=9&prid=4617

If you suffered a loss in The RealReal you have until January 24, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Resideo Technologies Class Action Investigation; REZI Lawsuit

Class Action Reports

Levi & Korsinsky Announces Resideo Technologies Class Action Investigation; REZI Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a REZI class action lawsuit has been commenced on behalf of investors who purchased Resideo Technologies, Inc. (REZI) securities between October 29, 2018 and October 22, 2019. For more on the Resideo Technologies Class Action please contact us today.

According to the Resideo Technologies lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the negative operational effects of the Company’s spin-off from Honeywell International Inc. were more substantial and persistent than disclosed and had negatively affected Resideo’s product sales, supply chain, and gross margins, putting the Company’s FY19 financial forecasts at risk; and (2) as a result of the foregoing, the Company’s financial guidance lacked a reasonable basis and the Company was not on track to make its FY19 guidance as claimed.

TO LEARN MORE ABOUT THE REZI CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/resideo-technologies-inc-loss-form?wire=9&prid=4609

If you suffered a loss in Resideo Technologies you have until January 7, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Yunji Class Action Investigation; YJ Lawsuit

Class Action Reports

Levi & Korsinsky Announces Yunji Class Action Investigation; YJ Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a YJ class action lawsuit has been commenced on behalf of investors who purchased Yunji Inc. (YJ) pursuant and/or traceable to the Company’s initial public offering in May 2019. For more on the Yunji Class Action please contact us today.

According to the Yunji lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company was shifting certain of its sales to its marketplace platform; (2) this supply chain restructuring was likely to disrupt Yunji’s relationships with suppliers; (3) this supply chain restructuring was likely to have an adverse impact on the Company’s financial results; and (4) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

TO LEARN MORE ABOUT THE YJ CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/yunji-inc-loss-form?prid=4602&wire=9

If you suffered a loss in Yunji you have until January 13, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Energy Transfer Class Action Investigation; ET Lawsuit

Class Action Reports

Levi & Korsinsky Announces Energy Transfer Class Action Investigation; ET Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a ET class action lawsuit has been commenced on behalf of investors who purchased Energy Transfer LP, (ET) securities between February 25, 2017 and November 11, 2019. For more on the Energy Transfer Class Action please contact us today.

According to the Energy Transfer lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Energy Transfer’s permits to conduct the Mariner East pipeline project in Pennsylvania were secured via bribery and/or other improper conduct; (2) the foregoing misconduct increased the risk that the Partnership and/or certain of its employees would be subject to government and/or regulatory action, thereby depreciating the Partnership’s unit value; and (3) as a result, the Partnership’s public statements were materially false and misleading at all relevant times.

TO LEARN MORE ABOUT THE ET CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/energy-transfer-lp-loss-form?prid=4588&wire=9

If you suffered a loss in Energy Transfer you have until January 20, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Sealed Air Corporation Class Action Investigation; SEE Lawsuit

Class Action Reports

Levi & Korsinsky Announces Sealed Air Class Action Investigation; SEE Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a SEE class action lawsuit has been commenced on behalf of investors who purchased Sealed Air Corporation, (SEE) securities between November 5, 2014 and August 6, 2018. For more on the Sealed Air Class Action please contact us today.

According to the Sealed Air lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Sealed Air had hired its auditor, E&Y, pursuant to a conflicted and improper process and in order to help facilitate defendants’ efforts to engage in accounting fraud; (2) Sealed Air’s deduction of $1.49 billion in connection with the Settlement was indefensible and done for the improper purpose of artificially inflating the Company’s financial results; (3) Sealed Air had artificially inflated its earnings, cash flows, and operating income during the Class Period; (4) as a result of the above, Sealed Air’s Class Period financial statements were materially false and misleading and not prepared in conformance with GAAP; and (5) as a result of the above, Sealed Air’s statements regarding its financial results, business, and prospects were materially misleading.

TO LEARN MORE ABOUT THE SEE CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/sealed-air-corporation-loss-form?wire=9&prid=4579

If you suffered a loss in Sealed Air you have until December 31, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Plantronics Class Action Investigation; PLT Lawsuit

Class Action Reports

Levi & Korsinsky Announces Plantronics Class Action Investigation; PLT Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a PLT class action lawsuit has been commenced on behalf of investors who purchased Plantronics, Inc. (PLT) securities between July 2, 2018 and November 5, 2019. For more on the Plantronics Class Action please contact us today.

According to the Plantronics lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company had engaged in channel stuffing to artificially boost sales; (2) the Company’s internal control over inventory levels was not effective; (3) the Company had not adequately monitored inventory levels ahead of multiple product launches, where the new models would displace demand for aging products; and (4) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

TO LEARN MORE ABOUT THE PLT CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/plantronics-inc-loss-form?wire=9&prid=4578

If you suffered a loss in Plantronics you have until January 13, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Aurora Cannabis Class Action Investigation; ACB Lawsuit

Class Action Reports

Levi & Korsinsky Announces Aurora Cannabis Class Action Investigation; ACB Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a ACB class action lawsuit has been commenced on behalf of investors who purchased Aurora Cannabis Inc. (ACB) securities between September 11, 2019 and November 14, 2019. For more on the Aurora Cannabis Class Action please contact us today.

According to the Aurora Cannabis lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) as opposed to the Company’s representations, Aurora’s revenue would decline in its first quarter of fiscal 2020 ended September 30, 2019; (2) the Company would halt construction on its Aurora Nordic 2 and Aurora Sun facilities; and (3) as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

TO LEARN MORE ABOUT THE ACB CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/aurora-cannabis-inc-loss-form?prid=4567&wire=9

If you suffered a loss in Aurora Cannabis you have until January 21, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Grubhub Class Action Investigation; GRUB Lawsuit

Class Action Reports

Levi & Korsinsky Announces Grubhub Class Action Investigation; GRUB Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a GRUB class action lawsuit has been commenced on behalf of investors who purchased Grubhub Inc. GRUB) securities between July 30, 2019 and October 28, 2019. For more on the Grubhub Class Action please contact us today.

According to the Grubhub lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) customer orders were actually declining, despite the massive investments that the Company had made to spur demand for and use of its platform; (2) Grubhub’s new customer additions were generating significantly lower revenues as compared to historic cohorts because these customers were more prone to using competitor platforms; (3) Grubhub’s vaunted business model under which it secured exclusive partnerships had failed, and Grubhub needed to engage in the same aggressive nonpartnered sales tactics embraced by its competitors to generate significant revenue growth; (4) Grubhub was required to spend substantial additional capital in order to grow revenues and retain market share in the face of heightened competitive dynamics and market saturation, eviscerating the Company’s profitability; and (5) Grubhub was tracking tens of millions of dollars below its revenue and earnings guidance and such guidance lacked any reasonable basis.

TO LEARN MORE ABOUT THE GRUB CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/grubhub-inc-loss-form?prid=4567&wire=9

If you suffered a loss in Grubhub you have until January 20, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Canopy Growth Corporation Class Action Investigation; CGC Lawsuit

Class Action Reports

Levi & Korsinsky Announces Canopy Growth Corporation Class Action Investigation; CGC Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a CGC class action lawsuit has been commenced on behalf of investors who purchased Canopy Growth Corporation (CGC) securities between June 21, 2019 and November 13, 2019. For more on the Canopy Growth Corporation Class Action please contact us today.

According to the Canopy Growth Corporation lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company was experiencing weak demand for its softgel and oil products; (2) as a result, the Company would be forced to take a CA$32.7 million restructuring charge due to poor sales, excessive returns, and excess inventory; and (3) as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

TO LEARN MORE ABOUT THE CGC CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/canopy-growth-corporation-loss-form?prid=4567&wire=9

If you suffered a loss in Canopy Growth Corporation you have until January 20, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Quad/Graphics Class Action Investigation; QUAD Lawsuit

Class Action Reports

Levi & Korsinsky Announces Quad/Graphics Class Action Investigation; QUAD Lawsuit

Levi & Korsinsky, LLP

November 14, 2019

Levi & Korsinsky, LLP announces that a QUAD class action lawsuit has been commenced on behalf of investors who purchased Quad/Graphics, Inc. (QUAD) securities between February 21, 2018 and October 29, 2019. For more on the Quad/Graphics Class Action please contact us today.

According to the Quad/Graphics lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company’s book business in United States was underperforming; (2) as a result, the Company was likely to divest its book business; (3) the Company was unreasonably vulnerable to decreases in market prices; (4) to remain financially flexible while market prices decreased, the Company was likely to cut its quarterly dividend and expand its cost reduction programs; and (5) as a result of the foregoing, positive statements about the Company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

TO LEARN MORE ABOUT THE QUAD CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/quad-graphics-inc-loss-form?wire=9&prid=4336

If you suffered a loss in Quad/Graphics you have until January 6, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Pareteum Class Action Investigation; TEUM Lawsuit

Class Action Reports

Levi & Korsinsky Announces Pareteum Class Action Investigation; TEUM Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a TEUM class action lawsuit has been commenced on behalf of investors who purchased Pareteum Corporation, (TEUM) securities between December 14, 2017 and October 21, 2019. For more on the Pareteum Class Action please contact us today.

According to the Pareteum lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) it  was  not  true  that  the  Company’s  purported success was the result of hyper-demand for Pareteum’s unique products or exceptional service,  or  the  Company’s  competent  management;  but,  in  fact,  Defendants  had  propped  up  the  Company’s  results  by  manipulating  Pareteum’s  accounting  for  revenues, income, and the important Backlog metric; (2) Defendants had  materially  overstated  the  Company’s  profitability  by  failing  to  properly  account  for  the  Company’s results of operations and by artificially inflating the Company’s financial results; (3) it was not true that Pareteum contained even the most minimally adequate systems of internal operational or financial controls necessary to assure that Pareteum’s reported financial statements were true, accurate, and/or reliable; (4) as a result, it also was not true that the Company’s financial statements and reports were prepared in accordance with GAAP and SEC rules; and (5) as  a  result  of  the  aforementioned  adverse  conditions, Defendants lacked any reasonable basis to claim that  Pareteum  was  operating  according  to  plan,  or  that  Pareteum  could  achieve  the  guidance  sponsored and/or endorsed by Defendants.

TO LEARN MORE ABOUT THE TEUM CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/pareteum-corporation-loss-form?wire=9&prid=4336

If you suffered a loss in Pareteum you have until December 23, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces iRobot Class Action Investigation; IRBT Lawsuit

Class Action Reports

Levi & Korsinsky Announces iRobot Class Action Investigation; IRBT Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a IRBT class action lawsuit has been commenced on behalf of investors who purchased iRobot Corporation, (IRBT) securities between November 21, 2016 and October 22, 2019. For more on the iRobot Class Action please contact us today.

According to the iRobot lawsuit, defendants misrepresented the reason for iRobot’s acquisitions of Tokyo-based Sales on Demand Corporation and privately-held Robopolis SAS, which was to control the Company’s largest distributors so that defendants could inflate sales and revenue figures by stuffing the channel. Defendants further misled investors by repeatedly telling them throughout the Class Period that the Company was seeing continued double-digit revenue growth, and by attributing the growth to increased demand for the Roomba vacuums, when in reality defendants were engaging in channel-stuffing to artificially boost sales. Defendants also misstated that the Company’s channel inventory levels had not changed and would not change dramatically from quarter to quarter or year over year, when in fact iRobot was deliberately stuffing the channel in order to claim false revenue growth.

TO LEARN MORE ABOUT THE IRBT CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/irobot-corporation-loss-form?wire=9&prid=4335

If you suffered a loss in iRobot you have until December 23, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Under Armour Class Action Investigation; UA Lawsuit

Class Action Reports

Levi & Korsinsky Announces Under Armour Class Action Investigation; UA Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a UA class action lawsuit has been commenced on behalf of investors who purchased Under Armour, Inc. (UA) securities between August 3, 2016 and November 1, 2019. For more on the Under Armour Class Action please contact us today.

According to the Under Armour lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Under Armour shifted sales from quarter to quarter to appear healthier, including to keep pace with their long-running year-over-year 20% net revenue growth; (2) undisclosed to the investing public, the Company had been under investigation by and cooperating with the U.S. Department of Justice and U.S. Securities and Exchange Commission since at least July 2017; and (3) as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

TO LEARN MORE ABOUT THE UA CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/under-armour-inc-loss-form?wire=9&prid=4333

If you suffered a loss in Under Armour you have until January 6, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Azz Class Action Investigation; AZZ Lawsuit

Class Action Reports

Levi & Korsinsky Announces Azz Class Action Investigation; AZZ Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a AZZ class action lawsuit has been commenced on behalf of investors who purchased Azz, Inc. (AZZ) securities between July 3, 2018 and October 8, 2019. For more on the Azz Class Action please contact us today.

According to the Azz lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company’s internal controls over financial reporting were not effective; (2) the Company improperly implemented ASC 606 which resulted in improper revenue reconciliations; and (3) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

TO LEARN MORE ABOUT THE AZZ CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/azz-inc-loss-form?prid=4329&wire=9.

If you suffered a loss in Azz you have until January 3, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces UP Fintech Holding Class Action Investigation; TIGR Lawsuit

Class Action Reports

Levi & Korsinsky Announces UP Fintech Holding Class Action Investigation; TIGR Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a TIGR class action lawsuit has been commenced on behalf of investors who purchased UP Fintech Holding Limited, (TIGR) (a) Fintech American Depository Shares pursuant and/or traceable to the Company’s initial public offering conducted on or about March 20, 2019; or (b) Fintech securities between March 20, 2019 and May 16, 2019. For more on the UP Fintech Holding Class Action please contact us today.

According to the UP Fintech Holding lawsuit, (1) Fintech was experiencing a material decrease in commissions because of a negative trend related to risk-averse investors in the market; (2) Fintech was unable to absorb costs associated with the rapid growth of its business and its status as a publicly listed company on a U.S. exchange; (3) Fintech was incurring significant additional expenses related to, inter alia, employee headcount and employee compensation and benefits; (4) all of the foregoing had led to Fintech significantly increasing operating costs and expenses; and (5) as a result, the documents filed by the Company in connection with the initial public offering were materially false and/or misleading and failed to state information required to be stated therein, and the Company’s Class Period statements were likewise materially false and/or misleading.

TO LEARN MORE ABOUT THE TIGR CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/up-fintech-holding-limited-loss-form?prid=4316&wire=9.

If you suffered a loss in UP Fintech Holding you have until January 6, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Zendesk Class Action Investigation; ZEN Lawsuit

Class Action Reports

Levi & Korsinsky Announces Zendesk Class Action Investigation; ZEN Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a ZEN class action lawsuit has been commenced on behalf of investors who purchased Zendesk, Inc. (ZEN) securities between February 6, 2019 and October 1, 2019. For more on the Zendesk Class Action please contact us today.

According to the Zendesk lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Zendesk’s clients had been subject to data breaches dating back to 2016; (2) Zendesk was experiencing slowing demand for its Software as a Service offerings, particularly in Germany, the United Kingdom, and Australia, due in large part to political uncertainty and China trade issues there; and (3) as a result of the foregoing, Zendesk’s business metrics and financial prospects were not as strong as defendants had led the market to believe during the Class Period.

TO LEARN MORE ABOUT THE ZEN CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/zendesk-inc-loss-form?prid=4320&wire=9.

If you suffered a loss in Zendesk you have until December 23, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Domo Class Action Investigation; DOMO Lawsuit

Class Action Reports

Levi & Korsinsky Announces Domo Class Action Investigation; DOMO Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a DOMO class action lawsuit has been commenced on behalf of investors who purchased Domo, Inc. (DOMO) pursuant and/or traceable to the Company’s initial public offering commenced on or around June 29, 2018; or (b) Domo securities between June 28, 2018 and September 5, 2019, both dates inclusive. For more on the Domo Class Action please contact us today.

According to the Domo lawsuit, (1) Domo was experiencing weakness in its enterprise and international businesses; (2) Domo’s billings growth had dramatically slowed; (3) all of the foregoing was reasonably likely to have a material negative impact on the Company’s financial results; and (4) as a result, the Offering Documents were materially false and/or misleading and failed to state information required to be stated therein and the Company’s public statements were materially false and misleading at all relevant times.

TO LEARN MORE ABOUT THE DOMO CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/domo-inc-loss-form?prid=4320&wire=9.

If you suffered a loss in Domo you have until December 16, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Twitter Class Action Investigation; TWTR Lawsuit

Class Action Reports

Levi & Korsinsky Announces Twitter Class Action Investigation; TWTR Lawsuit

Levi & Korsinsky, LLP

November 7, 2019

Levi & Korsinsky, LLP announces that a TWTR class action lawsuit has been commenced on behalf of investors who purchased Twitter, Inc. (TWTR) securities between August 6, 2019 and October 23, 2019. For more on the Twitter Class Action please contact us today.

According to the Twitter lawsuit, defendants engaged in a scheme to deceive the market and a course of conduct that artificially inflated Twitter’s common share price and operated as a fraud or deceit on purchasers of Twitter common stock by misrepresenting the Company’s operating condition and future business prospects. The scheme was perpetrated by making positive statements about Twitter’s business while defendants knew, or disregarded with deliberate recklessness, certain adverse facts. When defendants’ prior misrepresentations were disclosed and became apparent to the market, the price of Twitter’s common stock fell precipitously.

TO LEARN MORE ABOUT THE TWTR CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/twitter-inc-loss-form?wire=3

If you suffered a loss in Twitter you have until December 30, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces ProPetro Holding Class Action Investigation; PUMP Lawsuit

Class Action Reports

Levi & Korsinsky Announces ProPetro Holding Class Action Investigation; PUMP Lawsuit

Levi & Korsinsky, LLP

November 5, 2019

Levi & Korsinsky, LLP announces that a PUMP class action lawsuit has been commenced on behalf of investors who purchased ProPetro Holding Corp. (PUMP) pursuant and/or traceable to the Company’s initial public offering in March 2017 and/or between February 17, 2017 and August 8, 2019. For more on the ProPetro Holding Class Action please contact us today.

According to the ProPetro Holding lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company’s executive officers were improperly reimbursed for certain expenses; (2) the Company had engaged in certain undisclosed transactions with related parties; (3) the Company lacked adequate disclosure controls and procedures; (4) the Company lacked effective internal control over financial reporting; and (5) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

TO LEARN MORE ABOUT THE PUMP CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/propetro-holding-corp-loss-form?wire=3

If you suffered a loss in ProPetro Holding you have until November 15, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Uniti Group Class Action Investigation; UNIT Lawsuit

Class Action Reports

Levi & Korsinsky Announces Uniti Group Class Action Investigation; UNIT Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a UNIT class action lawsuit has been commenced on behalf of investors who purchased Uniti Group Inc. (UNIT) securities between April 20, 2015 and February 15, 2019. For more on the Uniti Group Class Action please contact us today.

According to the Uniti Group lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Uniti’s financial results were not sustainable because its customer Windstream had defaulted on its unsecured notes; and (2) as a result of the foregoing, Defendants’ statements about Uniti’s business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.

TO LEARN MORE ABOUT THE UNIT CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/uniti-group-inc-loss-form?wire=3

If you suffered a loss in Uniti Group you have until December 30, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Slack Technologies Class Action Investigation; WORK Lawsuit

Class Action Reports

Levi & Korsinsky Announces Slack Technologies Class Action Investigation; WORK Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a WORK class action lawsuit has been commenced on behalf of investors who purchased Slack Technologies, Inc. (WORK) pursuant and/or traceable to the Company’s initial public offering in June 20, 2019. For more on the Slack Technologies Class Action please contact us today.

According to the Slack Technologies lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company’s Slack Platform was susceptible to recurring service-level disruptions; (2) such disruptions were increasingly likely to occur as the Company scaled its services to a larger user base; (3) the Company provides credits even if a customer was not specifically affected by service-level disruptions; (4) as a result, any service-level disruptions would have a material adverse impact on the Company’s financial results; and (5) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

TO LEARN MORE ABOUT THE WORK CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/slack-technologies-inc-loss-form?wire=3

If you suffered a loss in Slack Technologies you have until November 18, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Uber Technologies Class Action Investigation; UBER Lawsuit

Class Action Reports

Levi & Korsinsky Announces Uber Technologies Class Action Investigation; UBER Lawsuit

Levi & Korsinsky, LLP

October 25, 2019

Levi & Korsinsky, LLP announces that a UBER class action lawsuit has been commenced on behalf of investors who purchased Uber Technologies, Inc. (UBER) pursuant and/or traceable to the Company’s initial public offering in May 10, 2019. For more on the Uber Technologies Class Action please contact us today.

According to the Uber Technologies lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) at the time of the initial public offering, Uber was rapidly increasing subsidies for customer’s rides and meals in a bid for market share, which caused the Company’s sales and marketing expenses to swell; and (2) Defendants were cutting (or planned to cut) costs in key areas that undermined the Company’s central growth opportunities.

TO LEARN MORE ABOUT THE UBER CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/uber-technologies-inc-loss-form?prid=4016&wire=1

If you suffered a loss in Uber Technologies you have until December 3, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces The Chemours Company Class Action Investigation; CC Lawsuit

Class Action Reports

Levi & Korsinsky Announces The Chemours Company Class Action Investigation; CC Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a CC class action lawsuit has been commenced on behalf of investors who purchased The Chemours Company, (CC) securities between February 16, 2017 and August 1, 2019. For more on the The Chemours Company Class Action please contact us today.

According to the The Chemours Company lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Chemours had not appropriately accounted and accrued reserves for its environmental liabilities; (2) the possibility of costs exceeding accrued amounts was greater than the Company had represented to a point that could be material; (3) the Company’s policies, standards and procedures were not properly designed to prevent unreasonable risk of harm to people and the environment (4) Chemours’  handling, manufacture, use, and disposal of hazardous substances was not in accordance with applicable environmental laws and regulations; and (5) as a result of these misrepresentations, Chemours shares traded at artificially inflated prices.

TO LEARN MORE ABOUT THE CC CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/the-chemours-company-loss-form?wire=3

If you suffered a loss in The Chemours Company you have until December 9, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Dropbox Class Action Investigation; DBX Lawsuit

Class Action Reports

Levi & Korsinsky Announces Dropbox Class Action Investigation; DBX Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a DBX class action lawsuit has been commenced on behalf of investors who purchased Dropbox, Inc. (DBX) pursuant and/or traceable to the Company’s initial public offering in March 23, 2018. For more on the Dropbox Class Action please contact us today.

According to the Dropbox lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Dropbox had materially overstated its ability to monetize its user base; (2) Dropbox was facing worsening revenue trends, which were negatively impacting the Company at the time of the initial public offering (“IPO”); (3) Dropbox was tracking below its internal revenue and monetization targets at the time of the IPO; and (4) as a result, defendants’ statements about Dropbox’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

TO LEARN MORE ABOUT THE DBX CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/dropbox-inc-loss-form?wire=3

If you suffered a loss in Dropbox you have until December 3, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Infosys Class Action Investigation; INFY Lawsuit

Class Action Reports

Levi & Korsinsky Announces Infosys Class Action Investigation; INFY Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a INFY class action lawsuit has been commenced on behalf of investors who purchased Infosys Limited, (INFY) securities between July 7, 2018 and October 20, 2019. For more on the Infosys Class Action please contact us today.

According to the Infosys lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company improperly recognized revenues to inflate short-term profits; (2) Chief Executive Officer Salil Parekh bypassed reviews and approvals for large deals to avoid accounting scrutiny; (3) management pressured the Company’s finance team to hide information from auditors and the Company’s Board of Directors; and (4) as a result of the aforementioned misconduct, Defendants’ statements about Infosys’s business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis at all relevant times.

TO LEARN MORE ABOUT THE INFY CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/infosys-limited-loss-form?wire=3

If you suffered a loss in Infosys you have until December 23, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Ruhnn Holding Class Action Investigation; RUHN Lawsuit

Class Action Reports

Levi & Korsinsky Announces Ruhnn Holding Class Action Investigation; RUHN Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a RUHN class action lawsuit has been commenced on behalf of investors who purchased Ruhnn Holding Limited (RUHN) pursuant and/or traceable to the Company’s initial public offering in April 3, 2019. For more on the Ruhnn Holding Class Action please contact us today.

According to the Ruhnn Holding lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) at the time of the initial public offering (“IPO”), the number of Ruhnn’s online stores had declined by nearly 40%; (2) at the time of the IPO, the number of Ruhnn’s full-service Key Opinion Leaders had declined by nearly 44%; (3) as a result, the Company’s net revenues derived from its full-service segment had declined by 46% on a sequential basis; and (3) as a result, defendants’ statements about Ruhnn’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

TO LEARN MORE ABOUT THE RUHN CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/ruhnn-holding-limited-loss-form?wire=3

If you suffered a loss in Ruhnn Holding you have until December 6, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Capital One Financial Corporation Class Action Investigation; COF Lawsuit

Class Action Reports

Levi & Korsinsky Announces Capital One Financial Corporation Class Action Investigation; COF Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a COF class action lawsuit has been commenced on behalf of investors who purchased Capital One Financial Corporation (COF) securities between February 2, 2018 and July 29, 2019. For more on the Capital One Financial Corporation Action please contact us today.

According to the Capital One Financial Corporation lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company did not maintain robust information security protections, and its protection did not shield personal information against security breaches; (2) such deficiencies heightened the Company’s exposure to a cyber-attack; and (3) as a result, Capital One’s public statements were materially false and misleading at all relevant times.

TO LEARN MORE ABOUT THE COF CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/capital-one-financial-corporation-loss-form?wire=3

If you suffered a loss in Capital One Financial Corporation you have until December 2, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces ADTRAN Class Action Investigation; ADTN Lawsuit

Class Action Reports

Levi & Korsinsky Announces ADTRAN Class Action Investigation; ADTN Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a ADTN class action lawsuit has been commenced on behalf of investors who purchased ADTRAN, Inc. (ADTN) securities between February 28, 2019 and October 9, 2019. For more on the ADTRAN Class Action please contact us today.

According to the ADTRAN lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) there were material weaknesses in the Company’s internal control over financial reporting; (2) as a result, certain E&O reserves had been improperly reported; (3) as a result, the Company’s financial results for certain periods were misstated; (4) there would be a pause in shipments to the Company’s Latin American customer; and (5) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

TO LEARN MORE ABOUT THE ADTN CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/adtran-inc-loss-form?wire=3

If you suffered a loss in ADTRAN you have until December 16, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Overstock.com Class Action Investigation; OSTK Lawsuit

Class Action Reports

Levi & Korsinsky Announces Overstock.com Class Action Investigation; OSTK Lawsuit

Levi & Korsinsky, LLP

October 9, 2019

Levi & Korsinsky, LLP announces that a OSTK class action lawsuit has been commenced on behalf of investors who purchased Overstock.com, Inc. (OSTK) securities between May 9, 2019 and September 23, 2019. For more on the Overstock.com Class Action please contact us today.

According to the Overstock.com lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) it was not true that Overstock would be able to support the launch of its tZERO crypto currency with earnings or cash flow from its retail operations and that whatever marginal improvements defendants had made by cutting costs and engineering earnings could not be sustained so as to generate positive EBITDA or cash from operations necessary to support its crypto currency operations; (2) there were extreme additional risks and substantial volatility in the price of Company shares was foreseeable, given defendants’ undisclosed plan to offer its tZERO Preferred Share Dividend as a means to squeeze short sellers out of Overstock and to prevent them from holding legitimate positions in the Company; (3) there was a foreseeable likelihood that the Company’s ability to accomplish its intended short squeeze would embolden the SEC or even market participants, such as major brokerage houses, to act to prevent this market manipulation; (4) it was not true that Overstock contained adequate systems of internal operational or financial controls, such that Overstock’s quarterly reports filed with the SEC were true, accurate or reliable; (5) as a result of the foregoing, it also was not true that the Company’s quarterly reports filed with the SEC were prepared in accordance with GAAP ad SEC rules; and (6) as a result of the aforementioned adverse conditions which defendants failed to disclose, defendants lacked any reasonable basis to claim that Overstock was operating according to plan, or that Overstock could achieve guidance sponsored and/or endorsed by defendants.

TO LEARN MORE ABOUT THE OSTK CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/overstock-com-inc-loss-form?prid=3795&wire=1

If you suffered a loss in Overstock.com you have until November 26, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 1000

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Altria Group Class Action Investigation; MO Lawsuit

Class Action Reports

Levi & Korsinsky Announces Altria Group Class Action Investigation; MO Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a MO class action lawsuit has been commenced on behalf of investors who purchased Altria Group, Inc. (MO) securities between December 20, 2018 and September 24, 2019. For more on the Altria Group Class Action please contact us today.

According to the Altria Group lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Altria had conducted insufficient due diligence into JUUL prior to the Company’s $12.8 billion investment, or 35% stake, in JUUL; (2) Altria consequently failed to inform investors, or account for, material risks associated with JUUL’s products and marketing practices, and the true value of JUUL and its products; (3) all of the foregoing, as well as mounting public scrutiny, negative publicity, and governmental pressure on e-vapor products and JUUL made it reasonably likely that Altria’s investment in JUUL would have a material negative impact on the Company’s reputation and operations; and (4) as a result, the Company’s public statements were materially false and misleading at all relevant times.

TO LEARN MORE ABOUT THE MO CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/altria-group-inc-loss-form?prid=3795&wire=1

If you suffered a loss in Altria Group you have until December 2, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Smiledirectclub Class Action Investigation; SDC Lawsuit

Class Action Reports

Levi & Korsinsky Announces Smiledirectclub Class Action Investigation; SDC Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a SDC class action lawsuit has been commenced on behalf of investors who purchased Smiledirectclub Inc. (SDC) pursuant and/or traceable to the Company’s initial public offering in September 2019. For more on the Smiledirectclub Class Action please contact us today.

According to the Smiledirectclub lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) administrative personnel, rather than licensed doctors, provided treatment to the Company’s customers and monitored their progress; (2) as a result, the Company’s practices did not qualify as teledentistry under applicable standards; (3) as a result, the Company was subject to regulatory scrutiny for the unlicensed practice of dentistry; (4) the efficacy of the Company’s treatment was overstated; (5) the Company had concealed these deceptive marketing practices prior to the IPO; and (6) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

TO LEARN MORE ABOUT THE SDC CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/smiledirectclub-inc-loss-form?prid=3817&wire=1

If you suffered a loss in Smiledirectclub you have until December 2, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Covetrus Class Action Investigation; CVET Lawsuit

Class Action Reports

Levi & Korsinsky Announces Covetrus Class Action Investigation; CVET Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a CVET class action lawsuit has been commenced on behalf of investors who purchased Covetrus, Inc. (CVET) securities between February 8, 2019 and August 12, 2019. For more on the Covetrus Class Action please contact us today.

According to the Covetrus lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company had overstated its capabilities with regard to inventory management and supply chain services; (2) Covetrus had understated the costs of the integration of Henry Schein’s Animal Health Business and VFC, including the timing and nature of those costs; (3) Covetrus had understated its separation costs from Henry Schein; and (4) the Company understated the impact on earnings from online competition and alternative distribution channels as well as the impact of the loss of a large customer in North America just prior to the Company’s separation from Henry Schein.

TO LEARN MORE ABOUT THE CVET CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/covetrus-inc-loss-form?prid=3821&wire=1

If you suffered a loss in Covetrus you have until November 29, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Myriad Genetics Class Action Investigation; MYGN Lawsuit

Class Action Reports

Levi & Korsinsky Announces Myriad Genetics Class Action Investigation; MYGN Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a MYGN class action lawsuit has been commenced on behalf of investors who purchased Myriad Genetics, Inc. (MYGN) securities between September 2, 2016 and August 13, 2019. For more on the Myriad Genetics Class Action please contact us today.

According to the Myriad Genetics lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Myriad’s product, GeneSight, lacked evidence or information sufficient to support the tests in their current form, including their purported benefits; (2) the U.S. Food and Drug Administration (“FDA”) had requested changes to GeneSight and questioned the validity of the test’s purported benefits; (3) Myriad had been in ongoing discussions with the FDA regarding the FDA’s requested changes to GeneSight; (4) Myriad’s acquisition of Counsyl-and thereby, Foresight-caused the Company to incur the risk of suffering from lower reimbursement for its expanded carrier screening tests, which had the potential to, and actually did, materialize into a material negative impact on the Company’s revenue; and (5) as a result, the Company’s public statements were materially false and misleading at all relevant times.

TO LEARN MORE ABOUT THE MYGN CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/myriad-genetics-inc-loss-form?prid=3820&wire=1

If you suffered a loss in Myriad Genetics you have until November 26, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Waitr Holdings Class Action Investigation; WTRH Lawsuit

Class Action Reports

Levi & Korsinsky Announces Waitr Holdings Class Action Investigation; WTRH Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a WTRH class action lawsuit has been commenced on behalf of investors who purchased Waitr Holdings Inc. (WTRH) securities between May 17, 2018 and August 8, 2019. For more on the Waitr Holdings Class Action please contact us today.

According to the Waitr Holdings lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Waitr lacked a plan to achieve profitability and, contrary to the statements of Company founder Chris Meaux, Waitr was not at or near profitability and Defendants had created the illusion of financial stability by engaging in a host of illegal and improper activities each designed to inflate revenues and earnings-such as unilaterally breaking low-rate contracts and imposing significantly higher rates, and by refusing to pay drivers for mileage related expenses-both of which ultimately resulted in independent class action lawsuits; and (2) Waitr’s technology provided no real advantage and the Company could not obtain the developer, programming, or engineering resources necessary to enhance, maintain, and develop industry leading software from its headquarter location in Lake Charles, Louisiana.

TO LEARN MORE ABOUT THE WTRH CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/waitr-holdings-inc-loss-form?prid=3820&wire=1

If you suffered a loss in Waitr Holdings you have until November 26, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Match Group Class Action Investigation; MTCH Lawsuit

Class Action Reports

Levi & Korsinsky Announces Match Group Class Action Investigation; MTCH Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a MTCH class action lawsuit has been commenced on behalf of investors who purchased Match Group, Inc. (MTCH) securities between August 6, 2019 and September 25, 2019. For more on the Match Group Class Action please contact us today.

According to the Match Group lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company used fake love interest ads to convince customers to buy and upgrade subscriptions; (2) the Company made it difficult and confusing for consumers to cancel their subscriptions; (3) as a result, the Company was reasonably likely to be subject to regulatory scrutiny; (4) the Company lacked adequate disclosure controls and procedures; and (5) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

TO LEARN MORE ABOUT THE MTCH CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/match-group-inc-loss-form?prid=3820&wire=1

If you suffered a loss in Match Group you have until December 2, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Sundial Growers Class Action Investigation; SNDL Lawsuit

Class Action Reports

Levi & Korsinsky Announces Sundial Growers Class Action Investigation; SNDL Lawsuit

Levi & Korsinsky, LLP

September 30, 2019

Levi & Korsinsky, LLP announces that a SNDL class action lawsuit has been commenced on behalf of investors who purchased Sundial Growers Inc. (SNDL) pursuant and/or traceable to the Company’s initial public offering in August 1, 2019. For more on the Sundial Growers Class Action please contact us today.

According to the Sundial Growers lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Sundial failed to supply saleable cannabis in line with contractual obligations to Zenabis Global Inc.; (2) due to material quality issues, Zenabis had to return or reject a total of 554 kg of cannabis to Sundial, valued at approximately U.S. $1.9 million (C$2.5 million); and (3) as a result, defendants’ statements about Sundial’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

TO LEARN MORE ABOUT THE SNDL CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/sundial-growers-inc-loss-form?wire=3

If you suffered a loss in Sundial Growers you have until November 25, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Ollies Bargain Outlet Holdings Class Action Investigation; OLLI Lawsuit

Class Action Reports

Levi & Korsinsky Announces Ollies Bargain Outlet Holdings Class Action Investigation; OLLI Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a OLLI class action lawsuit has been commenced on behalf of investors who purchased Ollies Bargain Outlet Holdings, Inc. (OLLI) securities between June 6, 2019 and August 28, 2019. For more on the Ollies Bargain Outlet Holdings Class Action please contact us today.

According to the Ollies Bargain Outlet Holdings lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company suffered a supply chain issue that impacted the initial inventory available at new stores; (2) as a result, the Company lacked sufficient inventory to meet demand at certain store locations; (3) as a result, the Company’s comparable store sales were likely to decrease quarter-over-quarter; and (4) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

TO LEARN MORE ABOUT THE OLLI CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/ollies-bargain-outlet-holdings-inc-loss-form?prid=3632&wire=1

If you suffered a loss in Ollies Bargain Outlet Holdings you have until November 18, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Eagle Bancorp Class Action Investigation; EGBN Lawsuit

Class Action Reports

Levi & Korsinsky Announces Eagle Bancorp Class Action Investigation; EGBN Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a EGBN class action lawsuit has been commenced on behalf of investors who purchased Eagle Bancorp, Inc. (EGBN) securities between March 2, 2015 and July 17, 2019. For more on the Eagle Bancorp Class Action please contact us today.

According to the Eagle Bancorp lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Eagle Bancorp’s internal controls and procedures and compliance policies were inadequate; (2) the foregoing shortcoming created a foreseeable risk of heightened regulatory scrutiny and the need for the Company undertake its own internal investigations; and (3) as a result, the Company’s public statements were materially false and misleading at all relevant times.

TO LEARN MORE ABOUT THE EGBN CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/eagle-bancorp-inc-loss-form?prid=3631&wire=1

If you suffered a loss in Eagle Bancorp you have until September 23, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Carbonite Class Action Investigation; CARB Lawsuit

Class Action Reports

Levi & Korsinsky Announces Carbonite Class Action Investigation; CARB Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a CARB class action lawsuit has been commenced on behalf of investors who purchased Carbonite, Inc. (CARB) securities between February 7, 2019 and July 25, 2019. For more on the Carbonite Class Action please contact us today.

According to the Carbonite lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Carbonite’s Server Backup VM Edition was of poor quality and technologically flawed; (2) Carbonite was receiving poor reviews and complaints from customers about the Server Backup VM Edition; (3) the poor quality and technological flaws of the Server Backup VM Edition was acting as a “disruptive” factor throughout the Carbonite salesforce and keeping that sales organization from closing opportunistically on several larger deals during fiscal 2019; and (4) as a result of the foregoing, Carbonite lacked any reasonable basis for issuing its positive projections and financial forecasts.

TO LEARN MORE ABOUT THE CARB CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/carbonite-inc-loss-form?prid=3659&wire=1

If you suffered a loss in Carbonite you have until September 30, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Meredith Corporation Class Action Investigation; MDP Lawsuit

Class Action Reports

Levi & Korsinsky Announces Meredith Corporation Class Action Investigation; MDP Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a MDP class action lawsuit has been commenced on behalf of investors who purchased Meredith Corporation, (MDP) securities between January 31, 2018 and September 5, 2019. For more on the Meredith Corporation Class Action please contact us today.

According to the Meredith Corporation lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Time, Inc. acquisition was not as profitable as the Company had claimed; (2) the Company would incur additional costs for strategic investments to improve the Time business; (3) as a result, the Company’s earnings would be materially and adversely impacted; and (4) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

TO LEARN MORE ABOUT THE MDP CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/meredith-corporation-loss-form?prid=3642&wire=1

If you suffered a loss in Meredith Corporation you have until November 5, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Pluralsight Class Action Investigation; PS Lawsuit

Class Action Reports

Levi & Korsinsky Announces Pluralsight Class Action Investigation; PS Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a PS class action lawsuit has been commenced on behalf of investors who purchased Pluralsight, Inc. (PS) securities between August 2, 2018 and July 31, 2019. For more on the Pluralsight Class Action please contact us today.

According to the Pluralsight lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: Pluralsight was experiencing substantial delays in hiring and properly training the salesforce necessary to meet its lofty billing projections. In addition, the Company knew at the time of the March 2019 secondary public offering (“SPO”) that it was behind schedule onboarding new sales representatives, which was hurting the Company’s sales execution and preventing Pluralsight from meeting its high growth projections. Instead of disclosing such facts at the time of the SPO, and to cash-out at inflated prices, Defendants intentionally obscured and omitted this pertinent information from investors.

TO LEARN MORE ABOUT THE PS CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/pluralsight-inc-loss-form?prid=3642&wire=1

If you suffered a loss in Pluralsight you have until October 15, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Just Energy Group Class Action Investigation; JE Lawsuit

Class Action Reports

Levi & Korsinsky Announces Just Energy Group Class Action Investigation; JE Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a JE class action lawsuit has been commenced on behalf of investors who purchased Just Energy Group, Inc. (JE) securities between November 9, 2017 and August 19, 2019. For more on the Just Energy Group Class Action please contact us today.

According to the Just Energy Group lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company experienced customer enrollment and nonpayment issues; (2) as a result, the Company was reasonably likely to incur an impairment charge to its accounts receivable; (3) as a result, the Company lacked adequate internal control over its financial reporting; and (4) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

TO LEARN MORE ABOUT THE JE CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/just-energy-group-inc-loss-form?prid=3642&wire=1

If you suffered a loss in Just Energy Group you have until September 30, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Farfetch Class Action Investigation; FTCH Lawsuit

Class Action Reports

Levi & Korsinsky Announces Farfetch Class Action Investigation; FTCH Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a FTCH class action lawsuit has been commenced on behalf of investors who purchased Farfetch Limited, (FTCH) securities between September 21, 2018 and August 8, 2019. For more on the Farfetch Class Action please contact us today.

According to the Farfetch lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company would refuse to reduce merchandise prices to match the rest of the market; (2) this sub-optimal pricing strategy rendered the Company’s platform highly susceptible to underpricing by competitors, despite what Defendants touted as a “superior” platform; and (3) as a result, the Company’s past and projected Platform Gross Merchandise Value growth rates were foreseeably unsustainable. As a result of the foregoing, Defendants’ statements about the Company’s business strategy and growth prospects lacked a reasonable basis at all relevant times.

TO LEARN MORE ABOUT THE FTCH CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/farfetch-loss-form?wire=3

If you suffered a loss in Farfetch you have until November 18, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Evolent Health Class Action Investigation; EVH Lawsuit

Class Action Reports

Levi & Korsinsky Announces Evolent Health Class Action Investigation; EVH Lawsuit

Levi & Korsinsky, LLP

September 24, 2019

Levi & Korsinsky, LLP announces that a EVH class action lawsuit has been commenced on behalf of investors who purchased Evolent Health, Inc. (EVH) securities between March 3, 2017 and May 28, 2019. For more on the Evolent Health Class Action please contact us today.

According to the Evolent Health lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Evolent’s partnership model was not aligned with its partners, as it was designed to parasitically increase its own revenue by extracting  enormous administrative and management fees at the expense of its partners such as Passport Health Plan (“Passport”); (2) Passport was struggling financially, particularly after Kentucky cut its reimbursement rates, and the partnership between Evolent and Passport was becoming increasingly unsustainable; (3) Evolent was draining Passport of functions, employees, and money to such an extent that Passport was left on the verge of insolvency; (4) for several months, Passport was conducting a bidding process to sell itself to a financial buyer to prevent liquidation; and (5) as a result of the foregoing, Defendants public statements were materially false and/or misleading and/or lacked a reasonable basis.

TO LEARN MORE ABOUT THE EVH CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/evolent-health-inc-loss-form?wire=3

If you suffered a loss in Evolent Health you have until October 7, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Karyopharm Therapeutics Class Action Investigation; KPTI Lawsuit

Class Action Reports

Levi & Korsinsky Announces Karyopharm Therapeutics Class Action Investigation; KPTI Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a KPTI class action lawsuit has been commenced on behalf of investors who purchased Karyopharm Therapeutics, Inc. (KPTI) securities between March 2, 2017 and February 22, 2019. For more on the Karyopharm Therapeutics Class Action please contact us today.

According to the Karyopharm Therapeutics lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company continued to tout the commercial prospects for selinexor and consistently described selinexor as having a “predictable and manageable tolerability profile” and a “very nice safety profile,” and assured investors that it was “well tolerated” by patients. (2) Karyopharm also claimed that selinexor had the potential to be used as a new treatment for MM, with limited and manageable side effects. (3) As a result of these misrepresentations, Karyopharm shares traded at artificially inflated prices during the Class Period.

TO LEARN MORE ABOUT THE KPTI CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/karyopharm-therapeutics-inc-loss-form?wire=3

If you suffered a loss in Karyopharm Therapeutics you have until September 23, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Sarepta Therapeutics Class Action Investigation; SRPT Lawsuit

Class Action Reports

Levi & Korsinsky Announces Sarepta Therapeutics Class Action Investigation; SRPT Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a SRPT class action lawsuit has been commenced on behalf of investors who purchased Sarepta Therapeutics, Inc. (SRPT) securities between September 6, 2017 and August 19, 2019. For more on the Sarepta Therapeutics Class Action please contact us today.

According to the Sarepta Therapeutics lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) golodirsen, Sarepta’s drug for the treatment of Duchenne muscular dystrophy, posed significant safety risks to patients; (2) consequently, the New Drug Application package for golodirsen’s accelerated approval was unlikely to receive Food and Drug Administration approval; and (3) as a result, Sarepta’s public statements were materially false and misleading at all relevant times.

TO LEARN MORE ABOUT THE SRPT CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/sarepta-therapeutics-inc-loss-form?wire=3

If you suffered a loss in Sarepta Therapeutics you have until October 29, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Cardinal Health Class Action Investigation; CAH Lawsuit

Class Action Reports

Levi & Korsinsky Announces Cardinal Health Class Action Investigation; CAH Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a CAH class action lawsuit has been commenced on behalf of investors who purchased Cardinal Health, Inc. (CAH) securities between March 2, 2015 and May 2, 2018. For more on the Cardinal Health Class Action please contact us today.

According to the Cardinal Health lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) following Cardinal’s acquisition of Cordis, the RFID [radio-frequency identification] inventory tracking technology and advanced supply chain solutions that Defendants told investors the Company would to use to improve Cordis’s performance were never implemented across Cordis; (2) Cordis’s antiquated and ineffective global supply chain was causing operational and inventory problems at Cordis; (3) as a result, Cordis manufactured and accumulated excessive amounts of cardiovascular product inventories, which sat on the shelf and became unsellable and/or expired; (4) the Company materially overstated Cordis’s inventory balances; (5) Cordis was not “performing well” and its integration was not “on track,” “going incredibly well” or “largely on plan”; and (6) to correct Cordis’s deficiencies, the Company would have to make substantial investments in Cordis’s IT and supporting infrastructure, thereby incurring significant Selling, General and Administrative Expenses charges beyond the levels internally budgeted or projected by Cardinal and diminishing operating earnings.

TO LEARN MORE ABOUT THE CAH CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/cardinal-health-inc-loss-form?wire=3

If you suffered a loss in Cardinal Health you have until September 30, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces CVS Health Corporation Class Action Investigation; CVS Lawsuit

Class Action Reports

Levi & Korsinsky Announces CVS Health Corporation Class Action Investigation; CVS Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a CVS class action lawsuit has been commenced on behalf of all former Aetna Inc. shareholders who acquired CVS Health Corporation (CVS) shares in exchange for their Aetna shares in connection with CVS’s acquisition of Aetna on November 28, 2018. For more on the CVS Health Corporation Class Action please contact us today.

According to the CVS Health Corporation lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) by the end of 2017, CVS’s financial condition and expected earnings had deteriorated as a result of rising costs and poor results being experienced in the long-term care (“LTC”) unit associated with the 2015 acquisition of Omnicare; (2) in 2017, deteriorating conditions and prospects in CVS ‘s LTC unit prompted CVS to undertake hasty acquisitions of LTC pharmacies to compensate for the declining LTC business and/or mask the expected LTC goodwill impairment ahead of the planned Acquisition; (3) although negative LTC performance factors prompted CVS and the CVS Individual Defendants to make hasty LTC pharmacy acquisitions in 2017, those same negative factors were being overlooked and ignored for purposes of undertaking, disclosing, and reporting the results of LTC goodwill impairment tests throughout 2017, in violation of GAAP; (4) the LTC goodwill being carried on CVS’s books as a result of the Omnicare acquisition was being carried at inflated values that would require billions of dollars in impairment charges that would be charged against earnings; and (5) as a result of the foregoing, CVS’s true business metrics and financial prospects were not as the Offering Documents represented.

TO LEARN MORE ABOUT THE CVS CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/cvs-health-corporation-loss-form-2?prid=3546&wire=1

If you suffered a loss in CVS Health Corporation you have until October 15, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Curaleaf Holdings Class Action Investigation; CURLF Lawsuit

Class Action Reports

Levi & Korsinsky Announces Curaleaf Holdings Class Action Investigation; CURLF Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a CURLF class action lawsuit has been commenced on behalf of investors who purchased Curaleaf Holdings, Inc. (CURLF) securities between November 21, 2018 and July 22, 2019. For more on the Curaleaf Holdings Class Action please contact us today.

According to the Curaleaf Holdings lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Curaleaf, on its website and social media pages, marketed its CBD products to be used as drugs and dietary supplements, contrary to law; (2) Curaleaf also sold unapproved animal drugs on its website; (3) such conduct would result in a warning letter from the U.S. Food and Drug Administration; and (4) as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

TO LEARN MORE ABOUT THE CURLF CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/curaleaf-holdings-inc-loss-form?prid=3546&wire=1

If you suffered a loss in Curaleaf Holdings you have until October 4, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Viewray Class Action Investigation; VRAY Lawsuit

Class Action Reports

Levi & Korsinsky Announces Viewray Class Action Investigation; VRAY Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a VRAY class action lawsuit has been commenced on behalf of investors who purchased Viewray, Inc. (VRAY) securities between March 15, 2019 and August 8, 2019. For more on the Viewray Class Action please contact us today.

According to the Viewray lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) demand for ViewRay systems had declined due in part to changes being made to Medicare reimbursement approaches first announced in November 2019 that could make purchases of new ViewRay systems less profitable for customers; (2) the Company’s reported backlog was overstated due to the inclusion of orders with insufficient surety as to permit for their inclusion in reported backlog; and (3) as a result of the foregoing, defendants’ positive statements about ViewRay’s business metrics and financial prospects during the Class Period were materially false and misleading and/or lacked a reasonable basis.

TO LEARN MORE ABOUT THE VRAY CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/viewray-inc-loss-form?prid=3551&wire=1

If you suffered a loss in Viewray you have until November 12, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Textron Class Action Investigation; TXT Lawsuit

Class Action Reports

Levi & Korsinsky Announces Textron Class Action Investigation; TXT Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a TXT class action lawsuit has been commenced on behalf of investors who purchased Textron Inc. (TXT) securities between January 31, 2018 and October 17, 2018. For more on the Textron Class Action please contact us today.

According to the Textron lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) end market sales of Arctic Cat products were slowing, resulting in a massive glut of old Arctic Cat inventory on dealers’ floors; (2) in order to clear out this old inventory, the Company provided significant price discounts, which negatively impacted Textron’s earnings; and (3) as a result, Textron’s positive statements about Arctic Cat’s business, operations, and prospects lacked a reasonable basis.

TO LEARN MORE ABOUT THE TXT CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/textron-inc-loss-form?prid=3551&wire=1

If you suffered a loss in Textron you have until October 21, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces 2U Class Action Investigation; TWOU Lawsuit

Class Action Reports

Levi & Korsinsky Announces 2U Class Action Investigation; TWOU Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a TWOU class action lawsuit has been commenced on behalf of investors who purchased 2U, Inc. (TWOU) securities between February 26, 2018 and July 30, 2019. For more on the 2U Class Action please contact us today.

According to the 2U lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) 2U’s business model was fundamentally flawed because the Company’s costs were growing disproportionately as it grew in size and complexity; (2) 2U could not take advantage of the promised economies of scale because its costs to attract each marginal student were actually increasing, not decreasing, as represented; (3) 2U was facing heightened competitive headwinds as alternative offerings flooded the marketplace and universities developed online courses in-house; (4) 2U’s growth rate in student enrollment was decelerating and was poised to decline as the Company reached market saturation; (5) 2U’s growth strategy was unsustainable, as the Company faced accelerating costs and had insufficient capital to achieve positive cash flows, improve margins or continue its revenue growth; and (6) as a result of (1)-(5), above, Defendants lacked any reasonable basis to issue 2U’s projections and financial forecasts.

TO LEARN MORE ABOUT THE TWOU CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/2u-inc-loss-form?prid=3553&wire=1

If you suffered a loss in 2U you have until October 7, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Valaris Class Action Investigation; VAL Lawsuit

Class Action Reports

Levi & Korsinsky Announces Valaris Class Action Investigation; VAL Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a VAL class action lawsuit has been commenced on behalf of investors who purchased Valaris plc, (VAL) securities between April 11, 2019 and July 31, 2019. For more on the Valaris Class Action please contact us today.

According to the Valaris lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company was plagued by a weak ultra-deepwater segment, massive cash usage, and significant negative cash flow; (2) the foregoing was reasonably likely to have a material negative impact on the Company’s second quarter 2019 results; (3) the merger leading to Valaris’s establishment could not deliver on its touted benefits; and (4) as a result, the Company’s public statements were materially false and misleading at all relevant times.

TO LEARN MORE ABOUT THE VAL CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/valaris-plc-loss-form?prid=3556&wire=1

If you suffered a loss in Valaris you have until October 21, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Granite Construction Class Action Investigation; GVA Lawsuit

Class Action Reports

Levi & Korsinsky Announces Granite Construction Class Action Investigation; GVA Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a GVA class action lawsuit has been commenced on behalf of investors who purchased Granite Construction Incorporated, (GVA) securities between October 26, 2018 and August 1, 2019. For more on the Granite Construction Class Action please contact us today.

According to the Granite Construction lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company had assumed certain risks in connection with its heavy civil joint venture projects bid between 2012 and 2014; (2) there was an “untenable” imbalance of risk sharing between the Company and the joint venture project owners; (3) as a result, the Company was reasonably likely to incur additional project costs for its joint venture projects; (4) the Company was reasonably likely to incur additional costs in connection with certain project disputes; and (5) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects and prospects were materially misleading and/or lacked a reasonable basis.

TO LEARN MORE ABOUT THE GVA CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/granite-construction-incorporated-loss-form?prid=3557&wire=1

If you suffered a loss in Granite Construction you have until October 15, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces GTT Communications Class Action Investigation; GTT Lawsuit

Class Action Reports

Levi & Korsinsky Announces GTT Communications Class Action Investigation; GTT Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a GTT class action lawsuit has been commenced on behalf of investors who purchased GTT Communications, Inc. (GTT) securities between February 26, 2018 and July 1, 2019. For more on the GTT Communications Class Action please contact us today.

According to the GTT Communications lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) following GTT’s acquisition of Interoute Communications Holdings S.A., there were delays in migrating Interoute’s legacy systems and processes into GTT’s client management database system; (2) Interoute had made a strategic priority shift to sell cloud services that was a higher percentage of Interoute’s sales in the two years leading up to the acquisition; (3) a material percentage of the Interoute sales representatives were not productive at selling GTT’s core cloud networking services; (4) GTT was unable to yield as many Interoute salespeople because Interoute had hired many sales people focused on cloud services and allowed underperforming sales representatives to remain at Interoute; and (5) as a result of the foregoing, Defendants’ public statements were materially false and/or misleading and/or lacked a reasonable basis.

TO LEARN MORE ABOUT THE GTT CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/gtt-communications-inc-loss-form?prid=3557&wire=1

If you suffered a loss in GTT Communications you have until September 30, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces L Brands Class Action Investigation; LB Lawsuit

Class Action Reports

Levi & Korsinsky Announces L Brands Class Action Investigation; LB Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a LB class action lawsuit has been commenced on behalf of investors who purchased L Brands, Inc. (LB) securities between May 31, 2018 and November 19, 2018. For more on the L Brands Class Action please contact us today.

According to the L Brands lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Victoria’s Secret and PINK businesses were having a material adverse effect on the Company’s cash flow, liquidity and debt levels; (2) Defendants lacked a reasonable basis for their positive statements about the ability of the Company to sustain its dividend; (3) the MD&A disclosures in filings L Brands made with the SEC were materially false and misleading; (4) the risk factor disclosures in filings L Brands made with the SEC were materially false and misleading; (5) the representations about L Brands’ disclosure controls in filings the Company made with the SEC were materially false and misleading; (6) the certifications issued by Defendants Wexner and Burgdoerfer on L Brands disclosure controls were materially false and misleading; and (7) based on the foregoing, Defendants lacked a reasonable basis for their positive statements about L Brands’ then-current business operations and future financial prospects.

TO LEARN MORE ABOUT THE LB CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/l-brands-inc-loss-form?prid=3557&wire=1

If you suffered a loss in L Brands you have until September 23, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces NetApp Class Action Investigation; NTAP Lawsuit

Class Action Reports

Levi & Korsinsky Announces NetApp Class Action Investigation; NTAP Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a NTAP class action lawsuit has been commenced on behalf of investors who purchased NetApp, Inc. (NTAP) securities between May 22, 2019 and August 1, 2019. For more on the NetApp Class Action please contact us today.

According to the NetApp lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company was unable to close large deals within the quarter and that the deals were pushed out to subsequent quarters or downsized; (2) as a result, the Company’s revenue would be materially impacted; (3) as a result, the Company would lower its fiscal 2020 guidance; and (4) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

TO LEARN MORE ABOUT THE NTAP CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/netapp-inc-loss-form?wire=3

If you suffered a loss in NetApp you have until October 15, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces International Flavors & Fragrances Class Action Investigation; IFF Lawsuit

Class Action Reports

Levi & Korsinsky Announces International Flavors & Fragrances Class Action Investigation; IFF Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a IFF class action lawsuit has been commenced on behalf of investors who purchased International Flavors & Fragrances Inc. (IFF) securities between May 7, 2018 and August 5, 2019. For more on the International Flavors & Fragrances Class Action please contact us today.

According to the International Flavors & Fragrances lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) that Frutarom Industries Ltd. (“Frutarom”), which the Company acquired in 2018, had bribed customers in Russia and Ukraine; (2) that senior management at Frutarom were aware of such improper payments; (3) that, as a result, Frutarom’s financial results were materially overstated; (4) that, as a result of the improper payments, the Company was reasonably likely to face regulatory scrutiny; (5) that the Company had not completed adequate due diligence before acquiring Frutarom; (6) that, as a result of the foregoing, the Company was unlikely to achieve purported synergies from the acquisition; and (7) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

TO LEARN MORE ABOUT THE IFF CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/international-flavors-fragrances-inc-loss-form?wire=3

If you suffered a loss in International Flavors & Fragrances you have until October 11, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Abiomed Class Action Investigation; ABMD Lawsuit

Class Action Reports

Levi & Korsinsky Announces Abiomed Class Action Investigation; ABMD Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a ABMD class action lawsuit has been commenced on behalf of investors who purchased Abiomed, Inc. (ABMD) securities between January 31, 2019 and July 31, 2019. For more on the Abiomed Class Action please contact us today.

According to the Abiomed lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Abiomed’s revenue growth was in decline; (2) the Company did not have a sufficient plan in place to stem its declining revenue growth; (3) the Company was unlikely to restore its revenue growth over the next several fiscal quarters; (4) consequently, Abiomed was reasonably likely to revise its full-year 2020 guidance in a way that would fall short of the Company’s prior projections and market expectations; and (5) as a result, the Company’s public statements were materially false and misleading at all relevant times.

TO LEARN MORE ABOUT THE ABMD CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/abiomed-inc-loss-form?wire=3

If you suffered a loss in Abiomed you have until October 7, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Greenlane Holdings Class Action Investigation; GNLN Lawsuit

Class Action Reports

Levi & Korsinsky Announces Greenlane Holdings Class Action Investigation; GNLN Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a GNLN class action lawsuit has been commenced on behalf of investors who purchased Greenlane Holdings, Inc. (GNLN) pursuant and/or traceable to the Company’s initial public offering in April 2019. For more on the Greenlane Holdings Class Action please contact us today.

According to the Greenlane Holdings lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the City of San Francisco had introduced a major initiative to ban the sale of e-cigarette products across three major cities and prohibit the manufacture of products at the headquarters of Greenlane’s key partner, JUUL Labs; (2)  if approved, the initiative would materially and adversely impact the Company’s financial results and prospects; and (3) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

TO LEARN MORE ABOUT THE GNLN CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/greenlane-loss-form?wire=3

If you suffered a loss in Greenlane Holdings you have until November 12, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces DXC Technology Company Class Action Investigation; DXC Lawsuit

Class Action Reports

Levi & Korsinsky Announces DXC Technology Company Class Action Investigation; DXC Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a DXC class action lawsuit has been commenced on behalf of investors who purchased DXC Technology Company, (DXC) pursuant and/or traceable to the Company’s initial public offering in April 2017. For more on the DXC Technology Company Class Action please contact us today.

According to the DXC Technology Company lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the planned “workforce optimization” plan involved implementing arbitrary quotas; (2) the plan would cut thousands of jobs at the Company; (3) jobs that were particularly at risk of being cut were held by longer-tenured, knowledgeable, and highly compensated senior personnel; (4) these job terminations were selectively timed to artificially inflate reported earnings and other financial metrics; (5) at the time of the formation of DXC Technology Company, J. Michael Lawrie (the incoming President, Chief Executive Officer, and Chairman of the Board at DXC) had forecasted plans for a $2.7 billion workforce reduction in the first year; (6) as a result of these workforce terminations, the Company was unlikely to deliver on client contracts; (7) that, as a result of the foregoing, the Company’s clients would be dissatisfied and the relationships would be impaired; and (8) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

TO LEARN MORE ABOUT THE DXC CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/dxc-technology-company-loss-form-2?wire=3

If you suffered a loss in DXC Technology Company you have until November 15, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Cadence Bancorporation Class Action Investigation; CADE Lawsuit

Class Action Reports

Levi & Korsinsky Announces Cadence Bancorporation Class Action Investigation; CADE Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a CADE class action lawsuit has been commenced on behalf of investors who purchased Cadence Bancorporation, (CADE) securities between July 23, 2018 and July 22, 2019. For more on the Cadence Bancorporation Class Action please contact us today.

According to the Cadence Bancorporation lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company lacked adequate internal controls to assess credit risk; (2) as a result, certain of the Company’s loans posed an increased risk of loss; (3) as a result, the Company was reasonably likely to incur significant losses for certain loans; (4) the Company’s financial results would suffer a material adverse impact; and (5) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

TO LEARN MORE ABOUT THE CADE CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/cadence-bankcorporation-loss-form?wire=3

If you suffered a loss in Cadence Bancorporation you have until November 15, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces MacroGenics Class Action Investigation; MGNX Lawsuit

Class Action Reports

Levi & Korsinsky Announces MacroGenics Class Action Investigation; MGNX Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a MGNX class action lawsuit has been commenced on behalf of investors who purchased MacroGenics, Inc. (MGNX) securities between February 6, 2019 and June 3, 2019. For more on the MacroGenics Class Action please contact us today.

According to the MacroGenics lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company had conducted the progression-free survival (“PFS”) and first interim overall survival (“OS”) analyses for the SOPHIA trial by no later than October 10, 2018; (2) the October 2018 PFS analysis showed a 0.9 month improvement in PFS; and (3) the October 2018 OS interim analysis did not produce a statistically significant result and the interim OS Kaplan-Meier curves crossed in several spots (thereby violating the constant hazard assumption) and separated late.

TO LEARN MORE ABOUT THE MGNX CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/macrogenics-inc-loss-form?wire=3

If you suffered a loss in MacroGenics you have until November 12, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Mallinckrodt Class Action Investigation; MNK Lawsuit

Class Action Reports

Levi & Korsinsky Announces Mallinckrodt Class Action Investigation; MNK Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a MNK class action lawsuit has been commenced on behalf of investors who purchased Mallinckrodt Public Limited Company, (MNK) securities between February 28, 2018 and July 16, 2019. For more on the Mallinckrodt Class Action please contact us today.

According to the Mallinckrodt lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Acthar posed significant safety concerns that rendered it a non-viable treatment for ALS; (2) accordingly, Mallinckrodt overstated the viability of Acthar as an ALS treatment; and (3) as a result, the Company’s public statements were materially false and misleading at all relevant times.

TO LEARN MORE ABOUT THE MNK CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/mallinckrodt-public-limited-company-loss-form?prid=3569&wire=1

If you suffered a loss in Mallinckrodt you have until September 24, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Levi & Korsinsky Announces National General Holdings Class Action Investigation; NGHC Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a NGHC class action lawsuit has been commenced on behalf of investors who purchased National General Holdings Corp., (NGHC) securities between August 6, 2015 and August 9, 2017. For more on the National General Holdings Class Action please contact us today.

According to the National General Holdings lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) National General was perpetrating a massive forced-placed CPI scheme to fraudulently saddle its own customers with unwanted and unneeded automobile insurance policies that it had underwritten; (2) National General’s illicit conduct in foisting unwanted and unneeded automobile insurance on its customers had resulted in some of the victims being declared delinquent, suffering adverse impacts to their creditworthiness, and/or having their cars improperly repossessed; (3) National General was exposed to an extreme risk of regulatory scrutiny, legal risks, and reputational harm as a result of its participation in the forced placed CPI scheme; (4) the Company had failed to maintain effective internal controls over its financial reporting, including by failing to maintain formal documentation sufficient to reasonably ensure the accuracy of internal reporting and accounting procedures across much of its business, including with respect to insurance policy premiums; (5) the Company’s reported quarterly revenues and policy premiums were in part the product of a fraudulent forced-placed insurance scheme and were therefore artificially inflated and unsustainable; and (6) National General had in fact lost substantial business with Wells Fargo because Wells Fargo had terminated the forced-placed CPI scheme after concluding that it posed excessive reputational risk and legal exposure.

TO LEARN MORE ABOUT THE KPTI CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/national-general-holdings-corp-loss-form?prid=3569&wire=1

If you suffered a loss in National General Holdings you have until September 23, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces 3M Company Class Action Investigation; MMM Lawsuit

Class Action Reports

Levi & Korsinsky Announces 3M Company Class Action Investigation; MMM Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a MMM class action lawsuit has been commenced on behalf of investors who purchased 3M Company (MMM) securities between February 9, 2017 and May 28, 2019. For more on the 3M Company Class Action please contact us today.

According to the 3M Company lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) 3M had vast internal evidence dating back decades confirming that polyfluoroalkyl substances (“PFAS”) are toxic (which was first publicly revealed in February 2018 by Minnesota’s Attorney General); (2) 3M had a decades-long history of suppressing negative information and/or damaging data about PFAS; and (3) 3M has legal exposure to state, county, and local governments and individuals around the country as a result of its knowledge and intentional concealment of the toxic harm caused by the use of PFAS.

TO LEARN MORE ABOUT THE MMM CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/3m-company-loss-form?prid=3569&wire=1

If you suffered a loss in 3M Company you have until September 27, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Granite Construction Class Action Investigation; GVA Lawsuit

Class Action Reports

Levi & Korsinsky Announces Granite Construction Class Action Investigation; GVA Lawsuit

Levi & Korsinsky, LLP

September 19, 2019

Levi & Korsinsky, LLP announces that a GVA class action lawsuit has been commenced on behalf of investors who purchased Granite Construction Incorporated, (GVA) securities between October 26, 2018 and August 1, 2019. For more on the Granite Construction Class Action please contact us today.

According to the Granite Construction lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company had assumed certain risks in connection with its heavy civil joint venture projects bid between 2012 and 2014; (2) there was an “untenable” imbalance of risk sharing between the Company and the joint venture project owners; (3) as a result, the Company was reasonably likely to incur additional project costs for its joint venture projects; (4) the Company was reasonably likely to incur additional costs in connection with certain project disputes; and (5) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects and prospects were materially misleading and/or lacked a reasonable basis.

TO LEARN MORE ABOUT THE GVA CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/granite-construction-incorporated-loss-form?prid=3451&wire=1

If you suffered a loss in Granite Construction you have until October 15, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Announces Karyopharm Therapeutics Class Action Investigation; KPTI Lawsuit

Class Action Reports

Levi & Korsinsky Announces Karyopharm Therapeutics Class Action Investigation; KPTI Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a KPTI class action lawsuit has been commenced on behalf of investors who purchased Karyopharm Therapeutics, Inc. (KPTI) securities between March 2, 2017 and February 22, 2019. For more on the Karyopharm Therapeutics Class Action please contact us today.

According to the Karyopharm Therapeutics lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company continued to tout the commercial prospects for selinexor and consistently described selinexor as having a “predictable and manageable tolerability profile” and a “very nice safety profile,” and assured investors that it was “well tolerated” by patients; (2) Karyopharm also claimed that selinexor had the potential to be used as a new treatment for MM, with limited and manageable side effects; and (3) As a result of these misrepresentations, Karyopharm shares traded at artificially inflated prices during the Class Period.

TO LEARN MORE ABOUT THE KPTI CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/karyopharm-therapeutics-inc-loss-form?prid=3451&wire=1

If you suffered a loss in Karyopharm Therapeutics you have until September 23, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Levi & Korsinsky Announces Netflix Class Action Investigation; NFLX Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a NFLX class action lawsuit has been commenced on behalf of investors who purchased Netflix, Inc. (NFLX) securities between April 17, 2019 and July 17, 2019. For more on the Netflix Class Action please contact us today.

According to the Netflix lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Netflix would not be able to gain its expected target number of new subscribers in the second quarter of 2019; (2) Netflix would also lose subscribers from the United States in the second quarter of 2019; and (3) as a result, Defendants’ public statements were materially false and misleading at all relevant times.

TO LEARN MORE ABOUT THE NFLX CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/netflix-inc-loss-form?prid=3451&wire=1

If you suffered a loss in Netflix you have until September 20, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Levi & Korsinsky Xerox Shareholder Lawsuit Class Action Proposed Settlement Eduard Korsinsky

Class Action News

Levi & Korsinsky Successfully Represent Objector in Proposed Settlement of Xerox Shareholder Lawsuit

Levi & Korsinsky, LLP

September 17, 2019

On September 12, 2019, Justice Barry R. Ostrager of the Supreme Court of the State of New York, Commercial Division, issued a Decision & Order in which he denied approval of a proposed settlement in a lawsuit brought on behalf of a proposed class of shareholders of Xerox Corporation. The proposed class action settlement would have released current and former company directors from potential liability for, among other things, giving activist investors control over Xerox’s board of directors and potentially exposing Xerox to massive liability in a contract action brought by Fujifilm Holdings Corporation concerning termination of a potential merger of the two companies.

 

Levi & Korsinsky originally filed a derivative suit on behalf of Xerox shareholder Carmen Ribbe in May 2018, after Justice Ostrager had preliminarily enjoined Xerox’s deal with Fuji. After the Court issued this injunction, purported class plaintiffs in a related litigation entered into what they claimed was a tri-partite, two-step settlement with Xerox and activist investors Darwin Deason and Carl Icahn. Pursuant to the settlement framework, the activist investors hand-picked a majority of directors to on a reconstituted Xerox board without any input from the other 85% of Xerox shareholders. Moreover, the purported class plaintiffs sought to grant releases from liability to certain current and former Xerox directors for the role they played in terminating the Fuji deal, as contemplated by the activist investors’ private settlement with Xerox.

 

Levi & Korsinsky represented Mr. Ribbe in connection with this settlement which—if approved—would have precluded his claims on behalf of Xerox and its shareholders challenging the release of claims against directors for their role in creating potential liability to Fuji and the activist investors’ arrogation of control, respectively. In the objection, Mr. Ribbe’s legal team pointed out that U.S. District Judge John G. Koeltl had denied Xerox’s motion to dismiss Fuji’s suit, which seeks in excess of $1 billion in damages, at a hearing last February. They also argued that Xerox shareholders should not be bound by the ceding of control over the Board to the activists and should be given a voice in who sits on the Xerox board.

 

In an interview with Reuters, Levi & Korsinsky’s Christopher Kupka and named partner Eduard Korsinsky expressed that Justice Ostrager clearly understood their point: The now-rejected settlement did not benefit shareholders and therefore did not merit approval. “The proof is in the pudding,” Korsinsky added, “The settlement was not approved and nothing is changing.” Levi & Korsinsky will continue to vigorously prosecute Mr. Ribbe’s claims on behalf of Xerox and its shareholders.

 

A full copy of the article is accessible here.

 

The Decision & Order of the Supreme Court is here.


Eduard Korsinsky, of Levi & Korsinsky, Quoted After Recent Xerox Ruling 2

Class Action News

Eduard Korsinsky Quoted After Recent Xerox Shareholder Litigation Ruling

Levi & Korsinsky, LLP

September 16, 2019

Eduard Korsinsky, of Levi & Korsinsky, LLP, Quoted After Recent Xerox Ruling

In a recent piece by Tom McParland of New York Law Journal, Eduard Korsinsky, Levi & Korsinsky’s (L&K) Founding Partner, was quoted as saying that his team would continue to press claims on behalf of Xerox shareholders who were harmed in the deal: “We’re gratified that Justice Ostrager saw our point of view,” he stated, “and we look forward to litigating the case on behalf of shareholders of Xerox, who have been damaged considerably.” L&K represented objecting shareholder Carmen Ribbe in the recent In re Xerox Corporation Consolidated Shareholder Litigation.

 

 

Eduard Korsinsky, of Levi & Korsinsky, Quoted After Recent Xerox Ruling 1

 

 

Find a full copy of the Law.com, here.

 


Quest Diagnostics Data Breach

Class Action News

Levi & Korsinsky, LLP Investigates Quest Diagnostics Data Breach

Levi & Korsinsky, LLP

June 21, 2019

Levi & Korsinsky, LLP is investigating the Quest Diagnostics data breach. On Monday, June 3, 2019, Quest Diagnostics revealed that American Medical Collection Agency (AMCA), one of its billing collection services, notified Quest Diagnostics that patient information was exposed to an unauthorized user between August 1, 2018 and March 30, 2019. The unauthorized user had access to credit card numbers, bank account information, medical information (not including lab results), and other sensitive data, including Social Security numbers. Approximately 11.9 million people are impacted by this data breach.

Levi & Korsinsky, LLP is investigating the Quest Diagnostics data breach incident. If you entrusted your personal and financial information to Quest Diagnostics, believe you are a victim of the data breach, and wish to discuss your legal rights, please contact Rosemary Rivas, Esq. (rrivas@zlk.com) or Courtney Maccarone, Esq. (cmaccarone@zlk.com) of Levi & Korsinsky, LLP.

To get more information regarding the investigation of Quest Diagnostics Incorporated; American Medical Collection Agency, Inc.; Optum 360 LLC, without cost or obligation, please call us at 415-373-1671 or complete our contact form.


TLGT Lawsuit; TLGT Class Action

Class Action Reports

Levi & Korsinsky Announce TLGT Lawsuit; TLGT Class Action

Levi & Korsinsky, LLP

May 9, 2019

Mo-Kan Iron Workers Pension Fund v. Teligent, Inc. et al 1:19-cv-03354-VM — On April 15, 2019, investors sued Teligent, Inc. (“Teligent” or the “Company”) in United States District Court, Southern District of New York. The TLGT class action alleges that the plaintiffs acquired Teligent stock at artificially inflated prices between May 2, 2017 and November 7, 2017 (the “Class Period”). They are now seeking compensation for financial losses incurred upon public revelation of the Company’s alleged misconduct during that time. For more information on the TLGT Lawsuit, please contact us today!

Summary of the Allegations

Company Background

Teligent (NASDAQ: TLGT) is a self-described specialty generic pharmaceutical company.

As such, its mission is to “be a leading player in the specialty generic prescription drug market.” To accomplish this, Teligent researches and engages in the development, production, distribution and sales of generic drugs.

According to the investor portion of its website, the Company had 22 Abbreviated New Drug Applications (ANDAs) on file at the FDA, representing a total addressable market of approximately $1.6 billion as of last June.

Teligent is incorporated in Delaware and its headquarters are located in Buena, New Jersey.

Summary of Facts

Teligent and its President/CEO (collectively the “Defendants”) are now accused of deceiving investors by lying and/or withholding critical information about the Company’s business practices, and operational and compliance policies during the Class Period.

Specifically, they are accused of omitting truthful information about certain product “non-conformities” and compliance (or lack thereof) with applicable regulations from SEC filings and related material. By knowingly or recklessly doing so, they allegedly caused Teligent stock to trade at artificially inflated prices during the time in question.

The initially surfaced after the market closed on November 6, 2017. That’s when the Company issued a press release announcing its results for the third quarter of 2017. According to the April 15 complaint, the press release “exposed the depths of Teligent’s R&D, production and legal issues.”

A closer look…

As also alleged in the April 15 complaint, the Defendants repeatedly made false and misleading public statements during the Class Period.

First, the Company “highlighted its revenue growth in the first quarter of 2017” on a form filed with the SEC on May 2, 2017.

Then in an ensuing earnings call, Teligent’s President/CEO stated in relevant part: “This growth has been driven by a combination of new product launches and competitive supply chain dynamics to which Teligent has been able to respond effectively.”

On the same conference call, Teligent’s President and CEO also stated in relevant part: “To the extent that we can replicate these timely approvals with our current investments in R&D, we will continue to deliver value in the form of the return on these investments as we launch products to the market.”

What the Company and its President/CEO allegedly failed to disclose, however, was that Teligent was experiencing “product non-conformities in R&D, and non-compliance with applicable regulations.”

Impact of the Alleged Fraud on Teligent’s Stock Price and Market Capitalization

The following chart illustrates the stock price during the class period:

 TLGT Class Action Lawsuit

Actions You May Take

If you have purchased shares during the Class Period, you may join the class action as a lead plaintiff, remain a passive class member, or opt out of this litigation and pursue individual claims that may not be available to the class as a whole.

NOTE: The deadline to file for lead plaintiff in this class action is June 14, 2019. You must file an application to be appointed lead plaintiff prior to this deadline in order to be considered by the Court. Typically, the plaintiff or plaintiffs with the largest losses are appointed lead plaintiff.

In order to identify your potential exposure to the alleged fraud during the time in question, you may wish to perform an analysis of your transactions in Teligent common stock using court approved loss calculation methods.

Recently Filed Cases

Listed below are recently filed securities class action cases being monitored by us, along with the class period and the deadline to file a motion to be appointed as the Lead Plaintiff in the action.  Please contact us if you would like an LK report for any of these cases:

TLGT Class Action Lawsuit

About Us

Levi & Korsinsky is a leading securities litigation firm with a hard-earned reputation for protecting investors’ rights and recovering losses arising from fraud, mismanagement and corporate abuse.  With thirty attorneys and offices in New York, Connecticut, California and Washington D.C., the firm is able to litigate cases in various jurisdictions in the U.S., England, and in other international jurisdictions.

Levi & Korsinsky provides portfolio monitoring services for high-net worth investors and institutional clients.  Our firm also assists investors in evaluating whether to opt-out of large securities class actions to pursue individual claims.

For additional information about this case or our institutional services, please contact us.


ORN Lawsuit; ORN Class Action

Class Action Reports

Levi & Korsinsky Announce ORN Lawsuit; ORN Class Action

Levi & Korsinsky, LLP

May 8, 2019

Heck v. Orion Group Holdings, Inc. et al 4:19-cv-01337 — On April 11, 2019, investors sued Orion Group Holdings, Inc. (“Orion” or the “Company”) in United States District Court for the Southern District of Texas, Houston Division. Plaintiffs in the ORN class action allege that they acquired Orion Stock at artificially inflated prices between March 13, 2018 and March 26, 2019 (the “Class Period”). They are now seeking compensation for financial losses incurred upon public revelation of the Company’s alleged misconduct during that time. For more information on the ORN Lawsuit, please contact us today!

Summary of the Allegations

Company Background

Orion (NYSE: ORN) is a self-described “leading specialty construction company.”

As such, the Company says it provides comprehensive land- and water-based construction services in the continental United States, Alaska, Canada and the Caribbean Basin.

Orion has two business divisions or “segments.” These are its heavy civil marine construction (HCMC) segment and its commercial concrete construction (CCC) segment.  The former is engaged in the construction of marine transportation facilities and marine pipelines. It also dredges waterways, channels and ports. The latter is engaged in the provision of “turnkey concrete construction services across the light commercial, structural, and other associated business areas.”

Orion is incorporated in Delaware and its executive offices are located in Houston, Texas.

Summary of Facts

Orion and three of its current and/or former senior officers (the “Individual Defendants”) are now accused of deceiving investors by lying and/or withholding critical information about the Company’s business practices, operations and prospects during the Class Period.

Specifically, they are accused of omitting truthful information about certain accounting practices and the efficacy of the Company’s internal control over financial reporting from SEC filings and related material. By knowingly or recklessly doing so, they allegedly caused Orion stock to trade at artificially inflated prices during the time in question.

The truth emerged in a series of events that transpired between October 18, 2018 and March 26, 2019. First, the Company announced that it “expected a significant revenue shortfall for the third quarter 2018 due to production delays, and that its Chief Financial Officer had resigned.”

Then, on March 28, 2019, the Company disclosed that it would miss the deadline for filing its annual report with the SEC because of “extended evaluations of goodwill impairment testing and income tax adjustments, among other things.” On that same day, the Company also revealed that it “expects that a significant change in results of operations from the corresponding period for the last fiscal year will be reflected in its financial statements.”

Finally, on March 26, 2019, Orion reported a net loss exceeding $94 million for the fourth quarter of 2018 “due to certain non-cash charges, including a $69.5 million goodwill impairment charge.”

A closer look…

As alleged in the April 11 complaint, the Company and/or Individual Defendants repeatedly made false and misleading public statements during the Class Period.

For example, in an annual report filed with the SEC on March 13, 2018, the Company stated in relevant part: “We could suffer contract losses if we fail to accurately estimate our costs or fail to execute within our cost estimates on fixed-price, lump sum contracts.”

Then, in a quarterly report filed with the SEC on May 4, 2018, Orion stated in relevant part: “[n]o indicators of goodwill impairment were identified during the three months ended March 31, 2018.”

Finally, in a quarterly report filed with the SEC on November 2, 2018, Orion also stated in pertinent part: “During the three months ended September 30, 2018, the Company identified potential indicators of impairment to goodwill for both its marine and concrete reporting units… After evaluating all events, circumstances and factors which could affect the significant inputs used to determine fair value, the Company determined it was not more likely than not that an impairment existed at either reporting unit.”

Impact of the Alleged Fraud on Orion’s Stock Price and Market Capitalization

Closing stock price prior to disclosures:

 

$3.19
Closing stock price the trading day after disclosures:

 

$2.97
One day stock price decrease (percentage) as a result of disclosures:

 

6.90%

The following chart illustrates the stock price during the class period:

 ORN Class Action Lawsuit

Actions You May Take

If you have purchased shares during the Class Period, you may join the class action as a lead plaintiff, remain a passive class member, or opt out of this litigation and pursue individual claims that may not be available to the class as a whole.

NOTE: The deadline to file for lead plaintiff in this class action is June 10, 2019. You must file an application to be appointed lead plaintiff prior to this deadline in order to be considered by the Court. Typically, the plaintiff or plaintiffs with the largest losses are appointed lead plaintiff.

In order to identify your potential exposure to the alleged fraud during the time in question, you may wish to perform an analysis of your transactions in Orion common stock using court approved loss calculation methods.

Recently Filed Cases

Listed below are recently filed securities class action cases being monitored by us, along with the class period and the deadline to file a motion to be appointed as the Lead Plaintiff in the action.  Please contact us if you would like an LK report for any of these cases:

ORN Class Action Lawsuit

About Us

Levi & Korsinsky is a leading securities litigation firm with a hard-earned reputation for protecting investors’ rights and recovering losses arising from fraud, mismanagement and corporate abuse.  With thirty attorneys and offices in New York, Connecticut, California and Washington D.C., the firm is able to litigate cases in various jurisdictions in the U.S., England, and in other international jurisdictions.

Levi & Korsinsky provides portfolio monitoring services for high-net worth investors and institutional clients.  Our firm also assists investors in evaluating whether to opt-out of large securities class actions to pursue individual claims.

For additional information about this case or our institutional services, please contact us.


ORN Lawsuit; ORN Class Action

Class Action Reports

Levi & Korsinsky Announce AAPL Lawsuit; AAPL Class Action

Levi & Korsinsky, LLP

May 7, 2019

City of Roseville Employees’ Retirement System v. Apple Inc. et al 4:19-cv-02033-YGR — On April 16, 2019, investors sued Apple, Inc. (“Apple” or the “Company”) in United States District Court, Northern District of California. Plaintiffs in the AAPL class action allege that they acquired Apple stock at artificially inflated prices between November 2, 2018 and January 2, 2019 (the “Class Period”). They are now seeking compensation for financial losses incurred upon public revelation of the Company’s alleged misconduct during that time. For more information on the AAPL lawsuit, please contact us today!

Summary of the Allegations

Company Background

The Company (NASDAQ: AAPL)  engages in the design, manufacturing, marketing and sales of “mobile communication and media devices, and personal computers.”

Bolstered by global marketing and sales, Apple’s smartphones are among its best-known products. However, the Company also designs makes and sells tablets, laptops and desktop computers. In addition to these devices, it sells ancillary products and services to customers in the United States and abroad.

According to the April 16 complaint, Apple had 4.75 billion shares issued and outstanding as of October 26,2018.

Summary of Facts

Apple, and two of its senior officers and/or directors (the “Individual Defendants”) are now accused of deceiving investors by lying and/or withholding critical information about the Company’s business practices and prospects during the Class Period.

Specifically, they are accused of omitting truthful information about the demand for some of its products and related issues from SEC filings and related material. By knowingly or recklessly doing so, they allegedly caused Apple stock prices to trade at artificially inflated prices during the time in question.

The truth came out after trading ended on January 2, 2019. At that time, Apple released a letter from its CEO, Tim Cook to investors. In it, Apple revealed that its first quarter revenues for 2019 fell well short of predictions made just a few weeks before. The Company acknowledged that it had experienced “fewer iPhone upgrades than [it] had anticipated,” and blamed the poor performance on the Chinese economy.

It said in pertinent part: “While we anticipated some challenges in key emerging markets, we did not foresee the magnitude of the economic deceleration, particularly in Greater China. In fact, most of our revenue shortfall to our guidance, and over 100 percent of our year-over-year worldwide revenue decline, occurred in Greater China across iPhone, Mac and iPad.”

A closer look…

As alleged in the April 16 complaint, the Company and/or Individual Defendants repeatedly made false and misleading public statements throughout the Class Period.

For instance, in a press release issued at the beginning of the Class Period, the Company stated in pertinent part: “[o]ver the past two months, [Apple had] delivered huge advancements for [its] customers through new versions of iPhone, Apple Watch, iPad and Mac and well as [its] four operating systems and [that it was] enter[ing] the holiday season with [its] strongest lineup of products and services ever.”

In an ensuing conference call with investors and securities analysts, one of the Individual Defendants reiterated the claim, and added that it justified “a new all-time record” of “expected revenue [of] between $89 billion and $93 billion.”

In response to questions about “macroeconomic uncertainty” in “emerging markets” during the same conference call, the other Individual Defendant stated in relevant part: “And so I think – or at least the way I see these is each one of the emerging markets has a bit of a different story. In relation to China specifically, I would not put China in that category. Our business was very strong last quarter.”

Impact of the Alleged Fraud on Apple’s Stock Price and Market Capitalization

Closing stock price prior to disclosures:

 

$157.92
Closing stock price the trading day after disclosures:

 

$142.19
One day stock price decrease (percentage) as a result of disclosures:

 

9.96%

The following chart illustrates the stock price during the class period:

 AAPL Class Action Lawsuit

Actions You May Take

If you have purchased shares during the Class Period, you may join the class action as a lead plaintiff, remain a passive class member, or opt out of this litigation and pursue individual claims that may not be available to the class as a whole.

NOTE: The deadline to file for lead plaintiff in this class action is June 17, 2019. You must file an application to be appointed lead plaintiff prior to this deadline in order to be considered by the Court. Typically, the plaintiff or plaintiffs with the largest losses are appointed lead plaintiff.

In order to identify your potential exposure to the alleged fraud during the time in question, you may wish to perform an analysis of your transactions in Apple common stock using court approved loss calculation methods.

Recently Filed Cases

Listed below are recently filed securities class action cases being monitored by us, along with the class period and the deadline to file a motion to be appointed as the Lead Plaintiff in the action.  Please contact us if you would like an LK report for any of these cases:

AAPL Class Action Lawsuit

About Us

Levi & Korsinsky is a leading securities litigation firm with a hard-earned reputation for protecting investors’ rights and recovering losses arising from fraud, mismanagement and corporate abuse.  With thirty attorneys and offices in New York, Connecticut, California and Washington D.C., the firm is able to litigate cases in various jurisdictions in the U.S., England, and in other international jurisdictions.

Levi & Korsinsky provides portfolio monitoring services for high-net worth investors and institutional clients.  Our firm also assists investors in evaluating whether to opt-out of large securities class actions to pursue individual claims.

For additional information about this case or our institutional services, please contact us.


ORN Lawsuit; ORN Class Action

Class Action Reports

Levi & Korsinsky Announce EB Lawsuit; EB Class Action

Levi & Korsinsky, LLP

May 3, 2019

Gomes v. Eventbrite, Inc. et al 5:19-cv-02019-EJD — On April 15, 2019, investors sued Eventbrite, Inc. (“Eventbrite” or the “Company”) in United States District Court, Northern District of California. The EB class action alleges that plaintiffs acquired Eventbrite stock based on a Registration Statement wrongfully issued in connection with the Company’s September 2018 IPO; and/or acquired Eventbrite stock at artificially inflated prices between September 20, 2018 and March 7, 2019 (the “Class Period”). Plaintiffs are now seeking compensation for financial losses sustained upon public revelation of the Company’s alleged misconduct during that time. For more information on the EB lawsuit, please contact us today!

Summary of the Allegations

Company Background

Eventbrite (NYSE: EB) says it facilitates live events by providing a “powerful, broad technology platform” that allows organizers to “plan, promote and produce live events.” Specifically, the Company claims that its platform allows event organizers to do so in a manner that minimizes complication and maximizes profit.

In all, Eventbrite claims, its platform powered nearly 4 million events – including “live experiences” in more than 170 countries – in 2018. The Company also says that more than 795,000 event creators used its platform last year.

Summary of Facts

The Company and two of its senior officers and/or directors (the “Individual Defendants”) are now accused of deceiving investors by lying and withholding critical  information about Eventbrite’s business practices, operations and prospects, during the Class Period.

Specifically, they are accused of omitting truthful information about complications stemming from Eventbrite’s September 2017 acquisition of Ticketfly from SEC filings and related material. By knowingly or recklessly doing so, they allegedly caused Eventbrite stock to trade at artificially inflated prices during the time in question.

Along with the Individual Defendants, eight Eventbrite directors who either signed or authorized the signing of the Registration Statement in question; and six companies that served as underwriters for the IPO in question, are also named as defendants in the complaint.

The truth emerged after the market closed on March 7, 2019. At that time, the Company issued a letter to shareholders indicating that Eventbrite’s “growth rate would be negatively impacted while it integrated Ticketfly.”

A closer look…

As alleged in the April 15 complaint, the Registration Statement was “negligently prepared.” Consequently, it was “materially false and misleading.”

As also alleged in the April 15 complaint, the Company and/or Individual Defendants repeatedly made false and misleading public statements during the Class Period.

For example, in a letter to shareholders issued on November 12, 2018, the Company stated in pertinent part: “Revenues grew by 45.1% to $73.6 million in the third quarter, with both Eventbrite platform growth and acquired businesses contributing to the increase in total sales.”

In the same letter, the Company also stated: “Gross profit increased by 41.7 % to $42.2 million. Gross margin was 57.2 %, down 140 basis points year-over-year due to amortization related to the Ticketfly platform.”

Finally, in the same letter, Eventbrite told its shareholders: “Our strategy is to operate a single technical platform globally, which means that we work to migrate customers from acquired platforms to the Eventbrite platform. This migration process has historically taken 12 to 24 months, over which the Eventbrite team engages with customers to support this process.”

Two days later, the Company filed a form with the SEC in which it “reaffirmed the previously reported third quarter 2018 financial results.”

Impact of the Alleged Fraud on GM’s Stock Price and Market Capitalization

Closing stock price prior to disclosures:

 

$32.42
Closing stock price the trading day after disclosures:

 

$24.46
One day stock price decrease (percentage) as a result of disclosures:

 

24.55%

The following chart illustrates the stock price during the class period:

 EB Class Action EB Lawsuit

Actions You May Take

If you have purchased shares during the Class Period, you may join the class action as a lead plaintiff, remain a passive class member, or opt out of this litigation and pursue individual claims that may not be available to the class as a whole.

NOTE: The deadline to file for lead plaintiff in this class action is June 17, 2019. You must file an application to be appointed lead plaintiff prior to this deadline in order to be considered by the Court. Typically, the plaintiff or plaintiffs with the largest losses are appointed lead plaintiff.

In order to identify your potential exposure to the alleged fraud during the time in question, you may wish to perform an analysis of your transactions in Eventbrite common stock using court approved loss calculation methods.

Recently Filed Cases

Listed below are recently filed securities class action cases being monitored by us, along with the class period and the deadline to file a motion to be appointed as the Lead Plaintiff in the action.  Please contact us if you would like an LK report for any of these cases:

EB Class Action EB Lawsuit

About Us

Levi & Korsinsky is a leading securities litigation firm with a hard-earned reputation for protecting investors’ rights and recovering losses arising from fraud, mismanagement and corporate abuse.  With thirty attorneys and offices in New York, Connecticut, California and Washington D.C., the firm is able to litigate cases in various jurisdictions in the U.S., England, and in other international jurisdictions.

Levi & Korsinsky provides portfolio monitoring services for high-net worth investors and institutional clients.  Our firm also assists investors in evaluating whether to opt-out of large securities class actions to pursue individual claims.

For additional information about this case or our institutional services, please contact us.


ORN Lawsuit; ORN Class Action

Class Action Reports

Levi & Korsinsky Announces NOK Lawsuit; NOK Class Action

Levi & Korsinsky, LLP

May 2, 2019

Tom v. Nokia Corporation et al 1:19-cv-03509-ALC — On April 19, 2019, investors sued Nokia Corporation (“Nokia” or the “Company”) in United States District Court, Southern District of New York. Plaintiffs in the NOK class action allege that they acquired the Company’s American Depository Shares (ADS) at artificially inflated prices between October 25, 2018 and March 21, 2019 (the “Class Period”). They are now seeking compensation for financial losses incurred upon public revelation of the Company’s alleged misconduct during that time. For more information on the NOK lawsuit, please contact us today!

Summary of the Allegations

Company Background

Nokia (NYSE:NOK) is a “network and technology company” engaged in the provision of hardware, software and related services for “telecommunications operators” and businesses. It is also engaged in the provision of “fixed networking solutions.”

The Company’s history dates to 1865, when it was founded as a single paper mill operation. Throughout its existence, the Company has adapted and provided products and services ranging from cable, paper products, rubber boots, tires, to televisions and mobile phones.

According to the Company’s website, Nokia didn’t devote its efforts to telecommunications until the 1990s. The benchmark of its success in the mobile phone sector occurred by 1998, when Nokia became “the best-selling mobile phone brand in the world.” Five years later, Nokia brought the first camera phone to the market. However, increased competition from other tech giants soon forced Nokia to team up with Microsoft. In 2014 Nokia sold its mobile and devices division to Microsoft.

Prior to that, in 2013, he Company adapted once again, laying the groundwork for its reemergence as a provider of network hardware and software by creating Nokia Networks. The Company also claims that its “2015 acquisition of Franco-American telecommunications equipment provider Alcatel-Lucent greatly broadened the scope” of its “portfolio and customer base.”

Nokia’s claims and/or lack of disclosures about that acquisition are at the crux of the April 19 complaint.

Summary of Facts

Nokia and two of its senior officers (the “Individual Defendants”) are now accused of deceiving investors by lying and/or withholding critical information about the Company’s business practices and prospects during the Class Period.

Specifically, they are accused of omitting truthful information about its acquisition of Alcatel-Lucent from SEC filings and related material. By knowingly or recklessly doing so, they allegedly caused Nokia ADS to trade at artificially inflated prices during the time in question.

The truth came out in an Annual Report that the Company filed with the SEC on March 21, 2019. In it, Nokia said in pertinent part: “During the course of the ongoing integration process, we have been made aware of certain practices relating to compliance issues at the former Alcatel-Lucent business that have raised concerns. We have initiated an internal investigation and voluntarily reported the matter to the relevant regulatory authorities, with whom we are cooperating with a view to resolving the matter.”

A closer look…

As alleged in the April 19 complaint, the Company and/or Individual Defendants repeatedly made false and misleading public statements during the Class Period.

For example, in a press release issued at the beginning of the Class Period, the Company said in pertinent part: “We expect to end 2018 with a strong financial position, based on strong seasonality in Q4.”

Then, in another press release issued on January 31, 2019, Nokia stated in relevant part: “”Our robust topline performance reflects strong competitiveness across our portfolio and that our strategy execution is tracking well.”

What the Company allegedly failed to disclose, however, was that Alcatel-Lucent had certain compliance issues that were potentially detrimental for various reasons.

Impact of the Alleged Fraud on Nokia’s ADS Price and Market Capitalization

Closing stock price prior to disclosures:

 

$6.26
Closing stock price the trading day after disclosures:

 

$5.88
One day stock price decrease (percentage) as a result of disclosures:

 

6.07%

The following chart illustrates the stock price during the class period:

 NOK Class Action, NOK Lawsuit

Actions You May Take

If you have purchased shares during the Class Period, you may join the class action as a lead plaintiff, remain a passive class member, or opt out of this litigation and pursue individual claims that may not be available to the class as a whole.

NOTE: The deadline to file for lead plaintiff in this class action is June 18, 2019. You must file an application to be appointed lead plaintiff prior to this deadline in order to be considered by the Court. Typically, the plaintiff or plaintiffs with the largest losses are appointed lead plaintiff.

In order to identify your potential exposure to the alleged fraud during the time in question, you may wish to perform an analysis of your transactions in Nokia ADS using court approved loss calculation methods.

Recently Filed Cases

Listed below are recently filed securities class action cases being monitored by us, along with the class period and the deadline to file a motion to be appointed as the Lead Plaintiff in the action.  Please contact us if you would like an LK report for any of these cases:

NOK Class Action, NOK Lawsuit

About Us

Levi & Korsinsky is a leading securities litigation firm with a hard-earned reputation for protecting investors’ rights and recovering losses arising from fraud, mismanagement and corporate abuse.  With thirty attorneys and offices in New York, Connecticut, California and Washington D.C., the firm is able to litigate cases in various jurisdictions in the U.S., England, and in other international jurisdictions.

Levi & Korsinsky provides portfolio monitoring services for high-net worth investors and institutional clients.  Our firm also assists investors in evaluating whether to opt-out of large securities class actions to pursue individual claims.

For additional information about this case or our institutional services, please contact us.


ORN Lawsuit; ORN Class Action

Class Action Reports

Levi & Korsinsky Announce FCHS Lawsuit; FCHS Class Action

Levi & Korsinsky, LLP

April 29, 2019

Mas Partners LP v. First Choice Healthcare Solutions Inc., et al 6:19-cv-00619 — On March 29, 2019, investors sued First Choice Healthcare Solutions, Inc. (“First Choice,” “FCHS,” or the “Company”) in United States District Court, Middle District of Florida. Plaintiffs in the FCHS class action allege that they acquired First Choice stock at artificially inflated prices between April 1, 2014 and November 14, 2018 (the “Class Period”). They are now seeking compensation for financial losses incurred upon public revelation of the Company’s alleged misconduct during that time. For more information on the FCHS Lawsuit, please contact us today!

Summary of the Allegations

Company Background

According to its website, the Company (OTC: FCHS) engages in the development of a “network of localized, integrated care platforms comprised of non-physician-owned medical centers.”

The Company says these “medical centers of excellence” are specifically designed to meet the needs of patients requiring specialized treatment and care including that related to: orthopedics, spine surgery, neurology, interventional pain management and “related diagnostic and ancillary services.” The Company also notes that it targets important markets in the southeastern region of the United States for the development of such centers.

Finally, the Company says its “flagship integrated platform,” including First Choice Medical Group, The B.A.C.K. Center and Crane Creek Surgery Center, now facilitates more than 100,000 patient visits annually,

Summary of Facts

First Choice and its former CEO/president/chairman (collectively, the “Defendants”) are now accused of deceiving investors by lying and/or withholding critical information about the Company’s business practices during the Class Period.

Specifically, they are accused of omitting truthful information about certain conduct and lack of compliance with internal policies from SEC filings and related material. By knowingly or recklessly doing so, they allegedly caused First Choice stock to trade at artificially inflated prices during the time in question.

The truth emerged in a series of events that transpired on November 14, 2018 and November 15, 2018. First, the U.S. Department of Justice (“DOJ”) filed an indictment against then-First Choice CEO Christian Romandetti, Sr., and several other participants in an alleged “pump and dump scheme.”

In a press release issued the next day (November 15), the DOJ announced the indictment and its charges against Romandetti “and his associates… with conducting a pump and dump scheme in coordination with Elite Stock Research (ESR), a boiler room, to defraud investors in FCHS… The charges include conspiracies to commit securities fraud, wire fraud and money laundering and substantive securities fraud.”

Also on November 15, the SEC filed a complaint and issued a press release announcing its charges “for defrauding elderly and unsophisticated investors.”

A closer look

As alleged in the March 29 complaint, the Defendants repeatedly made false and misleading public statements throughout the Class Period.

For example, signed certifications accompanying an Annual Report filed by the Company at the beginning of the Class Period stated that the Report: “did not contain any untrue statement of a material fact; or omit to state a material fact necessary to make the statements made, in light of the circumstances under which statements were made, not misleading with respect to the period covered by this report.”

Then, on another Annual Report filed with the SEC on April 15, 2015, the Company stated in pertinent part: “[the] market price of our common stock is likely to be similarly volatile, and investors in our common stock may experience a decrease, which could be substantial, in the value of their stock.”

Finally, on the same form, the Company stated in pertinent part: “On September 18, 2014, the Company entered into a cancelable 4-month agreement (the “Agreement”) to engage the services of Elite Stock Research, Inc.” However,  as the March 29 complaint alleges, the Company did not reveal at the time that it had enlisted the “boiler room operation” to “engage in a pump and dump scheme.”

Impact of the Alleged Fraud on First Choice’s Stock Price and Market Capitalization

Closing stock price prior to disclosures:

 

$1.01
Closing stock price the trading day after disclosures:

 

$0.35
One day stock price decrease (percentage) as a result of disclosures:

 

65.35%

The following chart illustrates the stock price during the class period:

 FCHS Class Action Lawsuit

Actions You May Take

If you have purchased shares during the Class Period, you may join the class action as a lead plaintiff, remain a passive class member, or opt out of this litigation and pursue individual claims that may not be available to the class as a whole.

NOTE: You must file an application to be appointed lead plaintiff prior to this deadline in order to be considered by the Court. Typically, the plaintiff or plaintiffs with the largest losses are appointed lead plaintiff.

In order to identify your potential exposure to the alleged fraud during the time in question, you may wish to perform an analysis of your transactions in First Choice common stock using court approved loss calculation methods.

Recently Filed Cases

Listed below are recently filed securities class action cases being monitored by us, along with the class period and the deadline to file a motion to be appointed as the Lead Plaintiff in the action.  Please contact us if you would like an LK report for any of these cases:

FCHS Class Action Lawsuit

About Us

Levi & Korsinsky is a leading securities litigation firm with a hard-earned reputation for protecting investors’ rights and recovering losses arising from fraud, mismanagement and corporate abuse.  With thirty attorneys and offices in New York, Connecticut, California and Washington D.C., the firm is able to litigate cases in various jurisdictions in the U.S., England, and in other international jurisdictions.

Levi & Korsinsky provides portfolio monitoring services for high-net worth investors and institutional clients.  Our firm also assists investors in evaluating whether to opt-out of large securities class actions to pursue individual claims.

For additional information about this case or our institutional services, please contact us.


ORN Lawsuit; ORN Class Action

Class Action Reports

Levi & Korsinsky Announce CRCM Lawsuit; CRCM Class Action

Levi & Korsinsky, LLP

April 26, 2019

Toussaint v. Care.com, Inc. et al 1:19-cv-10628-MLW — On April 3, 2019, investors sued Care.com, Inc. (“Care.com” or the “Company”) in United States District Court for the District of Massachusetts. Plaintiffs in the CRCM class action allege that they acquired Care.com stock at artificially inflated prices between March 27, 2015 and April 1, 2019 (the “Class Period”). They are now seeking compensation for financial losses incurred upon public revelation of the Company’s alleged misconduct during that time. For more information on the CRCM lawsuit, please contact us today!

Summary of the Allegations

Company Background

The Company (NYSE:CRCM) bills itself as “the world’s largest online family care platform.” As such, it says it provides a forum that allows families to “find, manage and pay for care and provide employment opportunities for caregivers.”

Founded in 2006, Care.com is now available in more than 20 countries globally. Since its inception, the Company claims, more than 13.4 million caregivers have joined its platform to seek employment, and more than 18.3 million families have joined to seek their services. The Company also claims that more than 1.6 million employees of its corporate clients have access to its services.

On its website, the Company maintains that it offers “a robust suite of safety tools and resources” to its users. The Company’s claims about its safety measures are at the crux of the April 3 complaint.

Summary of Facts

Care.com and two of its senior officers (the “Individual Defendants”) now stand accused of deceiving investors by lying and/or withholding critical information about the Company’s business practices during the Class Period.

Specifically, they are accused of omitting truthful information about the efficacy of Care.com’s screening measures from SEC filings. By knowingly or recklessly doing so, they allegedly caused Care.com stock to trade at artificially inflated prices during the time in question.

The truth came out in a series of events that transpired on March 8 and March 31, 2019. First, the Wall Street Journal published an article revealing that caregivers in the United States “who had police records were listed on Care.com and later were accused of committing crimes while caring for customers’ children or elderly relatives…”

Then, in an ensuing article, the Wall Street Journal reported that “hundreds of daycare centers listed as ‘state licensed’ on the Care.com website did not appear to be, and that tens of thousands of unverified daycare listings were scrubbed from the March 8, 2019 Wall Street Journal article was published.”

A closer look…

As alleged in the April 3 complaint, the Company and/or Individual Defendants repeatedly made false and misleading public statements during the Class Period.

For instance, in an annual report filed with the SEC at the beginning of Class Period, the Company stated in pertinent part: “We have invested in building a differentiated member experience for finding and managing care. Examples of these investments include… the proactive screening of certain member information against various databases and other sources for criminal or other inappropriate activity, and the use of technology to help identify and prevent inappropriate activity through our platform.”

As the complaint alleges, the Company reiterated the statement on forms filed with the SEC on four additional occasions. Furthermore, in each case, the Individual Defendants signed certifications in accordance with federal law. By doing so they attested that they had reviewed the material on the form, that it did not contain any “untrue statements,” and that the Company’s internal controls “are effective.”

Impact of the Alleged Fraud on Care.com’s Stock Price and Market Capitalization

Closing stock price prior to disclosures:

 

$19.76
Closing stock price the trading day after disclosures:

 

$18.45
One day stock price decrease (percentage) as a result of disclosures:

 

6.62%

The following chart illustrates the stock price during the class period:

 CRCM Class Action Lawsuit

Actions You May Take

If you have purchased shares during the Class Period, you may join the class action as a lead plaintiff, remain a passive class member, or opt out of this litigation and pursue individual claims that may not be available to the class as a whole.

NOTE: The deadline to file for lead plaintiff in this class action is June 3, 2019. You must file an application to be appointed lead plaintiff prior to this deadline in order to be considered by the Court. Typically, the plaintiff or plaintiffs with the largest losses are appointed lead plaintiff.

In order to identify your potential exposure to the alleged fraud during the time in question, you may wish to perform an analysis of your transactions in Care.com common stock using court approved loss calculation methods.

Recently Filed Cases

Listed below are recently filed securities class action cases being monitored by us, along with the class period and the deadline to file a motion to be appointed as the Lead Plaintiff in the action.  Please contact us if you would like an LK report for any of these cases:

CRCM Class Action Lawsuit

About Us

Levi & Korsinsky is a leading securities litigation firm with a hard-earned reputation for protecting investors’ rights and recovering losses arising from fraud, mismanagement and corporate abuse.  With thirty attorneys and offices in New York, Connecticut, California and Washington D.C., the firm is able to litigate cases in various jurisdictions in the U.S., England, and in other international jurisdictions.

Levi & Korsinsky provides portfolio monitoring services for high-net worth investors and institutional clients.  Our firm also assists investors in evaluating whether to opt-out of large securities class actions to pursue individual claims.

For additional information about this case or our institutional services, please contact us.


ORN Lawsuit; ORN Class Action

Class Action Reports

Levi & Korsinsky Announce AT&T Lawsuit; AT&T Class Action

Levi & Korsinsky, LLP

April 25, 2019

Gross v. AT&T, Inc. et al 1:19-cv-02892-VEC — On April 1, 2019, investors sued AT&T, Inc. (“AT&T” or the “Company”) in United States District Court, Southern District of New York. The AT&T class action alleges that plaintiffs acquired AT&T stock at artificially inflated prices between October 22, 2016 and October 24, 2018 (the “Class Period”); and/or or in connection with a Registration Statement associated with the Company’s June 2018 acquisition of and merger with Time Warner. Plaintiffs are now seeking compensation for financial losses incurred upon public revelation of the Company’s alleged misconduct during those times. For more information on the AT&T Lawsuit, please contact us today!

Summary of the Allegations

Company Background

The Company (NYSE: T) is a self-described “global leader in telecommunications, media, entertainment and technology.”

As such, the Company has four business units or segments. These are: AT&T Communications, WarnerMedia, AT&T Latin America, and Xandr. Collectively, the Company says, these divisions represent “the four key elements that define a modern media company,” allowing it to create and provide premium content, high-speed networks, and more.

AT&T is incorporated in Delaware and maintains its headquarters in Dallas, Texas.

Summary of Facts

AT&T, and two of its senior officers and 12 of its directors (collectively the “Individual Defendants”) are now accused of deceiving investors during the Class Period.

Specifically, they are accused of doing so by: making false and misleading statements in and/or approving of the statements made in the Registration Statement; or by making false and misleading public statements following the merger and acquisition of Time Warner.

The truth came out on October 24, 2018, when AT&T announced its results for the third quarter of 2018. These results were significant because they were the first following the acquisition of and merger with Time Warner. Alarmingly, the results reflected dramatic losses in the number of “Traditional DirecTV” satellite subscriber losses and “DirecTV Now” subscribers.

In all, the results for the quarter reflected a net loss of more than 290,000 total video subscribers. This prompted one analyst to lambast the Company, saying: “AT&T hit a brick wall when it raised TV prices.” Based on the results another analyst concluded that, “…the stock is likely dead money now.”

A closer look…

As alleged in the April 1 complaint, the Company and/or Individual Defendants repeatedly made false and misleading public statements during the Class Period.

For example, in an announcement about the acquisition made at the beginning of the Class Period, the Company said the transaction would: “[combine] Time Warner’s vast library content and the ability to create new premium content that connects audiences around the world, with AT&T’s extensive customer relationships, world’s largest pay TV subscriber base and leading scale in TV, mobile and broadband distribution.”

Then, in the Registration Statement approved by the SEC on January 5, 2017 and declared effective as of the next day, the Company touted: “yearly and quarterly growth trends in AT&T’s Entertainment Group segment, particularly Video Entertainment, including quarterly subscriber gains in its DirecTV Now services sufficient to offset any decrease in traditional satellite DirecTV subscribers…”

Finally, in a June 21, 2018 press release following the acquisition, the Company stated that it, “expects total video and broadband subscribers to increase, with DirecTV Now subscribers more than offsetting continued declines in traditional TV subscribers.”

What the Company never disclosed, however, was that it had “substantially increased prices while at the same time discontinuing promotional discounts for its DirecTV Now service.” The Company also failed to disclose that this resulted in a lack of renewals and new subscribers.

Impact of the Alleged Fraud on AT&T’s Stock Price and Market Capitalization

Closing stock price prior to disclosures:

 

$33.02
Closing stock price the trading day after disclosures:

 

$29.09
One day stock price decrease (percentage) as a result of disclosures:

 

11.90%

The following chart illustrates the stock price during the class period:

 T Class Action Lawsuit

Actions You May Take

If you have purchased shares during the Class Period, you may join the class action as a lead plaintiff, remain a passive class member, or opt out of this litigation and pursue individual claims that may not be available to the class as a whole.

NOTE: The deadline to file for lead plaintiff in this class action is May 31, 2019. You must file an application to be appointed lead plaintiff prior to this deadline in order to be considered by the Court. Typically, the plaintiff or plaintiffs with the largest losses are appointed lead plaintiff.

In order to identify your potential exposure to the alleged fraud during the time in question, you may wish to perform an analysis of your transactions in AT&T common stock using court approved loss calculation methods.

Recently Filed Cases

Listed below are recently filed securities class action cases being monitored by us, along with the class period and the deadline to file a motion to be appointed as the Lead Plaintiff in the action.  Please contact us if you would like an LK report for any of these cases:

T Class Action Lawsuit

About Us

Levi & Korsinsky is a leading securities litigation firm with a hard-earned reputation for protecting investors’ rights and recovering losses arising from fraud, mismanagement and corporate abuse.  With thirty attorneys and offices in New York, Connecticut, California and Washington D.C., the firm is able to litigate cases in various jurisdictions in the U.S., England, and in other international jurisdictions.

Levi & Korsinsky provides portfolio monitoring services for high-net worth investors and institutional clients.  Our firm also assists investors in evaluating whether to opt-out of large securities class actions to pursue individual claims.

For additional information about this case or our institutional services, please contact us.


TLGT Lawsuit; TLGT Class Action

Class Action Reports

Levi & Korsinsky Announce AMRS Lawsuit; AMRS Class Action

Levi & Korsinsky, LLP

April 24, 2019

Mulderrig v. Amyris, Inc., et al 4:19-cv-01765-YGR — On April 3, 2019, investors sued Amyris, Inc. (“Amyris” or the “Company” in United States District Court, Northern District of California. The AMRS class action alleges that plaintiffs acquired Amyris stock at artificially inflated prices between March 15, 2018 and March 19, 2019 (the “Class Period”). They are now seeking compensation for financial losses incurred upon public revelation of the Company’s alleged misconduct during that time. For more information on the AMRS Lawsuit, please contact us today!

Summary of the Allegations

Company Background

The Company (NASDAQ: AMRS) is an “integrated renewable products company “that engages in the creation and provision of” sustainably sourced product.

As such, Amyris claims that it uses “innovative ​bioscience solutions” to ​turn plant sugars into ​hydrocarbon molecules, ​specialty ingredients and ​consumer products.” These products are then used in select markets including  ​“specialty and performance ​chemicals, fragrance ​ingredients, and cosmetic ​emollients.”

Amyris is incorporated in Delaware and its headquarters are located in Emeryville, California.

Summary of Facts

The Company and two of its senior officers (the “Individual Defendants”) are now accused of deceiving investors by lying and withholding critical information about the Company’s business practices and prospects during the Class Period.

Specifically, they are accused of omitting truthful information about the efficacy of its accounting practices and internal controls over financial reporting from SEC filings and related material. By knowingly or recklessly doing so, they allegedly caused Amyris stock to trade at artificially inflated prices during the time in question.

The truth came out after the market closed on March 19, 2019, when the Company filed a form with the SEC. In it, Amyris announced that it was “in the process of completing its evaluation internal control over financial reporting and may have further deficiencies to report.” The Company also stated that it expected to “continue to report that there is substantial doubt about its ability to continue as a going concern.”

A closer look…

As alleged in the April 3 complaint, the Company and/or Individual Defendants repeatedly made false and misleading public statements during the Class Period.

For instance, on a form filed with the SEC on April 2, 2018, the Company stated in pertinent part: “Amyris, Inc. (the “Company”) was unable to file its Annual Report… within the prescribed time period without unreasonable effort and expense because of the significant time and resources the were devoted to the accounting for and disclosure of the significant transaction with Koninkliijke DSM N.V. that closed on December 28, 2017.”

Then, on another form filed with the SEC on April 17, 2018, Amyris disclosed “certain material weaknesses identified by management.”

On yet another form filed with the SEC on May 18, 2018, the Company also stated that, “the previously-identified material weakness in internal control over financial reporting had not yet been remediated.”

Finally, in a press release issued on November 13, 2018, one of the Individual Defendants stated in pertinent part: “… we are very disappointed with the volatility of the Vitamin E market and its direct impact on our third quarter revenue. Some of this shortfall is expected be [sic] made up with our core market revenue performance through year end.”

What the Company never disclosed, however, was that the actual cause of its material weakness in its internal control over financial reporting was a lack of “sufficient resources to accurately account for certain transactions.”

Impact of the Alleged Fraud on Amyris’s Stock Price and Market Capitalization

Closing stock price prior to disclosures:

 

$3.88
Closing stock price the trading day after disclosures:

 

$3.10
One day stock price decrease (percentage) as a result of disclosures:

 

20.10%

The following chart illustrates the stock price during the class period:

 AMRS Class Action Lawsuit

Actions You May Take

If you have purchased shares during the Class Period, you may join the class action as a lead plaintiff, remain a passive class member, or opt out of this litigation and pursue individual claims that may not be available to the class as a whole.

NOTE: You must file an application to be appointed lead plaintiff prior to this deadline in order to be considered by the Court. Typically, the plaintiff or plaintiffs with the largest losses are appointed lead plaintiff.

In order to identify your potential exposure to the alleged fraud during the time in question, you may wish to perform an analysis of your transactions in Amyris common stock using court approved loss calculation methods.

Recently Filed Cases

Listed below are recently filed securities class action cases being monitored by us, along with the class period and the deadline to file a motion to be appointed as the Lead Plaintiff in the action.  Please contact us if you would like an LK report for any of these cases:

AMRS Class Action Lawsuit

About Us

Levi & Korsinsky is a leading securities litigation firm with a hard-earned reputation for protecting investors’ rights and recovering losses arising from fraud, mismanagement and corporate abuse.  With thirty attorneys and offices in New York, Connecticut, California and Washington D.C., the firm is able to litigate cases in various jurisdictions in the U.S., England, and in other international jurisdictions.

Levi & Korsinsky provides portfolio monitoring services for high-net worth investors and institutional clients.  Our firm also assists investors in evaluating whether to opt-out of large securities class actions to pursue individual claims.

For additional information about this case or our institutional services, please contact us.